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ABSTRACT 
Since contrasts agents are used in magnetic resonance imaging (MRI), numerous efforts have 
been done to increase their relaxivity (parameter allowing to quantify contrast agent 
efficiency). Few years ago, the Merbach group developed the chelating agent DTTA 
(H4DTTA = diethylenetriaminetetraacetic acid = N,N’-[iminobis(ethane-2,1-diyl)]bis[N-
(carboxymethyl)glycine]), which contains when complexed with gadolinium(III) in aqueous 
solution two inner-sphere coordination sites for water molecules. This chelate unit complexed 
with gadolinium(III) presents also a relatively fast inner-sphere water exchange rate which is 
favorable for the relaxivity.  
Three types of compounds have been studied in this thesis, all of them containing the DTTA 
chelate unit. The first is considered to be the monomer and allows studying the stability of the 
chelate unit. The second is a close derivative to the metallostar compound {Fe[Gd2bpy-
DTTA2(H2O)4]3}4-, when the iron(II) central ion is replaced by a ruthenium(II) ion. The third 
is represented by the DTTA thiol derivative coated to gold nanoparticles. 
The first part of this thesis, chapter II, is thus the study of the physicochemical properties of 
the DTTA chelating moiety. For this purpose, the methylated derivative H4DTTA-Me (N,N’-
[(methylimino)bis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine]) was synthesized. 
Protonation and deuteration constants of the ligand were determined in an aqueous solution 
by potentimetry and 1H NMR pH titration and compared to various DTTA derivatives. 
Stability constants were measured for the chelates formed with Gd3+ (log KGdL = 18.60 ± 
0.10) and Zn2+ (log KZnL = 17.69 ± 0.10). A novel approach of determining in a direct way the 
relative conditional stability constant of two paramagnetic complexes by 1H NMR 
relaxometry is presented and was used for the Gd3+ complexes [Gd(DTTA-Me)(H2O)2]- (L1) 
and [Gd(DTPA-BMA)(H2O)] (L2) [
 
K
L1/ L2
* (at pH 8.3, 25°C) = 6.4 ± 0.3]. The transmetalation 
reaction of the Gd3+ complex with Zn2+ in phosphate buffer solution (pH 7.0) was measured 
to be twice as fast for [Gd(DTTA-Me)(H2O)2]- in comparison to that for [Gd(DTPA-
BMA)(H2O)]. This can be rationalized by the higher affinity of Zn2+ toward DTTA-Me4- if 
compared to DTPA-BMA3-. The formation of a ternary complex with L-lactate, which is 
Abstract 
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common for DO3A-based heptadentate complexes, has not been observed for [Gd(DTTA-
Me)(H2O)2]- as monitored by 1H NMR relaxometric titrations. From the results, it was 
concluded that the heptadentate DTTA-Me4- behaves similarly to the commercial octadentate 
DTPA-BMA3- with respect to stability. Considering recent suspicions against [Gd(DTPA-
BMA)(H2O)] for being involved in Nephrogenic Systemic Fibrosis (NSF) disease, DTTA-
type chelates will not be admitted as contrast agents in clinical MRI. However, their use in 
vitro and in animal studies is absolutely conceivable, mainly at high magnetic fields, where 
the increase of inner-sphere-coordination water actually seams to be the only promising way 
to increase the relaxivity markedly.  
The second part of this thesis, chapter III, presents the synthesis in aqueous solution and the 
magnetic and optical properties of the Ru(II)-based metallostars Na4{Ru[Ln2bpy-
DTTA2(H2O)4]3} (Ln = Y, Gd, and Eu). The synthesis and the purification of the new, highly 
stable heptametallic entities have been optimized for the diamagnetic Y3+ complex and 
followed by 1H NMR. The europium(III) ruthenium-based metallostar {Ru[Eu2bpy-
DTTA2(H2O)4]3}4- displays sensitized 5D07FJ luminescence upon excitation of the tris-(2,2’-
bipyridyl)ruthenium(II) unit in both the ultraviolet around 293 nm, as well as in the visible 
around 450 nm (1MLCT state). NMRD profiles at two temperatures (25°C and 37°C) were 
measured on the {Ru[Gd2bpy-DTTA2(H2O)4]3}4-. NMRD profiles of the ruthenium-based 
{Ru[Gd2bpy-DTTA2(H2O)4]3}4- and iron-based {Fe[Gd2bpy-DTTA2(H2O)4]3}4- metallostars 
were fitted with SBM theory coupled to the model-free Lipary-Szabo method for internal 
motion as well as with the modified Florence approach. Comparison of both fitting methods 
shows that the Florence approach is able to fit NMRD profiles up to 100 MHz, fails however 
at higher frequencies because it does not account for internal motion. Overall, the results 
detailed point to the heptametallic self-assembled edifices being potential relaxivity and 
luminescence bimodal bioprobes. 
The third part of this thesis, chapter IV, is devoted to nano objects. We developed small, 
water-dispersible, stable nanoparticles covalently linked to Ln-DTTA derivative complexes 
(with Ln=Gd and Y) on the surface. Characterizations of these DTTA thiol capped gold 
nanoparticles (Gd-DtNP) using TEM images, dynamic light scattering technique and STEM 
with EDX analysis indicate 1.5-15.5 nm particle diameters, coated by Ln-Dt complexes on 
the surface. Molecular modeling shows a rough distance in the range of 1.3 nm between the 
lanthanide(III) ion and gold core surface and the structure that possess Ln-DtNP offers to 
  Abstract 
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lanthanide(III) a tightly bonding on the surface of particles. Accurate Au, Gd and Y 
concentrations have been determined by ICP-MS technique. Bulk magnetic susceptibility of 
samples with different gadolinium concentration has been established following the Evans 
method and no significant magnetic contribution can be attributed to the gold core. NMRD 
profiles of Gd-DtNP at 25°C show very high relaxivities and present broad relaxivity humps 
indicating very large systems with slow rotational motion. The modified Florence approach 
allows fitting well the experimental NMRD profil of Gd-DtNP, and the fitted electronic 
relaxation parameters are in good coherence with what was expected from the Ru-based 
metallostar values. Our Gd-DtNP systems are very rigid nano-object.  
 
Key words: MRI, gadolinium(III), relaxivity, synthesis, DTTA, DTTA-Me, Metallostar, 
ruthenium(II), gold, nanoparticle, contrast agent. 
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RÉSUMÉ 
Depuis l’utilisation d’agents de contraste en imagerie par résonance magnétique (IRM), de 
nombreux efforts sont dirigés vers l’augmentation de la relaxivité (paramètre qui permet de 
quantifier l’efficacité d’un agent de contraste). Il y a maintenant quelques années, le groupe 
Merbach a mis au point l’agent chélatant DTTA (H4DTTA = acide diethylène triaminetetra 
acétique = N,N’-[iminobis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine]) qui laisse, 
lorsqu’il est complexé au gadolinium(III) en milieu aqueux, deux sites de coordination en 
première sphère pour des molécules d’eau. Cette unité chélatante a de plus une vitesse 
d’échange d’eau en première sphère assez rapide, ce qui est favorable à la relaxivité.  
Trois types de composés ont été étudiés dans cette thèse, tous trois contenant l’unité 
chélatante DTTA. Le premier, le plus petit, est considéré comme le monomère et permet 
d’étudier la stabilité de l’unité chélatante. Le deuxième est un dérivé du composé métallostar 
{Fe[Gd2bpy-DTTA2(H2O)4]3}4-, ou le fer central a été remplacé par un ion ruthénium(II). Le 
troisième est représenté par des nanoparticules d’or contenant à la surface des dérivé thiolé de 
cette unité chélatante. 
La première partie de la thèse, le chapitre II, est donc l’étude des propriétés physico-
chimiques de l’unité chelatante DTTA, et ceci à l’aide du dérivé méthylé synthétisé H4DTTA-
Me (N,N’-[(methylimino)bis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine]). Les constantes 
de protonation et de deutération du ligand ont été déterminées en solution aqueuse par 
potentiométrie et par titration pH en utilisant la RMN du proton. Ces constantes ont été 
comparées à d’autres dérivés DTTA. Les constantes de stabilité ont été mesurées pour des 
complexes formés avec l’ion gadolinium(III) (log KGdL = 18.60 ± 0.10) et le ion zinc(II) (log 
KZnL = 17.69 ± 0.10). Une nouvelle approche est présentée pour la détermination de manière 
directe d’une constante conditionnelle de stabilité relative de deux complexes 
paramagnétiques par RMN du proton et a été utilisée pour les complexes [Gd(DTTA-
Me)(H2O)2]- (L1) et [Gd(DTPA-BMA)(H2O)] (L2) [
 
K
L1/ L2
* (à pH 8.3, 25°C) = 6.4 ± 0.3]. La 
réaction de transmétallation pour le complexe de [Gd(DTTA-Me)(H2O)2]- avec du Zn2+ dans 
une solution tamponnée phosphate (pH 7.0) a été mesurée et s’est révélée deux fois plus 
Résumé  
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rapide que pour le complexe de [Gd(DTPA-BMA)(H2O)]. Ceci peut être rationalisé par une 
plus grande affinité du zinc(II) pour le ligand DTTA-Me4- en comparaison au ligand DTPA-
BMA3-. La formation du complexe ternaire avec un L-lactate, observé par titration 
relaxométrique en RMN du proton n’a pas été observée pour le complexe [Gd(DTTA-
Me)(H2O)2]-, mais est courante pour les complexes heptadentés basés sur le DO3A. Ces 
résultats indiquent que la stabilité du ligand heptadenté DTTA-Me4- est similaire à l’octadenté 
commercial DTPA-BMA3-. En considérant les récentes suspissions sur le [Gd(DTPA-
BMA)(H2O)] quant à son implication dans la maladie de fibrose systémique néphrogénique, 
les chélates du type DTTA ne seront pas admis comme agents de contrast en IRM clinique. 
Toutefois, l’utilisation du complexe [Gd(DTTA-Me)(H2O)2]- comme agent de contraste en 
condition in vitro et animale est tout à fait concevable, principalement à haut champs, où 
l’augmentation du nombre de molécules d’eau en première sphère de coordination du 
gadolinium(III) semble être la meilleure voie pour augmenter la relaxivité. 
La deuxième partie de la thèse, le chapitre III, présente la synthèse en solution aqueuse du 
composé ruthénium(II) du Metallostar Na4{Ru[Ln2bpy-DTTA2(H2O)4]3} (Ln = Y, Gd, et Eu), 
ainsi que ces propriétés magnétiques et optiques. La synthèse et la purification de cette 
nouvelle entité heptamétallique ont été optimisées sur le complexe yttrium(III) et suivi par 
RMN du proton. Le complexe europium(III) {Ru[Eu2bpy-DTTA2(H2O)4]3}4- présente une 
transition de type 5D07FJ après excitation de l’unité tris-(2,2’-bipyridyl)ruthenium(II) 
luminescent aux deux longueurs d’onde suivantes : dans l’ultraviolet autour de 293 nm, et 
dans le visible autour de 450 nm (état 1MLCT). Les profils NMRD ont été effectués sur le 
complexe {Ru[Gd2bpy-DTTA2(H2O)4]3}4- à deux températures (25°C et 37°C). Les fits des 
profils NMRD des Metallostars du ruthénium(II) {Ru[Gd2bpy-DTTA2(H2O)4]3}4- et du fer(II) 
{Fe[Gd2bpy-DTTA2(H2O)4]3}4- ont été effectués à l’aide de la théorie de Solomon-
Bloembergen-Morgan (S-B-M) couplée au model développé par Lipary-Szabo, et de 
l’approche modifiée de Florence. La comparaison des deux methodes de fit indique que 
l’approche modifiée de Florence est la seule capable de fitter les profiles NMRD correctement 
jusqu’à 100 MHz, mais échoue par contre à des champs plus élevés car elle ne prend pas en 
compte les mouvements internes. Parmi tous les résultats présentés dans le chapitre III, nous 
avons réussi à démontrer que le ruthénium(II) Metallostar est un object heptamétallique auto-
assemblé ayant un potentiel comme agent bimodal (magnétique et luminescent).  
  Résumé 
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La troisième partie de la thèse, le chapitre IV, se concentre sur des objects nanoparticulaires. 
Nous avons développé de petites nanoparticules, stables et solubles en solution aqueuse, liées 
de manière covalente à des complexes contenant l’unité chélatante [Ln(DTTA)(H2O)2]- avec 
Ln=Gd et Y. La caractérisation de ces nanoparticules entourées de DTTA thiolés (Ln-DtNP) a 
été effectuée en utilisant des images TEM, la technique de diffusion dynamique de la lumière 
(DLS) et le STEM avec analyse EDX, et indique des diamètres de 1.5-15.5 nm et la présence 
des complexes Ln-Dt à la surface des nanoparticules. La modélisation moléculaire indique 
une distance d’environ 1.3 nm entre les centres lanthanides et la surface des nanoparticules et 
que la structure des nano-objects Ln-DtNP offre aux centres lanthanide(III) un environnement 
de grande promiscuité. Grâce à la technique de l’ICP-MS (induced coupled plasma–mass 
spectrometry), les concentrations d’or, de gadolinium et d’yttrium ont été établies avec 
précision. La susceptibilité magnétique du bulk de solutions de Gd-DtNP de différentes 
concentrations a été établi à l’aide de la méthode d’Evans. Nous n’avons pas observé de 
contribution magnétique significative provenant des corps d’or. Les profils NMRD à 25°C 
indiquent de très grandes relaxivités, jusqu’à haut champs (< 200 MHz) et indiquent une large 
bosse à moyen-haut champs, montrant la présence de très grands systèmes ayant un 
mouvement rotationel lent. L’approche modifiée de Florence permet de fitter correctement les 
points expérimentaux du profil NMRD du composé Gd-DtNP(1). Les paramètres 
électroniques de fit sont cohérents avec ceux obtenus pour les Metallostars. Nos systèmes Gd-
DtNP sont de très rigides nano-objets.  
 
Mots clés: IRM, gadolinium(III), relaxivité, synthèse, DTTA, DTTA-Me, Metallostar, 
ruthénium(II), or, nanoparticule, agent de contraste. 
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SYMBOLS AND ABBREVIATIONS 
Chemical formulas 
AIBN azobisisobutyronitrile 
BEATA4- N,N-bis(2-aminoethyl)aniline-N’,N’,N’’,N’’-tetraacetate 
BEBTA4- [(benzylimino)bis(ethylenenitrilo)]tetraacetate 
bpy bipyridine 
DO3A3- 1,4,7,10-tetraazacyclododecane-N,N’,N’’-triacetate 
DOTA4- 1,4,7,10-tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetate 
DTPA5- diethylenetriamine-N,N,N’,N’’,N’’-pentaacetate 
DTPA-BMA3- 1,7-bis[(N-methylcarbonyl)methyl]-1,4,7-triazaheptane-1,4,7-triacetate 
DTTA4- diethylenetriamine-N,N,N’’,N’’-tetraacetate 
DTTA-Me4- N,N’-[(methylimino)bis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine] 
DTTA-prop5- diethylenetriamine-N,N,N’’,N’’-tetraacetic-N’-propionic acetate 
DPTPA5- dipropylenetriamine-N,N,N’,N’’,N’’-pentaacetate 
EDTA4- 1,2-ethylenediamine-N,N,N’,N’-tetraacetate 
EGTA4- ethylenebis(oxyethylenenitrilo)tetracetate 
EPTPA5- ethylenepropylenetriamine-N,N,N’,N’’,N’’-pentaacetate 
EPTPA-bz-NO25- (p-nitrobenzyl) ethylenepropylenetriamine-N,N,N’,N’’,N’’-pentaacetate 
HEPES 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid) 
HSA human serum albumin 
mX(DTTA)28- bis(diethylenetriamine-N,N,N’’,N’’-tetraacetate)-m-xylene 
PAAHC polyallylamine hydrochloride 
PAMAM poly(amidoamine) 
PAN polyacrylonitril 
PBS phosphate buffered saline 
PVP poly-N-vinyl-2-pyrrolidone 
pX(DTTA)28- bis(diethylenetriamine-N,N,N’’,N’’-tetraacetate)-p-xylene 
SDBS sodium dodecylbenzenesulphonate 
TETA4- 1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetate 
terpy 2,2’:6’,2’’-terpyridine 
tpy-DTTA4- 4’-(diethylenetriamino-N’,N’,N’’,N’’-tetraacetate)-2,2’:6’,2’’-terpyridine 
TTAHA N-tris(2-aminoethyl)amine-N’,N’,N’’,N’’,N’’’,N’’’-hexaacetate 
Experimental techniques 
DLS Dynamic Light Scattering 
EPR Electron Paramagnetic Resonance 
ESI-MS ElectroSpray Ionization – Mass Spectrometry 
ICP-MS Inductive Coupled Plasma – Mass Spectrometry 
MRI Magnetic Resonance Imaging 
MRT Magnetic Resonance Tomography 
NMR Nuclear Magnetic Resonance 
Symbols and abbreviations 
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NMRD Nuclear Magnetic Relaxation Dispersion 
STEM Scanning Transmission Electron Microscopy 
TEM Transmission Electron Microscopy 
UV-Vis Ultra-Violet-Visible 
XAFS X-ray Absorption Fine Structure 
Symbols 
ħ Planck’s constant divided by 2π 
A/ ħ hyperfine or scalar coupling constant 
aGdH distance of closest approach of bulk water protons to the GdIII centre 
B magnetic field 
COS outer sphere constant 
CO cuboctahedron 
Ddiff298 constant for intermolecular translational diffusion 
DH hydrodynamic diameter 
DGdH diffusion coefficient 
DtNP DTTA thiol capped gold nanoparticles 
EDGdH activation energy for the diffusion 
ER activation energy for the rotational correlation time 
Ev activation energy for the modulation of the ZFS 
fcc Face-centered cubic 
gL isotropic Landé factor 
h Planck’s constant 
I nuclear spin 
kB Boltzmann constant 
kex water exchange rate 
Ki thermodynamic protonation constant 
KiD thermodynamic deuteration constant 
KL1/L2* conditional relative stability constant 
KML thermodynamic stability constant 
KML* conditional stability constant 
LD50 lethal dose of a substance which leads, given in a single dosis, to the death 
of 50% of a population 
NA Avogadro’s number 
NSF nephrogenic systemic fibrosis 
P pressure 
Pm mole fraction of bound water 
pO2 oxygen partial pressure 
q hydration number 
R perfect gas constant 
R1(2) longitudinal (transverse) relaxation rate 
r1(2) longitudinal (transverse) proton relaxivity 
rGdH effective Gd
III electron spin-water protons distance 
rGdO mean gadolinium(III)-oxygen distance 
S electron spin 
S2 degree of spatial restriction of the local motion 
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SPIO superparamagnetic iron oxide 
T temperature 
T1(e) (electronic) longitudinal relaxation time 
T1(2)m longitudinal (transverse) relaxation time of a bound water molecule 
T2(e) (electronic) transverse relaxation time 
TO truncated octahedron 
ZFS zero field splitting 
Δ2 trace of square of the ZFS tensor 
ΔH‡ activation enthalpy for the water exchange 
ΔHpp peak-to-peak EPR linewidth 
Δs2 static ZFS parameter 
Δt2 transient ZFS parameter 
Δx 
1H-NMR shift observed between two proton NMR signals 
χ quadrupolar coupling constant 
γI nuclear gyromagnetic ratio 
γS electronic gyromagnetic ratio 
η - asymmetry parameter (quadrupolar relaxation) 
- viscosity (Debye-Stokes equation) 
µ0 vacuum permeability 
µB Bohr magneton 
µeff effective magnetic moment 
ν frequency 
τg correlation time of the slow global motion 
τl correlation time of the rapid local motion 
τm mean residence time of a bound water molecule 
τRH rotational correlation time for the Gd
III-Hwater vector 
τRO rotational correlation time for the Gd
III-Owater vector 
τv correlation time for the modulation of the ZFS 
ω angular frequency 
ωI proton resonance frequency 
ωm chemical shift difference between bound and bulk water 
ωS Larmor frequency of the S spin 
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I.1 MAGNETIC RESONANCE IMAGING : OVERVIEW 
I.1.1 Magnetic Resonance Imaging (MRI) 
Magnetic resonance imaging (MRI) is known as a harmless and non-invasive diagnostic 
imaging technique, allowing images of biological tissues having substantial populations of 
atomic nuclei that are susceptible to nuclear magnetic resonance (NMR). Magnetic resonance 
imaging is also known as magnetic resonance tomography (MRT).  
Magnetic resonance imaging has proven to be a useful technology both for the detection and 
diagnosis of human disease as well as for research into the understanding of basic animal 
physiology. MRI is well suited to the visualization of soft tissues and is primarily used for 
diagnosing disease pathologies and internal injuries. 
In general, magnetic resonance imaging is a technique of applying a gradient magnetic field 
and a radio frequency (RF) wave to a subject in a static magnetic field, producing an image 
based on magnetic resonance signals emitted from protons in a region examined. (Figure I.1-
1) MRI systems include a super conducting magnet capable of producing a strong, 
homogenous magnetic field; a radio frequency (RF) transmitter and receiver system; a 
gradient coil system, all three surrounding the patient; and a computer receiving the signals 
from the receiver coil and processing the signals into images.  
MRI utilizes hydrogen nuclear (proton) spins of the water molecules in the human body, 
which are polarized by the strong static homogenous magnetic field generated by the magnet. 
The reason is that the human body is primarily water and fat. Water and fat have many 
hydrogen atoms that make the human body approximately 63% hydrogen atoms. Moreover, 
given that hydrogen nuclei have 99.985% natural abundance and are very sensitive in NMR, 
magnetic resonance imaging thus images the NMR signal of the hydrogen nuclei. 
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Figure I.1-1: MRI scanner. Superconducting magnet surrounded by liquid 
helium lines up the water protons inside the body and the radio transceiver 
causes the water protons to flip on their axes.1 
More precisely, when the high frequency magnetic field is applied to the subject placed in the 
homogeneous static magnetic field, it excites proton nuclear spins within the patient's tissues. 
The excited proton spins rotate at a rate dependent upon the static magnetic field. As they flip, 
they emit radio frequency signals, referred as magnetic resonance signals. MRI detects these 
nuclear magnetic resonance (NMR) signals given off by protons after excitation. The detected 
signals are functions of the tissue and the strength of the magnetic field. By applying 
magnetic field gradients (Figure I.1-2) so that the magnitude of the magnetic field varies with 
location within the patient's body, the magnetic resonance phenomenon can be limited to only 
a particular region, or slice, of the patient's body, so that all of the detected magnetic 
resonance signals come from that slice.  
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Figure I.1-2: MRI Scanner gradient magnets, modifying the magnetic field 
at very particular points (voxel). Work in conjunction with the radio 
frequency (RF) pulses to produce the scanner’s picture by encoding the 
spatial distribution of the water protons.1 
The signal intensity of a volume element, a voxel, composing the slice depends not only on 
the quantity of protons present in this voxel but also on the ability the protons have to return 
to the equilibrium state after being excited with the radio frequency pulse, that means their 
relaxation properties. The return of excited nuclei from the high-energy state to the low 
energy or ground state is associated with loss of energy to the surrounding nuclei. 
Macroscopically, relaxation can be characterized by the longitudinal return of the 
magnetization to its ground state in the direction of the main magnetic field. In this thesis, we 
will be focused in so-called T1-contrast agent. The T1 longitudinal relaxation time is the time 
for the magnetization to return to 63% of its original value. Spins are considered completely 
relaxed after 3-5 T1 times. T1 relaxation is fastest when the motion of the nucleus (rotations or 
"tumbling rate" and translations) matches the Larmor frequency. As a result, T1 relaxation is 
dependent on the main magnetic field strength that specifies the Larmor frequency. Higher 
magnetic fields are often associated with longer T1 times.  
Different tissues have different T1 values. For example, fluids have long T1 (1500-2000 ms), 
and water based tissues are in the 400-1200 ms range, while fat based tissues are in the 
shorter 100-150 ms range. The contrast of the image is provided by the intensity differences 
between the voxels. The 2D image is composed of pixels which intensities are proportional to 
the signal intensity of the corresponding voxel. Images of soft tissues in the body like 
muscles, spinal cord or brain (Figure I.1-3 and I.1-4), are normal outcomes of an MRI 
examination.  
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Figure I.1-3: T1-weighted MRI images of the brain and skull – Transverse 
sections.2 
 
Figure I.1-4: T1-weighted MRI images of the brain and skull – Sagittal 
sections.2 
The duration of a MRI examination may be painful and the contrast between the tissues and 
in particular between healthy and diseased tissues might be not sufficient to ensure the early 
detection of a tumor. Thus, in many cases, the successful use of MRI would not have been 
possible without a class of pharmacological products, called contrast agents. The role of the 
contrast agent is to accelerate the relaxation of the surrounding protons, allowing reducing the 
examination time and improving the contrast of the image. 
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I.1.2 Gd(III)-complexes as MRI contrast agents 
The effectiveness of an MRI contrast agent is usually measured in terms of relaxivity; the 
paramagnetic enhancement of the longitudinal relaxation rate of water protons in presence of 
1 mM paramagnetic ion concentration. Agents based on Mn2+, Mn3+, Fe3+ and Cu2+ 
paramagnetic ions have been studied, but Gadolinium (III) complexes are far the most widely 
used contrast media in clinical practice.3 This choice is explained by the fact that the 
lanthanide Gd3+ ion has seven unpaired electrons, which make it the most paramagnetic metal 
ion, and has also a relatively slow electronic relaxation, optimizing the relaxation 
enhancement of surrounding protons.  
 
Figure I.1-5: MR images of a human brain before (A) and after (B) injection 
of a Gd3+ contrast agent. 
The free gadolinium (III) ion cannot be injected however into living organisms as it induces 
toxicity in many ways. Gadolinium (III) can form hydroxo complexes and precipitate at 
physiological pH. It can also replace other metal ions in enzymes, or may interfere in Ca2+ 
regulated signal transmission processes due to its similar size to calcium(II). (LD50 values for 
free Gadolinium (III) are in the range of 0.1-2 mmol/kg)  
The requirement of being non-toxic imposes Gadolinium (III) ions to be complexed, and 
given that lanthanide complexes are predominantly of ionic nature, stable complex can be 
achieved only with multidentate ligands as poly(aminocarboxylates). Thermodynamic 
stability and kinetic inertness of these complexes become thus the most important criteria for 
safe in vivo applications. 
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I.1.3 Thermodynamic stabilities 
The thermodynamic stability constants KML of a Gd3+ complex, which is related to its safety 
as MRI contrast agent, are most often determined by pH-potentiometric titration. Given the 
protonation constants of the ligand are necessary for calculation of the complex stability 
constant, the ligand is titrated in the presence and absence of metal ions. Potentiometric 
titration technique works well when equilibrium is reached rapidly which is usually the case 
for linear ligands. For macrocyclic compounds, such as DOTA, complex formation is very 
slow and other technique as batch method4, 5 is used instead of direct titration. The 
protonation order of the donors groups of the ligands and protonation constants Ki can be 
calculated as well according to 1H NMR titration curve. 
In vivo toxicity and complex stability correlation is an important question in contrast agent 
field. Endogenously, Gd3+ complex, free ligand and free metal can each participate in many 
side reactions. For instance, Gd3+ complexes can interact with endogenous metal ions 
following transmetallation process, inducing replacement of endogenous metal by Gd3+ in 
metabolic process. Conditional stability constants KML* at physiological pH, which are 
correlated to the selectivity of a given ligand for Gd3+ over endogenous metals, are thus 
widely used to compare the behavior of different complexes. Based on simple model, Laurent 
and al. 6 studied the physicochemical properties of clinical low molecular weight gadolinium 
contrast agents under identical experimental conditions, in three different media (pure water, 
zinc(II)-containing aqueous solutions and HSA-containing solutions). Osmolality, viscosity 
and stability versus transmetallation by zinc(II) ions were carried out for more comprehensive 
description. Terreno et al. 7 describe also a multinuclear NMRD relaxometry study of ternary 
adducts formed between heptadentae Gd3+ chelates and L-lactate. Several models have been 
proposed in the literature also to simulate coordination equilibria in the blood plasma. 8-10 
I.1.4 Paramagnetic relaxation enhancement (PRE) theory 
Randomly fluctuating magnetic fields cause relaxation of excited proton spins. The 
longitudinal T1 relaxation time representing the spin-lattice relaxation is the time for the NMR 
signal to recover 63% of its initial value. The name spin-lattice relaxation refers to the fact 
that the spins give the energy they obtained from the radio-frequency pulse back to the 
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surrounding lattice in order to restore their equilibrium state before being flipped into the 
magnetic transverse plane and thus characterizes the rate at which the longitudinal Mz 
component of the magnetization vector recovers. 
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The important source of randomly fluctuating fields comes from the unpaired electrons of the 
paramagnetic metal center. The paramagnetism of a compound can affect nuclear spins by 
inducing chemical shifts and by increasing the nuclear relaxation rates. Depending on the 
paramagnetic substance, it can be used as an effective shift or relaxation reagent. For instance, 
Tm(III) and Dy(III) complexes have been applied as 23Na shift reagents11 and Gd(III) 
complexes are used as contrast agent in MRI.3  
Relaxation and chemical shift mechanisms induced by paramagnetic species 
In general terms, a paramagnetic species can induce a nuclear spin relaxation and a chemical 
shift in nuclear resonance frequencies via three general mechanisms: the diamagnetic, the 
bulk susceptibility and the hyperfine mechanisms.  
Diamagnetic shifts are generally related to the induced shifts in nuclei of a ligand during 
complex formation with a metal ion. The diamagnetic shift is that which would have been 
observed if the metal contained no unpaired electrons. The diamagnetic contributions in 
comparison with the paramagnetic contributions are usually small and may often be 
neglected.  
The second mechanism, the bulk magnetic susceptibility, originates from the partial 
alignment of the magnetic moments of the paramagnetic species by the magnetic field. 
Because of this partial alignment, the bulk magnetic susceptibility of an entire sample is 
affected. The use of an inert molecule allows the determination of the influence of a 
paramagnetic compound on the chemical shifts considering only the bulk magnetic 
susceptibility. 12 To this chemical shift mechanism corresponds the Curie relaxation 
mechanism.13 
The third chemical shift mechanism is the hyperfine one. There are two components of the 
hyperfine shift, the contact (or scalar) contribution and the dipolar (or pseudo-contact) 
contribution. Both of the hyperfine mechanisms require an interaction either through bond 
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(contact) or through space (dipolar) between the paramagnetic center and the atom, which 
bears the nuclear spin. To these two main chemical shift mechanisms correspond the scalar 
and dipolar relaxation mechanisms.  
Relaxivity r1 
The paramagnetic relaxation enhancement (PRE) of a contrast agent is characterized by the 
relaxivity r1, which represents the enhancement of the free water proton longitudinal 
relaxation rate R1para = 1/T1,para per mM of paramagnetic element.  
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The enhancement is due to the modulation of through-space dipole-dipole interactions 
between the unpaired electron spin of the paramagnetic ion and hydrogen nuclei. For 
convenience, the relaxivity r1 can be separated into an inner sphere (water molecule(s) 
directly coordinated to the Gd(III) centre) and an outer sphere (bulk water diffusing close 
around the paramagnetic compound) contribution. The inner-sphere relaxivity is due to 
interaction between protons of the water molecule bound in the first coordination sphere of 
the Gadolinium (III) complex and the unpaired electron spin of the paramagnetic ion. The 
outer-sphere relaxivity is more a consequence of through-space interaction with protons 
outside the first coordination shell. From the inner sphere water contribution, the 
enhancement of the longitudinal relaxation rates of the hydrogen bulk water nuclei due to the 
exchange with the inner sphere water is given by equ. I.1-3: 
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The inner sphere contribution is directly proportional to the mole fraction of bound water, Pm, 
which is itself directly proportional to the concentration of the Gd3+ center and the number of 
water molecules coordinated to the paramagnetic ion, q. The inner sphere contribution is also 
inversely proportional to the sum of the mean of residence lifetime of the coordinated water 
molecules τm (τm = 1/kex, where kex is the exchange rate constant) and their longitudinal 
relaxation time T1m. T1m is governed mainly by field dependent dipolar relaxation mechanism 
but also slightly by the scalar relaxation mechanism. However, since the protons of the 
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coordinated water are relatively far from the paramagnetic centre, the scalar relaxation 
mechanism represents only a neglibible contribution to the overall relaxation mechanism of 
the first sphere coordinated water molecule. In considering only the dipolar contribution and 
ignoring the scalar contribution to longitudinal proton relaxation, the longitudinal relaxation 
time of the coordinated water T1m is described (Solomon, Bloembergen theory14) as: 
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where rGdH is the effective distance between the gadolinium electron spin and the water 
protons (fixed to 3.1 A), γΙ is the nuclear gyromagnetic ratio of the proton (γΙ = 2.765 x 10
8 rad 
s-1 T-1), γs is the electronic gyromagnetic ratio (γs = 1.76 x 1011 rad s-1 T-1), ωI is the proton 
resonance frequency and J(ωi ; τdiH) are the spectral density functions depending on τdiH, 
which is the global correlation time described as: 
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τm, as described before, is the mean of residence lifetime of the coordinated waters (τm = 
1/kex, where kex is the exchange rate), τR is the rotational correlation time of the Gd3+ – Hwater 
vector of the complex and Tie (τS) are the Gd3+ longitudinal and transverse electronic 
relaxation time. 
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Figure I.1-6: Relaxivity of a T1 contrast agent: influence of various 
parameters.15  
The kinetic behavior of particles is in general described by correlation functions. Spectral 
density functions J(ω;τdiH) are obtained from these correlation functions by Fourier transform. 
Assuming exponential behavior for the correlation functions leads a Lorentzien function for 
the spectral density functions. For instance, in considering high molecular weight molecules, 
the spectral density function when the tumbling is not fast enough compared to the resonance 
frequency (non-extreme narrowing condition) is expressed by: 
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In the so-called extreme narrowing conditions (ω2τ2<<1), the spectral density function is 
simplified as: 
J
n
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Rotation is often assumed to be isotropic, however for large flexible molecules with slow 
rotation this may not be valid. Anisotropic rotation or internal motion within a molecule 
reduces the correlation time from that predicted by an isotropic model based on molecular 
weight. Lipari and Szabo16, 17 propose to distinguish two statistically independent motions, a 
local motion with a correlation time τl and a global motion with a correlation time τg. The 
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general order parameter F (called usually S2) describes the degree of spatial restriction of the 
local motion. If the local motion is isotropic, F=0; if the rotational dynamics is only governed 
by the global motion, F=1. 
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1H NMR dispersion (NMRD) fit 
The variation of relaxivity r1 as a function of the external magnetic field is called nuclear 
magnetic relaxation dispersion (NMRD). For years, fits of 1H NMRD profiles were 
performed with the electronic relaxation part treated following the Solomon-Bloembergen-
Morgan (SBM) theory14, 18, 19 together with the Lipari-Szabo model-free approach16, 17 for 
internal rotation consideration (SBM-LS). In this approach the electron spin relaxation rates, 
1/Tie, are due to the time dependent transient zero-field-splitting (ZFS) and no static ZFS is 
considered. It can be seen from numerous publications20-24 that SBM theory is not accurately 
able to reproduce the flat dispersion at Larmor frequencies between 0.5 and 8 MHz.  
A new approach, the "modified Florence method"25 has been developed by Bertini et al.26 and 
Kruk et al.27. This approach assumes a slow reorientation of the paramagnetic complex, a lack 
of correlation between the rotation and translation of the complex and the electron spin 
dynamics and includes a transient and a static ZFS.27 The electron spin relaxation uses the 
pseudorotation model for the modulation of the transient ZFS and is described by a Redfield 
formulation. It has been shown that the "modified Florence method" is well-suited for fitting 
experimental NMRD profiles for slowly-rotating complexes of Gd3+.25 In general, NMRD 
profiles are well fitted up to 100 MHz. At higher frequencies the modified Florence approach 
can underestimate the relaxivities because it assumes rigid molecules and neglects internal 
motion. The Lipari-Szabo model-free approach16, 17 is not yet implemented in the modified 
Florence approach. 
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I.1.5 Nanoparticles 
Magnetic resonance imaging has proven to be an enormously useful technology both for the 
detection and diagnosis of human disease as well as for research into the understanding of 
basic animal physiology. MRI is well suited to the visualization of soft tissues and is 
primarily used for diagnosing disease pathologies and internal injuries, but its non-ability to 
detect the very small tumors is explained by a lack of sensitivity that is inherent to the MRI 
process, which detects the difference between malignant and normal tissue.  
Due to their physical properties and ability to function at the cellular and molecular level of 
biological interations, nanoparticles are being actively investigated as next generation of 
magnetic resonance imaging contrast agents28 and as carriers for targeted drug delivery29, 
with a wide range of applications in the detection, diagnosis, and treatment of illnesses, such 
as cancer30 and cardiovascular disease.31  
The ability of nanoparticles to enhance proton relaxation of specific tissues and serve as 
magnetic resonance imaging contrast agents have been actively investigated mainly as T2-
contrast agents in the form of superparamagnetic iron oxides (SPIO) for over two decades, 
with applications such as liver/spleen imaging (i.e., Endorem® and Feridex IV®).32-36 
A significant challenge associated with the application of these nanoparticles systems is their 
behavior in vivo. The efficacy of these systems is often compromised due to recognition and 
clearance by the reticuloendothelial system and by their non-ability of overcoming biological 
barriers. To increase the effectiveness of these nano-objects, several techniques are under 
study, including reducing the size or incorporating novel cores, coating materials and 
functional ligands to improve the detection and specific delivery of these nanoparticles.  
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I.2 SCOPE OF THE THESIS 
Since contrasts agents are used in magnetic resonance imaging (MRI), numerous efforts have 
been undertaken to increase their relaxivity (parameter allowing to quantify contrast agent 
efficiency). Few years ago, Merbach group developed the chelating agent DTTA (H4DTTA = 
diethylenetriaminetetraacetic acid = N,N’-[iminobis(ethane-2,1-diyl)]bis[N-(carboxymethyl) 
glycine]), which contains when complexed with gadolinium(III) in aqueous solution two 
inner-sphere coordination sites for water molecules. This chelate unit complexed with 
gadolinium(III) presents also a relatively fast inner-sphere water exchange rate which is 
favorable for the relaxivity.  
Three compounds will be studied in this thesis, all of them containing the DTTA chelate unit.  
The first, the smallest, is the methylated derivative H4DTTA-Me (N,N’-
[(methylimino)bis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine]). This compound, 
considered as the monomer, will allow studying the physicochemical properties of the DTTA 
chelating moiety. 
 
Figure I.2-1: [Gd(DTTA-Me)(H2O)2]− 
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The second compound will be the Ru(II)-based metallostar Na4{Ru[Ln2bpy-DTTA2(H2O)4]3} 
(Ln = Y, Gd, and Eu), a close derivative to the metallostar compound Na4{Fe[Gd2bpy-
DTTA2(H2O)4]3}4-. The challenge will be to synthesise this heptametallic self-assembled 
edifice and demonstrate whether it acts as potential bimodal (magnetic and luminescent) 
bioprobe. 
 
Figure I.2-2: {Ru[Ln2bpy-DTTA2(H2O)4]3}4- 
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The third compound is represented by Gd-DTTA chelate units derivated with thiol function 
and linked to gold nanoparticles. The interesting rigidity of this system will probably show a 
high relaxivity due to a long rotational correlation time. Several publications report magnetic 
behaviour of small transition metal nanoparticles. We will try to establish if there is any 
contribution to the paramagnetic relaxation enhancement observed. 
 
Figure I.2-3: Gold nanoparticle coated with Gd-DTTA thiol derivatives. 
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II.1  INTRODUCTION 
The use of paramagnetic gadolinium chelates as contrast agents for medical magnetic 
resonance imaging (MRI) has increased considerably during the last two decades. A great 
effort has been spent in the same time period to develop new compounds giving better 
contrast.1-3 The parameters that can be tuned in order to obtain more efficient agents, meaning 
to increase water proton relaxivity, are the rotational tumbling time of the complex, the 
exchange rate of water molecules from the first coordination sphere of Gd3+ and the number 
of water molecules in the first sphere. A stringent condition for all new chelating ligands is 
that the complex formed with the gadolinium ion is thermodynamically stable and kinetically 
inert and therefore all commercial MRI contrast agents have only one water molecule in the 
first coordination sphere. The safety of gadolinium based contrast agents became an important 
issue since it has become the leading suspect for Nephrogenic Systemic Fibrosis (NSF), a 
disease with high morbidity and mortality.4-7 Besides the application in medical diagnostics, 
MRI contrast agents are also used in medical research and pharmacological studies. These 
studies in general performed in vitro or in animals, depend on the development of new agents 
delivering good contrast at high magnetic fields. Restrictions concerning high complex 
stability are however often less severe than in case of clinical use. 
A common approach achieving high relaxivity is to load a rigid macromolecule like a 
dendrimer with many chelate units binding Gd3+.8-11 Relaxivities up to ~30 mM-1s-1 (at 20 
MHz) have been achieved in this way. The relaxivity values are, however, strongly magnetic-
field-dependent and at fields of 3T and above, relaxivity drops rapidly even below those of 
small commercial contrast agents. In contrast to that field-dependent boost in efficiency, 
raising the number of inner-sphere water molecules leads to an increase in relaxivity, which is 
proportional to the number of water molecules and independent of the magnetic field. 
Therefore, several research groups devoted their efforts to the synthesis of chelates allowing 
the presence of more than one water molecule in the first coordination sphere of the metal.12-15 
Because the stability of the chelate complexes is a major concern, macrocyclic ligands based 
on the DO3A unit have often been chosen.16-20 Gadolinium complexes of these ligands are 
thermodynamically and kinetically relatively stable 21 and have two inner-sphere water 
molecules. However, it has been found that these compounds can form ternary complexes 
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with anionic metabolites present in serum.18, 20, 22 Bidentate anions like lactate or carbonate 
bind directly to the paramagnetic center and replace the two inner-sphere water molecules. As 
a consequence, the relaxivity drops by about 60%, leading, on one hand, to a loss in efficiency 
as a contrast agent, but allowing, on the other hand, eventually monitoring in the presence of 
such anions.  
Our group recently developed small to medium sized molecules binding two to six Gd3+ ions 
with heptadentate acyclic DTTA chelating groups (H4DTTA = diethylenetriaminetetraacetic 
acid = N,N’-[iminobis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine]).23-27 In these 
complexes, each Gd3+ binds two water molecules that exchange relatively rapidly with the 
bulk, leading to moderately high relaxivities. Interestingly, relaxivities at magnetic fields of 3 
T and above are still relatively high, leading to better contrast that of commercial contrast 
agents.25 Measurements of stability constants on complexes with DTTA4- showed that 
complex stability constants, KML, vary strongly depending on the group bound to the central 
nitrogen.26  
In this chapter, we present a study of complexes with DTTA-Me4- (H4DTTA-Me = N,N’-
[(methylimino)bis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine]) which mimics the DTTA 
chelating unit linked by a methylene group to organic backbones. Already in 1957, 
Schwarzenbach et al. presented protonation constants, Ki, and complex stability constants, 
KML, for some divalent ion complexes of the DTTA-Me4- ligand.28 Here we report the 
protonation and stability constants of DTTA-Me4- and its Gd3+ (Na[Gd(DTTA-Me)(H2O)2] = 
sodium{[N,N’-[(methylimino-κN)bis(ethane-2,1-diyl)]bis[N-(carboxy-κO)methyl]glycinato-
κN,-κO]](4−)}gadolinite(1−)) and Zn2+ complexes, respectively, determined by potentiometry 
and 1H NMR pH titrations. NMR relaxometry is used to determine the conditional relative 
stability constant, 
 
K
L1/ L2
* , of [Gd(DTTA-Me)(H2O)2]− with respect to the commercial contrast 
agent Omniscan® [(Gd(DTPA-BMA)(H2O)], to measure transmetalation towards endogenous 
Zn2+ ions and to assess a possible formation of ternary complexes with the bidentate ligand L-
lactate.  
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II.2 EXPERIMENTAL SECTION 
II.2.1 Synthesis of H4DTTA-Me 
All commercial reagents were used as received unless otherwise noted. 
N,N’-[(methylimino)bis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine]tetrakis(1,1-
dimethylethyl) ester 
N-methyl-2-2’ diaminodiethylamine (1.0 g) was dissolved in 24 ml dry DMF in the presence 
of 4.1 equivalents of K2CO3 (4.84 g). A total of 4.1 equiv of tert-butyl bromoacetate (6.8 g) 
was added dropwise. The solution was stirred overnight at room temperature under argon 
atmosphere. The solvent was evaporated, and water and dichloromethane (60 mL and 40 mL, 
respectively) were added to the residue. The crude product was extracted three times with 
dichloromethane (40 mL). The combined organic phases were dried with sodium sulphate, 
filtered and evaporated. The product was purified by silica gel chromatography (eluant 1:3 
ethyl acetate / hexane), and 1.3 g of N,N’-[(methylimino)bis(ethane-2,1-diyl)]bis[N-
(carboxymethyl)glycine]tetrakis(1,1-dimethylethyl) ester (yellow oil) were obtained (yield 27 
%).1H NMR, 400 MHz, CDCl3, δ in ppm : 1.45 (s, 36 H); 2.24 (s, 3 H); 2.52 (m, 4 H); 2.83 
(m, 4 H); 3.45 (s, 8 H). MS (ESI): m/z: 574 [MH]+.  
N,N’-[(methylimino)bis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine]  
The intermediate N,N’-[(methylimino)bis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine] 
tetrakis(1,1-dimethylethyl) ester was deprotected by stirring overnight in 150 mL of boiling 6 
M HCl. After evaporation, the crude product was washed three times in water by dissolution 
and evaporation and then purified by ion-exchange chromatography on Bio-Rad AG 50W-8X 
resin eluted with a gradient of HCl (1-5 M) and then aqueous NH3. The pure fractions were 
evaporated and washed three times with water; the resulting white solid N,N’-
[(methylimino)bis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine] was dried under vacuum 
(yield 50 %). 1H NMR (400 MHz, D2O, δ in ppm at pH ~ 2): 2.98 (s, 3 H); 3.45 (m, 4 H); 
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3.50 (m, 4 H); 3.88 (s, 8 H). MS (ESI): m/z:  350 [MH]+. Elem anal. Calcd for H4DTTA-
Me(HCl)3(H2O)4 : C, 29.41; H, 6.21; N, 7.91. Found: C, 29.56; H,5.85; N, 7.65. 
II.2.2 Protonation and Stability Constants by Potentiometric Measurements 
Stock solutions of GdCl3 (97.7 mM) and ZnCl2 (89.5 mM) were prepared with double-
distilled water, and standardized by titration with Na2H2EDTA solution in urotropine buffer at 
pH 5.8 using xylenol orange as the indicator. A stock solution of the ligand H4DTTA-Me 
(13.4 mM) was prepared and titrated with Na2H2EDTA solution in a urotropin buffer at pH 
5.8 using xylenol orange as the indicator in the presence of an excess of Gd3+. The 
concentration of the ligand solution was confirmed by potentiometry on the basis of titration 
curves obtained in the absence and in the presence of a 50-fold excess of CaCl2.  
The protonation constants of the ligand DTTA-Me4- and the stability constants of its 
complexes with Gd3+ and Zn2+ (CL = 3 mM, CM = 3 mM; I = 0.1 M KCl, titrated with 50 mM 
KOH) were determined by pH potentiometric titrations. The titrations were carried out using 
3 mL sample volumes in a thermostatted glass-jacketed vessel (25 ± 0.2°C) with a magnetic 
stirrer (under a dinitrogen atmosphere to avoid the effects of CO2) and dosed with a Metrohm 
Dosimat 665 automatic burette. A combined glass electrode (C14/02-SC, reference electrode 
Ag/AgCl in 3 M KCl, Moeller Scientific Glass Instruments, Switzerland) connected to a 
Metrohm 692 pH/ion meter was used to measure the pH. The hydrogen ion concentration was 
calculated from the measured pH values by using a correction term, obtained as the difference 
between the measured and calculated pH values in a titration of HCl (0.1 M) with 
standardized KOH, as suggested by Irving et al.29 The potentiometric data (about 160 points 
collected over the pH range 2-12) were refined with the Hyperquad 2000 program.30,31 
II.2.3 Deuteration Constants by 1H-NMR Measurements 
An aqueous stock solution of H4DTTA-Me (3 mM) was prepared in D2O (99.8%), with I = 
0.1 M NaCl. DCl or NaOD solutions were added to 5 mL of this solution, placed into a glass-
jacketed vessel (25 ± 0.2 °C) with a magnetic stirrer (in an N2 atmosphere to avoid the effects 
of CO2). The pH was measured as described above. For NMR titration ~400 µL of the 
solution were placed into a 5 mm NMR tube and 1H NMR spectra were recorded on a Bruker 
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Avance-400 (25 ± 0.2 °C, measured by a substitution technique32). After the NMR 
measurement, the solution was poured back to the thermostatted vessel. The chemical shifts 
were recorded using tert-butyl alcohol as an internal standard (1.24 ppm). The chemical shift 
data (about 40 points collected over the pD range 2-12) were refined with the 
Visualiseur/Optimiseur programs running on a Matlab platform.33 
II.2.4 Conditional Relative Stability Constant 
 
K
L1 / L2
*  of [Gd(DTTA-Me)(H2O)2]− 
Relative to [Gd(DTPA-BMA)(H2O)] 
The H3DTPA-BMA was synthesized according to a procedure described by Geraldes et al.34 
Aqueous solutions of the complexes [Gd(DTTA-Me)(H2O)2]− (sol L1) and [(Gd(DTPA-
BMA)(H2O)] (sol L2), each containing a 3-fold excess of ligand, were prepared, and the pH 
was set to 8.4 (sol L1: 4 mM GdCl3 and 12 mM H4DTTA-Me and sol L2: 4 mM GdCl3 and 12 
mM H3DTPA-BMA). Seven samples (m = 1 - 7) containing 1.40 mL of different amounts of 
sol L1 and sol L2 (0, 16, 33, 50, 67, 84 and 100 % of sol L2) were prepared in 2 mL flasks. 
Through the addition of ~0.60 mL (exactly weighted) of water containing NaCl, final 
concentrations for each sample were CGd = 3 mM, 
 
C
m
L
1 + C
m
L
2 = 9 mM, and I = 0.1 M NaCl. 
Measurements of the water proton longitudinal relaxation rates, 
 
R
1
= 1 T
1
, were performed on 
a Bruker Minispec mq60 (60 MHz) at 25 ± 0.2 °C (measured by a substitution technique32). 
NMR tubes were left 15 min inside the thermostated probe before measurement. Relaxivities 
and pHs of the samples were checked two weeks later to confirm that systems had reached the 
equilibrium. 
II.2.5 Transmetallation of [Gd(DTTA-Me)(H2O)2]− with Zn2+ 
Transmetalation reactions with Zn2+ were studied as described by Laurent et al.35 Equimolar 
amounts of ZnCl2 were added to [Gd(DTTA-Me)(H2O)2]− and to [(Gd(DTPA-BMA)(H2O)] 
solutions (2.5 mM each) containing a phosphate buffer (pH 7, [KH2PO4] = 26 mM, 
[Na2HPO4] = 41 mM). The samples were vigorously stirred and the water proton longitudinal 
relaxation rates measured on a Bruker Minispec mq60 (60 MHz, 37 °C). The measurements 
were carried out over 3 days using an automatic measurement routine. 
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II.2.6 Search for Ternary Adduct Formation between [Gd(DTTA-Me)(H2O)2]− and L-
Lactate 
Formation of ternary adducts can be studied by measuring the water proton relaxivity.20 
Solutions of 1 mM [Gd(DTTA-Me)(H2O)2]− containing increasing amounts of lactate (0, 
0.24, 0.97, 1.49, 1.95, 7.57, 12.2, 20.1, 30.3, 40.1, and 50.0 mM), were prepared at pH 7.0. 
Measurements of the water proton longitudinal relaxation rates, R1, were performed with a 
Stelar fast-field cycling relaxometer at 10 MHz and 25 ± 0.2 °C (measured by a substitution 
technique32).  
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II.3 RESULTS AND DISCUSSION 
II.3.1 Potentiometry 
Protonation constants of DTTA-Me4− were determined by potentiometry. From literature data 
on acyclic poly(aminocarboxylate) molecules, four protonation can be expected over the the 
pH range 2 to 12 for DTTA-Me4−. The stepwise protonation constants Ki (eq. II.3-1) were 
obtained by fitting of the potentiometric data (Figure II.3-1).  
 
K
i
=
H
i
L!" #$
H
i%1
L!" #$ H
+!
"
#
$
 with i > 0
 
II.3-1 
An analysis of the potentiometric data using five protonation constants has been performed 
because of a significant improvement of the quality of fit. The protonation constant for the 
first protonation step, K1, of DTTA-Me4− is similar to that of DTPA4− and TTAHA6−. 
However, the ligand tpy-DTTA4− (Figure II.3-2) has a K1, which is about two orders of 
magnitude lower.23, 24 These results suggest that for all of these ligands the first protonation 
occurs on the central nitrogen. The loss of basicity of the central nitrogen for tpy-DTTA4− 
with respect to DTTA-Me4−, DTPA4−, and TTAHA6− is a consequence of the direct binding of 
the terpyridine moiety to the central nitrogen instead of a methylene group. Costa et al.23, 24 
investigated ligands where two DTTA chelators are linked in para and meta positions to a 
xylene core via a methylene group. The first protonation constants for pX(DTTA)28− and 
mX(DTTA)28− (Table II.3-1) are intermediate between the values of TTAHA6−, DTPA5−, and 
DTTA-Me4−, and that of tpy-DTTA4−. In this case, the methylene group is intercalated 
between the aromatic ring and the polyaminocarboxylate and quenches partially inductive or 
mesomeric effects, affecting the protonation constants of the DTTA entities. The decrease 
from log K4 to log K5 is larger for DTTA-Me4− than expected by a statistical approach (0.3). 
The protonation constant log K6 for DTTA-Me4− could not be determined because it occurs 
below pH 2. 
Chapter II. Physicochemical properties of the high field MRI relevant [Gd(DTTA-Me)(H2O)2]- -complex 
54   Thesis Loïck Moriggi 
 
Figure II.3-1.Titration curves at 25 °C and I=0.1 M KCl of the DTTA-Me4- 
ligand and its Ca2+, Zn2+, and Gd3+ complexes. 
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Table II.3-1: Thermodynamic Protonation and Stability Constants for Various Ligands and Their Gd3+ and Zn2+ complexes (T = 25°C, I = 0.1 M) 
Ligand DTTA-Me4- a bpy(DTTA)2
8- 
b p,mX(DTTA)2
8-  c tpy-DTTA
4- 
d TTAHA
6- e DTPA5- f EDTA4- DTPA-BMA3- g 
   para meta      
log K1 10.75 (0.03) h 9.87 i 9.84 9.45 8.65 10.66 10.41 10.08 j 9.37 
log K2 7.56 (0.03) h 9.16 i 8.80 8.12 7.63 8.56 8.37 6.42 j 4.38 
log K3 3.76 (0.05) h 3.09 i 3.52 3.97 5.25 8.38 4.09 3.11 j 3.31 
log K4 2.74 (0.05) h 1.5 i 2.40 2.70 3.30 2.92 2.51 2.33 j 1.43 
log K5 1.90 (0.15) - - - - 2.39 2.04 - - 
log K6 - - - - - 2.0 - - - 
log KGdL 18.60 (0.10) 18.2 19.1 17.0 10.87 19.0 22.5 17.7 j 16.85 
log KGdHL 2.12 (0.24) - 2.1 3.2 3.73 8.3 1.8 - - 
log KZnL 17.69 (0.10) 18.0 17.94 16.19 - 18.91 18.29 16.4 k 12.04 
log KZnHL 3.73 (0.10) 3.4 3.76 4.24 - 8.01 5.6 - 4.04 
log KZnH2L - - - - - 3.68 - - - 
pGd l 15.8 (0.1) 14.9 16.2 15.1 10.6 15.5 19.2 15.9 15.8 
a I = 0.1M KCl; this work; numbers in parentheses correspond to two times standard deviation. b I = 0.1 M (CH3)4NCl; from ref [26]; c I = 0.1 M (CH3)4NCl; from ref [23]. d I 
= 0.1 M KCl; from ref [24]. e I = 0.1 M KCl; from ref [36] f I = 0.1 M KCl; from ref [37]. g I = 0.1 M KCl; from ref [38]. h from Ref [28] at T = 20°C, I = 0.1 M KCl: log K1 
= 10.89, log K2 = 7.39, log K3 = 3.65, log K4 = 2.8.. i Protonation constants of the poly(aminocarboxylate) moiety. j I = 0.1 M KCl; from ref [39]. k From r [40].pM values of 
GdL complexes under physiologically relevant conditions (pH 7.4; [Gd]total = 1µM; [L]total = 10 µM) 
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Figure II.3-2. Ligands containing DTTA chelating units. 
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II.3.2 1H NMR in D2O 
1H NMR chemical shifts of DTTA-Me4− were assigned on the basis of signal multiplicities. 
Samples were prepared in D2O and pD values have been obtained from the equation pD = 
pHapparent + 0.44,36 where pHapparent is the measured pH of the sample. The pD dependences of 
the chemical shifts, 
 
!
X
obs
D
+( ) , of the doublets d1 and d2 and the singlets s1 and s2 (Figure 
II.3-3) due to successive deuteration of DTTA-Me4− can be expressed as in eq II.2: 
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X
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D
+( ) = Pi "! X
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L
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II.3-2 
 
 
Figure II.3-3: DTTA-Me4- ligand. 
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 are the intrinsic chemical shifts of the protons X (X = s1, s2, d1 or d2) of the 
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L
i!4  species (i = 0 - 5) and 
 
P
i
 are the fractional populations of species L4-, DL3-, D2L2-, 
D3L-, D4L and D5L+, respectively:  
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II.3-3 
 
 
L
Total
is the total concentration of the ligand L, 
 
!
i
D are the cumulative deuteration constants, 
[D+] is the deuteron concentration in mol/L calculated as 10-pD, and
 
P
0
, the fractional 
population of species L4-, is given by eq II.4:  
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The stepwise deuteration constants 
 
K
i
D  are expressed following eq II.5:  
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II.3-5 
 
The 
 
log K
i
D values of DTTA-Me4− in D2O were calculated from least-squares refinement of 
the chemical shifts measured as a function of pD (eq II.3-5). The deuteration constants found, 
log K1D = 11.40, log K2D = 8.10, log K3D = 4.10, log K4D = 3.54 and log K5D = 2.53, are higher 
than those obtained in H2O by potentiometry because the deuteron interacts more strongly 
with oxygen and nitrogen atoms than the proton does. Corrected 
 
log  K
i
H  values were 
calculated from log KiD according to  log Ki
D
= 0.32 +1.044 ! log  K
i
H  37, 38: log K1H = 10.61, 
log K2H = 7.45, log K3H = 3.62, log K4H = 3.09 and log K5H = 2.12. Taking into account that 
pHapparent had to be converted to pD and that an empirical correction has been used to calculate 
log KiH, the protonation constants as obtained from the deuteration constants are in good 
accordance with potentiometric values (Table II.3-1).  
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Figure II.3-4: 1H NMR (400 MHz) DTTA-Me4- chemical shifts versus pD in 
D2O at room temperature and I=0.1 M KCl. Lines were calculated using the 
fit parameters from eq 2 to eq 6 describing the first five deuteration steps of 
DTTA-Me4-. 
The microscopic titration scheme obtained by 1H NMR spectroscopy is indicative of the 
deuteration sites. The deuteration of a basic site leads to a deshielding of adjacent protons.  
Following Figure II.3-1, by lowering pD the protons d1 and s1 become first strongly 
deshielded while d2 and s2 are much less affected. It is, therefore, concluded that the first 
deuteration step, described by K1, occurs mainly on the central nitrogen. Between pD 9.5 and 
pD ~6, protons d1 and s1 become again more shielded and protons d2 and s2 become 
deshielded. In the second deuteration step, both terminal nitrogen atoms are deuterated and 
the deuterium on the central nitrogen is released. The bisdeuterated ligand undergoes 
stabilization by the formation of five-membered rings due to hydrogen-bond formation 
between the proton on the terminal nitrogen and an oxygen atom of the carboxylate group, 
lowering strongly the log K3D value. A similar behavior has been already found by 1H NMR 
titration on DTPA5- and EPTPA.39-41  
The three subsequent 
 
log K
i
D values, corresponding to a repeated deuteration of central 
nitrogen (
 
log K
3
D), and the deuteration of the first and second carboxylate (
 
log K
4
D 
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and
 
log K
5
D), are confirmed by the chemical shift changes of the d1/s1, and d2/s2 protons, 
respectively.  
II.3.3 Stability Constants by Potentiometry 
The thermodynamic stability of a metal M with charge m complexed to a chelate L with 
charge n is given by the stability constant 
 
K
ML
 (eq II.3-6):  
 
K
ML
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ML
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"
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$  are the equilibrium concentrations of the metal ion, the 
deprotonated ligand and the complex, respectively. At low pH, protonation of the complexes 
occurs, which is characterized by the complex protonation constants 
 
K
MH
i
L
 (eq II.3-7): 
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The stability constants KML and KMHL of the complexes [Mm(DTTA-Me)]m-4 (Mm =Gd3+, 
Zn2+) were obtained by fitting potentiometric data measured over the pH range 2-12 (Figure 
II.3-1). The thermodynamic stability of [Gd(DTTA-Me)(H2O)2]− (Table II.3-1) is comparable 
to those of [Gd(TTAHA)(H2O)2]3−, [Gd2(pX(DTTA)2)(H2O)4]4− and 
[Gd2(mX(DTTA)2)(H2O)4]4−. All of these compounds bind the metal via a heptadentate 
DTTA4− unit with a methylene group on the central nitrogen. Replacing this nonionic 
methylene group by a metal binding acetate group results in an increase of the stability 
constant by 3 - 4 orders of magnitude, as was found for the octadentate DTPA5− (Table 
II.3-1). Replacing the methylene group on the central nitrogen by a tpy group leads, however, 
to a decrease in KGdL of nearly eight orders of magnitude. Tse and Powell observed a much 
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smaller decrease of log KGdL from 17.50 to 15.42 on going from to BEBTA4− to BEATA4− 
(Table II.3-1) where an electron-withdrawing phenyl group is replaced by an electron-
donating benzyl.42  
The pGd value (eq II.8), usually calculated for pH 7.4, [Gd]total = [ML] = 1 µM, and [L]total = 
10 µM,43 expresses the influence of the ligand HiL basicity and the protonation of the 
complex. A higher pGd value means higher complex stability under these conditions, with 
 
!
L
(eq II.3-9) being the inverse of the 
 
L
4!"
#
$
%  population fraction for an H5L ligand. 
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Table II.3-1 shows pGd values for several poly(aminocarboxylate) Gd3+ complexes. The pGd 
of [Gd(DTTA-Me)(H2O)2]− (pGd = 15.8) is much smaller than for DTPA or DOTA (pGd = 
19.2) complexes, but it is about the same as for the DTPA-BMA and for the EDTA 
complexes.  
II.3.4 Conditional Relative Stability Constant 
 
K
L1 / L2
*  of [Gd(DTTA-Me)(H2O)2]− 
Relative to [Gd(DTPA-BMA)(H2O)] 
The conditional relative stability constant 
 
K
L1/ L2
*  (eq II.3-10) is defined by the ratio between 
the two conditional stability constants 
 
K
GdL
1
*  and 
 
K
GdL
2
*  of the Gd3+ complexes [Gd(DTTA-
Me)(H2O)2]− and [Gd(DTPA-BMA)(H2O)], respectively. These two constants, depending on 
pH, are equal to their corresponding thermodynamic stability constants 
 
K
GdL
1
 and 
 
K
GdL
2
 
divided by the inverse of their non protonated ligand fractions αL1 and αL2, respectively (eq 
II.10). 
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The conditional relative stability constant 
 
K
L1/ L2
*  of gadolinium complexes can be measured 
via 1H relaxivity measurements provided the relaxivities of the two complexes, 
 
r
1
GdL
1 and
 
r
1
GdL
2 , 
are sufficiently different. The relaxivity of a paramagnetic compound in aqueous solution is 
commonly expressed by eq II.3-11: 44 
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1/T1 and 1/T1,H2O are the measured longitudinal relaxation rates of water protons of solutions 
 
C
m
L
2 with and without the paramagnetic ion, respectively. The relaxivity, 
 
r
1
m , of a sample 
composed of a mixture of sol L1 and sol L2 (see Chapter II.2) is given by the relative 
concentrations [GdL1] and [GdL2] at equilibrium in respect to the total concentration of 
gadolinium in the mixture, 
 
C
m
Gd (eq II.3-12): 
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If the total concentrations of the two ligands in the mixture 
 
C
m
L
1 and 
 
C
m
L
2  are known, the 
conditional relative stability constant 
 
K
L1/ L2
*  can be calculated with eq II.13 (see Chapter 
IV.1.3): 
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From the compositions of the individual samples we can calculate relaxivities using
 
K
L1/ L2
* , 
 
r
1
GdL
1  and 
 
r
1
GdL
2  as parameters (see Chapter Appendix, scheme VI.1.2-1). Experimental data 
can be fitted by this function yielding the conditional relative stability constant 
 
K
L1/ L2
*  = 6.4 ± 
0.3 at pH = 8.3 and 25 °C (Figure II.3-5). At that pH, both ligands exist mainly in the 
monoprotonated form in solution and the [H+] concentration is not altered by the 
establishment of the equilibrium as defined in eq II.3-14.  
 
Figure II.3-5. Relaxivities 
1
m
r  of samples containing different 
concentrations of DTPA-BMA (% L2). The conditional stability constant 
*
L1/ L2
K  is calculated from a fit. 
The thermodynamic relative stability constant KL1/L2 (eq 10), which is independent from the 
pH, can be calculated using 
 
!
L
1
= 332.4 and 
 
!
L
2
= 12.7 (calculated from values in Table II.3-1 
and sample compositions) as KL1/L2 = 168. The conditional relative stability constant 
 
K
L1/ L2
*  
obtained from the competition experiment by relaxometry can be compared to the value 
II.3-14 
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2
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  Chapter II. Physicochemical properties of the high field MRI relevant [Gd(DTTA-Me)(H2O)2]- -complex 
Thesis Loïck Moriggi  65 
calculated from the stability constants from several potentiometric experiments log KGd-DTTA-
Me =18.60 (this work, Table II.3-1) and log KGd-DTPA-BMA =16.85, reported by Rizkalla et al.45 
Both the directly measured and the calculated 
 
K
L1/ L2
*  show a higher relative thermodynamic 
stability of [Gd(DTTA-Me)(H2O)2]- compared to [Gd(DTPA-BMA)(H2O)] (Table II.3-2) at 
pH 8.3. The conditional relative stability constant 
 
log K
L1/ L2
*  as a function of the pH is shown 
in Figure II.3-6. At pH above 6.8, [Gd(DTTA-Me)(H2O)2]- is more stable than [Gd(DTPA-
BMA)(H2O)]. Especially at physiological pH 7.4, the gadolinium complex with the 
heptadentate DTTA-Me4- is about three times more stable than the one with the octadentate 
DTPA-BMA3-, as calculated from the directly measured
 
K
L1/ L2
* .  
 
 
Figure II.3-6: Conditional relative stability constant 
 
log K
L1/ L2
*  as a 
function of pH. 
Relative stability constants of very stable complexes are often measured by competition 
experiments. In the case of complexes of lanthanide cations, the methods mainly used are 
spectrophotometric competition titration using colored ligands46, 47 or potentiometric 
competition experiments using, for example, EDTA48, 49. The measurement of 1H NMR 
relaxivities at one magnetic field in mixed solutions of gadolinium complexes is a simple 
method to establishing the relative stabilities of gadolinium complexes. The only necessary 
condition is that the relaxivities of the two individual complexes have to be sufficiently 
different with respect to experimental uncertainty. By a proper choice of the magnetic field, 
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such a difference in the relaxivity can always be found and therefore the relative stability 
constants can be measured directly for any couple of gadolinium complexes. The standard 
deviation of 5% on 
 
K
L1/ L2
*  obtained in our case is much lower than what can typically be 
obtained by potentiometric competition experiments. 
Table II.3-2. Conditional, KL1/L2*, and Thermodynamic, KL1/L2, Relative 
Stability Constants (T=25 °C, I = 0.1M) for [Gd(DTTA-Me)(H2O)2]- (GdL1) 
and [Gd(DTPA-BMA)(H2O)] (GdL2) from Relaxivity and Potentiometric 
Experiments. 
 relaxivity a potentiometry b 
log
 
K
L1/ L2
* ,   pH 8.3 0.81 ± 0.02c 0.33 
log
 
K
L1/ L2
*
,   pH 7.4 0.47 -0.01 
log KL1/L2 2.23 1.75d 
a I = 0.1 M NaCl. b I = 0.1 M KCl; log KML for [(Gd(DTPA-BMA)(H2O)] from ref. 
[38]. cMeasured directly. dCalculated from log KGdL and log KGdL1. 
II.3.5 Transmetalation of [Gd(DTTA-Me)(H2O)2]- with Zn2+ 
Zn2+ is one of the most abundant endogenous metal ions with a concentration of ~32 µM in 
the human plasma.50 To determine the stability of the [Gd(DTTA-Me)(H2O)2]− complex 
against the presence of Zn2+ ions, a transmetalation experiment was carried out in phosphate 
buffer (pH 7.0).35 Replacement of Gd3+ in the complex with Zn2+ leads to free gadolinium 
ions, which precipitate in the presence of phosphate as GdPO4. Because Zn2+ is diamagnetic, 
the total amount of paramagnetic species in solution decreases and therefore the measured 
decrease in relaxation allows on to following the transmetalation reaction. 
In Figure II.3-7, the evolution with time of the ratio of relaxation rates 
 
R
1
m
R
1,0
 where 
 
R
1
m  is 
the relaxation rate at time t and 
 
R
1,0
 is the relaxation rate at time zero (just before successive 
addition of phosphate and Zn2+) is shown for [Gd(DTTA-Me)(H2O)2]− together with the 
evolution of [(Gd-DTPA-BMA)(H2O)] as comparison. After a small initial increase (Figure 
II.3-7 inset), the relative relaxation rates of both complexes decrease because of the 
transmetalation reaction. According to Laurent et al.,35, 51 two characteristic values can be 
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used to describe the behavior of a Gd3+ chelate in a transmetalation experiment, i.e. the time 
to reach 
 
R
1
m
R
1,0
 = 0.8 (ratio index) which gives information about the kinetics of the 
reaction, and the 
 
R
1
m
R
1,0
 value at very long time, t=∞ (long time index, considered after 3 
days = 4320 min), reflecting the thermodynamic aspect of the system. 
 
Figure II.3-7: Evolution of R
1
m
R
1,0
(T= 310 K; B = 1.41 T, 60 MHz; pH 7.0) 
versus time for (○) [Gd(DTTA-Me)(H2O)2]- and (●) [Gd(DTPA-BMA)(H2O)] 
complexes in the presence of equimolar amounts of Zn2+ ions in phosphate 
buffer solution. Evolution of () [Gd(DTTA-Me)(H2O)2]- in a phosphate 
buffer solution without Zn2+ ions. 
From the values in Table II.3-3, it can be concluded that transmetalation is twice as fast for 
[Gd(DTTA-Me)(H2O)2]− as compared to [(Gd-DTPA-BMA)(H2O)]. In any case, both are 
much less stable in respect to transmetalation than the complexes with cyclic ligands like 
DOTA4- or HPDO3A3- which are especially kinetically stable.35, 52 The lower relative 
thermodynamic stability of [Gd(DTTA-Me)(H2O)2]− against transmetalation with Zn2+ as 
compared to [(Gd(DTPA-BMA)(H2O)] can be understood by comparing the stability 
constants KML for Gd3+ and Zn2+ (Table 1). Even if [Gd(DTTA-Me)(H2O)2]− has a higher 
stability that of [(Gd(DTPA-BMA)(H2O)], the relative stability with respect to Zn2+ is lower 
as a consequences of the high stability of the zinc complex of DTTA-Me4-: log (KGd-DTTA-
Me/KZn-DTTA-Me) = 0.91 in respect to log (KGd-DTPA-BMA/KZn-DTPA-BMA) = 4.81.53 
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Table II.3-3: Transmetalation with Zn2+: time required to reach the ratio 
 
R
1
m
t( ) R1,0  = 0.8 (ratio index. 
ref. [55]) and value of 
 
R
1
m
t = 4320( ) R1,0  (long time index ref. [55]) for [Gd(DTTA-Me)(H2O)2]
- and 
[Gd(DTPA-BMA)(H2O)] (37° C, pH 7.0). 
 t for R
1
m
t( ) R1,0  = 0.8 R1
m
t = 4320( ) R1,0   
 [min]   
[Gd(DTTA-Me)(H2O)2]- 44 0.07 this work 
[Gd(DTPA-BMA)(H2O)] 100 / 100 0.11 / 0.10 this work / [55] 
[Gd(DTPA)(H2O)]2- 250 0.49 [55] 
[Gd(DOTA)(H2O)]- >5000 0.99 [55] 
[Gd(HPDO3A)(H2O)]- >5000 0.99 [55] 
 
To confirm that the presence of Zn2+ ions is provoking transmetalation we performed a blank 
experiment (Figure II.3-7). A sample containing the [Gd(DTTA-Me)(H2O)2]− complex only 
with phosphate buffer but without Zn2+ ions shows no change in relaxivity over more than 
three days, confirming that phosphate at the considered concentration and pH is unable to 
extract Gd3+ from the chelate. 
II.3.6 Search for Adduct Formation between [Gd(DTTA-Me)(H2O)2]− and L-lactate 
It has been shown by NMR18, 20 and by luminescence emission studies 54, 55 that lanthanide 
complexes with heptadentate DO3A based ligands form ternary adducts with bidentate anions 
like carbonate, acetate, phosphate, malonate, and lactate. The anions replace the two water 
molecules from the first coordination sphere of the lanthanide, leading in the case of 
gadolinium complexes to a substantial decrease in relaxivity. Like DO3A based ligands, 
DTTA-Me4- is heptadentate and its Gd3+ complex has also two water molecules in the first 
coordination sphere. Therefore, it could be prone to bind bidentate anions. We studied the 
eventual complex formation of [Gd(DTTA-Me)(H2O)2]− with L-lactate anions, which are 
present in human blood at ~2 mM, concentrations up to 25 mM can be found under stress or 
shock.56, 57 Following Terreno et al.20 we used 1H NMR relaxivity, r1, to detect the 
replacement of first sphere-water molecules by a lactate anion.  
  Chapter II. Physicochemical properties of the high field MRI relevant [Gd(DTTA-Me)(H2O)2]- -complex 
Thesis Loïck Moriggi  69 
The change in relaxivity upon titration of [Gd(DTTA-Me)(H2O)2]− with L-lactate is shown in 
Figure II.3-8. Addition of 10 equivalents of lactate to a 1mM solution of [Gd(DTTA-
Me)(H2O)2]− leads only to a slight decrease in r1 of 6.5 %. This decrease is much smaller than 
that observed on complexes based on cyclic DO3A derivatives (Figure II.3-8). Even with 50 
equivalents of lactate relaxivity decreases by about 2 mM-1 s-1. Possible explanations for the 
small decrease of r1 are (1) the formation of a small amount of the ternary adduct [Gd(DTTA-
Me)(C3O3H5)]2−, (2) the replacement of only one water molecule on some of the Gd3+ 
complexes, and (3) the formation of an outer-sphere complex, leading to an decrease of outer-
sphere relaxation. 
 
Figure II.3-8: Relaxivity 
1
m
r  (T = 298 K; B = 0.235 T, 10 MHz; pH 7.0) 
versus L-lactate equivalents for 1 mM solutions of [Gd(DTTA-Me)(H2O)2]- 
() (this work), and [Gd(DO3A)(H2O)2] (---), [Gd(MBzDO3AM)(H2O)2]3- 
(- · - · -) from ref [20]. 
The difference in the formation of ternary complexes between compounds with cyclic ligands 
(DO3A-based) and the acyclic ligand (DTTA-Me4-) is probably due to the arrangement of the 
two first-shell water molecules. In DO3A-type complexes, these water molecules are 
adjacent, allowing a bidentate binding of the anion. In the [Gd(DTTA-Me)(H2O)2]− complex, 
the two water molecules are probably not next to each other and the lactate could only bind 
via one oxygen to the gadolinium. Furthermore, in contrast to DO3A complexes of 
gadolinium, the [Gd(DTTA-Me)(H2O)2]− complexes is negatively charged and the formation 
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of ternary adducts with anions is less favorable. Furthermore, in contrast to DO3A complexes 
of gadolinium, the [Gd(DTTA-Me)(H2O)2]− complex is negatively charged and the formation 
of ternary adducts or outer-sphere complexes with anions is less favorable. 
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II.4 CONCLUSION 
We report the synthesis and physicochemical characterization of the gadolinium complex 
with DTTA-Me4-, derived from the parent TTAHA6-. As other DTTA-type complexes, used, 
for example, in the metallostar 26, [Gd(DTTA-Me)(H2O)2]- has two water molecules directly 
bound to the paramagnetic center. The complex shows thermodynamic protonation and 
stability constants similar to DTTA bound to bpy or a xylene via a CH2 group. From 1H NMR 
it was concluded that the first protonation occurs on the central nitrogen, followed by 
protonation of the two terminal nitrogen atoms and deprotonation of the central one. The next 
protonation steps are a repeated protonation of the central nitrogen followed by the 
protonation of carboxylic acids. The pGd value, which is indicative for the stability at 
physiological conditions, is very close to that of [Gd(DTPA-BMA)(H2O)]. 
To measure the conditional relative stability constant for two gadolinium complexes, we 
propose a method based on relaxivity measurements. This versatile method allows the 
determination of the relative stability for any couple of ligands, provided its 1H NMR 
relaxivities are sufficiently different at an appropriate magnetic field. Using this method, we 
found that in a slightly basic environment (pH 8.3) the [Gd(DTTA-Me)(H2O)2]- complex has 
a higher stability in respect to [Gd(DTPA-BMA)(H2O)] as has been shown by the direct 
competition experiment using relaxivities as the indicator. Transmetellation with Zn2+ is 
however, less favorable for the heptadentate DTTA-Me4- compared to the octadentate DTPA-
BMA3-. Whereas the long time behavior of both complexes is similar, showing relatively 
strong transmetalation, the metal exchange from Gd3+ to Zn2+ is about twice as fast for 
DTTA-Me4- due to the higher stability of the zinc complex. In contrast to DO3A-based 
ligands with two water molecules in the first coordination sphere, the formation of ternary 
complexes with the bidentate lactose anion is very week. Even at a 10-fold excess of the 
anion, the measured relaxivity decreases only very slightly.   
From the results, it can be concluded that the Gd3+ complexe of heptadentate DTTA-Me4- 
behaves similarly as that of the commercial octadentate DTPA-BMA3-. Considering recent 
suspicions against [Gd(DTPA-BMA)(H2O)] for being involved in Nephrogenic Systemic 
Fibrosis (NSF) disease, DTTA-type chelates will not be admitted as contrast agents in clinical 
MRI. However, their use in vitro and in animal studies is absolutely conceivable, mainly at 
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high magnetic fields, where the increase of inner-sphere-coordination water actually seams to 
be the only promising way to increase the relaxivity.  
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III.1 INTRODUCTION 
The development of lanthanide-containing markers and labels for analytical and biophysical 
purposes is presently a very active field of research in view of important applications in 
magnetic resonance imaging (MRI)1 and optical cell imaging and sensing.2-4 
Complexes of trivalent gadolinium act as contrast agents for T1-weighted MR images since 
they decrease the longitudinal relaxation time T1 by increasing the relaxation rate of the spins 
of the surrounding water protons. The effectiveness of an MRI contrast agent is measured in 
terms of its relaxivity, r1, which is defined as the longitudinal relaxation rate in s-1 measured 
in a solution of a Gd3+ concentration of 1 mM. The water proton relaxivity of a gadolinium 
compound is mainly governed by four parameters: the number of water molecules in the first 
sphere of Gd3+ (q), the exchange rate for these water molecules, the relaxation behaviour of 
the electron spin of Gd3+, and the rotational diffusion of the complex in solution (τR).5-8 The 
influence of these parameters on r1 varies strongly with the strength of magnetic field applied, 
with exception of the coordination number q which is mainly a linear scaling factor. 
Typically, mid- and large-size compounds (MW > 1200 g mol-1) show a maximum of 
relaxivity at fields between 0.24 and 2.4 T corresponding to proton resonance frequencies of 
10 to 100 MHz. The value and the exact field of the relaxivity maximum strongly depend on 
the rotational correlation time τR: the slower is the rotational diffusion of the complex (long 
τR), the higher is the relaxivity and the lower is the magnetic field of the maximum 
Livramento et al 9-11 presented recently a compound they named metallostar which is based on 
the concept of self-assembly of gadolinium chelates around a d-transition metal centre first 
described by Jacques and Desreux.12,13 Three bipyridyl ligands, each bearing two chelating 
units complexed with Gd3+, self-assemble with Fe2+ to form an edifice with six paramagnetic 
centres. The use of DTTA as chelating group (q = 2) leads to a total number of 12 water 
molecules bound to Gd3+ and a relaxivity of 33.2 s-1 mM-1 at 1.4 T (60 MHz) and 25 °C. The 
r1-values of this metallostar were found to be remarkable at very high magnetic fields (r1 = 
15.8 s-1 mM-1 at 4.7 T, 200 MHz, and 37 °C) and led to signal enhancement in the inversion 
recovery MRI images on mice considerably higher than after the injection of the commercial 
contrast agent [Gd(DOTA)(H2O)]-.9 
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Relaxivity measurements in mouse serum and phosphate-buffered saline (PBS) solution 
showed that metallostars may not have sufficiently long-term stability in biological media 10 
and therefore an increase in stability of the bipyridyl binding to the d-transition metal centre is 
desirable. In order to increase the thermodynamic and kinetic stability of metallostar 
molecules we have chosen Ru2+ as the central metal ion since [Ru(bpy)3]2+ is known for its 
outstanding chemical stability.14-16 Furthermore, this compound has remarkable photophysical 
properties, in particular it features metal-to-ligand charge transfer states which are shifted into 
the visible part of the spectrum.16 
In the same time numerous lanthanide complexes with encapsulating ligands have been 
developed, which exhibit reasonable visible or near-infrared emission in solution upon 
excitation in the near UV.17-19 The main problem of these systems in bioanalytical 
applications is autofluorescence and photodegradation of the biological species with UV light. 
A possible way to circumvent these difficulties is to develop luminescent markers in which 
the emission can be excited in the visible part of the electromagnetic spectrum,20, 21 in 
particular through states involving d-transition metal ions.22 Combining the [Ru(bpy)3]2+ 
centre with a luminescent lanthanide chelate could therefore lead to a compound with 
interesting bimodal properties as both MRI contrast agent and luminescent probe. 
 
Figure III.1-1: Self-assembled Ru(II)-based metallostar systems 
{Ru[Ln2bpy-DTTA2(H2O)4]3}4- with (Ln = Y, Gd, or Eu). 
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In this chapter, we report the synthesis and properties of three d/f heptametallic assemblies 
{Ru[Ln2bpy-DTTA2(H2O)4]3}4- with Ln = Y3+, Gd3+, Eu3+ (Figure III.1-1). While the 
diamagnetic yttrium complex allows structural characterization by 1H NMR spectroscopy, the 
gadolinium complex is used to obtain the relaxivity properties via nuclear magnetic relaxation 
dispersion (NMRD) profiles. Luminescence properties of the europium assembly are 
presented. 
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III.2 EXPERIMENTAL SECTION 
III.2.1  Synthesis and Characterization 
The synthesis of the ligand H8bpy-DTTA2 has been described in a previous communication.11 
[Ru(H2O)6](OTs)2 (OTs- = p-toluenesulfonate anion) was synthesized according to the 
literature.23  
H8bpy-DTTA2 was first reacted with a slight excess (1-2%) of LnCl3 (Ln= Y3+, Gd3+, Eu3+) to 
form [Ln2bpy-DTTA2(H2O)4]2-. The synthesis of metallostars was first optimized with the 
diamagnetic yttrium complex in D2O and under argon atmosphere to allow monitoring the 
degree of completion of the reaction by 1H NMR. All equipment was carefully degassed 
under Ar atmosphere. In a round-bottomed flask, 2 mL of D2O were added to 
[Ru(H2O)6](OTs)2 (37.7 µmol) under stirring. In a second flask, a stoechiometric excess of 
[Y2bipy-DTTA2(H2O)4]2- (118.8 µmol) was dissolved in 4 mL of D2O. The pD was adjusted 
to 6.5 with 0.1 M NaOD. The purple Ru2+ solution was slowly transferred by cannula to the 
ligand-containing solution and the complexation reaction was performed at 95°C. Colour 
changed rapidly to dark red. Triethylamine (240 µmol) was added after 4 h. After 6 h of 
continuous stirring at 95°C, the reaction was complete as indicated by 1H NMR, and the 
solution displayed an intense orange colour. The solution was filtered (Schleicher and 
Schuell, RC-L 58, 0.2 µm) and evaporated to dryness. The remaining orange solid was 
dissolved in 2 mL H2O and loaded onto an exclusion-size column (Sephadex LH-20, 100 g, 
40 cm high, 4 cm diam.). The column was eluted with H2O until the first front (orange) was 
released. Eluate was recovered by fractions of 10 mL until all the second front (red) was 
released of the column. The 10 mL eluates were evaporated under reduced pressure to 
complete dryness, re-dissolved in D2O and characterized by 1H NMR (Figure III.3-1). Pure 
Na4{Ru[Y2bpy-DTTA2(H2O)4]3} was obtained as an orange solid in 47 % yield (17.7 µmol, 
68.8 mg) and was characterized in solution by UV-Vis and 1H NMR (400 MHz, D2O, pD = 
6.85 ): δ = 7.21 (d, 6H), 7.64 (d, 6H), 8.34 (s, 6H). 
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Synthesis with of {Ru[Ln2bpy-DTTA2(H2O)4]3}4- with Ln = Gd and Eu has been performed 
following the same procedure. Due to the paramagnetism of Gd3+ and Eu3+, characterization 
of the elutes was only accomplished by UV-vis spectroscopy. 
III.2.2 1H NMR spectroscopy 
All 1H NMR spectra were recorded on a Bruker DRX-400 spectrometer (9.4 T). The water 
peak was used as an internal reference (δ = 4.8 ppm).  
III.2.3  1H relaxivity 
The 1/T1 NMRD profiles of {Ru[Gd2bpy-DTTA2(H2O)4]3}4- were measured at 25.0°C, and 
37.0°C on a Stelar Spinmaster fast field cycling NMR relaxometer (2.35·10-4 - 0.47 T; 1H 
Larmor frequencies: 0.01–20 MHz) equipped with a VTC90 temperature control unit, on 
Bruker Minispecs (0.71 T (30 MHz), 0.94 T (40 MHz), and 1.41 T (60 MHz)), on a Bruker 
Avance-200 console connected to 2.35 T (100 MHz), and 4.7 T (200 MHz) cryomagnets, on a 
Bruker DRX-400 (9.4 T, 400 MHz), and on a Bruker Avance-II 800 (18.8 T, 800 MHz) 
spectrometer. Sample solutions were placed in cylindrical sample containers placed in NMR 
tubes with 10- or 7.5-mm for relaxometer and high field measurements or for the Bruker 
Minispecs, respectively. The diamagnetic corrections to the 1H longitudinal relaxation rates 
were 0.37 s-1 (25.0°C), and 0.33 s-1 (37.0°C). In all NMRD measurements the temperature 
was determined by a substitution technique.24 The gadolinium concentration of the sample 
was 8.31 mM as obtained from susceptibility measurements performed at 9.4 T.25 Least-
squares fitting of the NMRD data was performed by means of the programs 
VISUALISEUR/OPTIMISEUR 26 running on a Matlab platform, version 6.5 for the 
Solomon-Bloembergen-Morgan theory with Lipari-Szabo model-free approach and by using 
the “modified Florence” program.27, 28 
III.2.4  Optical Spectroscopy 
Room temperature (295 K) absorption spectra have been measured on a Lambda 900 
spectrometer from Perkin Elmer using 1-cm quartz Suprasil® (QS) cells. 
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Steady-state, gated emission, and excitation spectra, as well as lifetime measurements have 
been recorded on a Fluorolog-FL22-3 spectrometer from Horiba-Jobin-Yvon equipped with a 
450 W xenon arc light source, a UV xenon flash tube, a Spex R928 photomultiplier, and 
double excitation and emission monochromators. For room temperature luminescence 
measurements the same quartz cell as for absorption was used and for the cryogenic 
experiments aqueous solutions containing 10 vol% of spectrophotometric grade Glycerol 
from Acros Organics, were transferred into quartz tubes and cooled to 77 K by immersion of 
the quartz tubes in liquid nitrogen. 
Emission and excitation spectra have been corrected for the instrumental response and the 
source intensity, respectively, and are displayed as photon flux versus wavelength. 
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III.3 RESULTS AND DISCUSSION 
III.3.1  The Ru(II) based metallostar - a synthetic challenge 
Livramento and al. reported the synthesis of {Fe[Gd2bpy-DTTA2(H2O)4]3}.4-10, 11 The 
metallostar {Fe[Gd2bpy-DTTA2-(H2O)4]3}4- forms instantaneously on adding Fe2+ to a 
solution of [Gd2bpy-DTTA-)2(H2O)4]2-. The synthesis of the ruthenium analogue proved to be 
more tedious, due to fast oxidation of Ru2+ in presence of O2 and due to the high stability of 
the {Ru[Gd2bpy-DTTA2(H2O)4]2}2- intermediate. Rather than forming the Ru3+ complex 
followed by in situ reduction, as it is commonly the case for Ru(II)-terpyridine complexes, we 
started from the hexaaqua ruthenium(II) salt [Ru(H2O)6](OTs)2, which allowed us to avoid 
numerous purification steps. As for the iron analogue the ruthenium metallostar was 
synthesized in two steps: firstly, the ligand bpy-DTTA28- was complexed with two lanthanide 
ions and secondly, the three [Ln2(bipyDTTA)2]2- anionic complexes were self-assembled 
around the transition metal ion. To avoid side products with one carboxylate arm released 
from the lanthanide as observed by Costa et al.29, a 1-2% excess of the lanthanide salt was 
used to allow full complexation of the chelating ligand before reaction with Ru2+. All of the 
solids, solvents, as well as the glassware were carefully degassed and the complexation 
reaction was performed at 95°C in aqueous medium under Ar atmosphere to avoid both 
oxidation from O2 and N2 fixation to Ru2+. On one hand, low pH values are usually preferred 
because they slow down the oxidation of Ru2+; on the other hand, an acidic medium also 
slows down the complexation reaction by protonating the bipyridyl nitrogen atoms.10 The 
reaction was therefore started at pH 6.5 and was complete after 6 hours. Two equivalents of 
triethylamine per bipyridine moiety had to be added to prevent a decrease in pH due to 
protons released during the complexation with Ru2+. 
Chapter III. Ruthenium-based metallostar: synthesis, sensitized luminescence and 1H relaxivity 
88  Thesis Loïck Moriggi 
 
Figure III.3-1. Signal of aromatic protons in the 1H NMR spectra of L2- : 
[Y2bpy-DTTA2(H2O)4]2-, RuL22-: {Ru[Y2bpy-DTTA2(H2O)4]2}2- and RuL34- : 
{Ru[Y2bpy-DTTA2(H2O)4]3}4- before (upper figure) and after (lower figure) 
purification with Sephadex LH20 size-exclusion chromatography. 
The chromatographic purification of {Ru[Ln2bpy-DTTA2(H2O)4]3}4- has been monitored by 
1H NMR for Ln = Y (Figure III.3-1). The first 40 mL of eluate coming out of the size-
exclusion column contain pure orange {Ru[Y2bpy-DTTA2(H2O)4]3}4-. The following 10 mL 
present traces of {Ru[Y2bpy-DTTA2(H2O)4]2(H2O)2}2- and the last 40 mL contain a mixture 
of red {Ru[Y2bpy-DTTA2(H2O)4]3}4-, {Ru[Y2bpy-DTTA2(H2O)4]2(H2O)2}2- and free [Y2bpy-
DTTA2(H2O)4]4- ligand.  
III.3.2  Optical characterization of the tris-(2,2’-bipyridyl)ruthenium(II) unit 
Room-temperature absorption (Figure III.3-2(a)), excitation (Figure III.3-2(b), dotted trace) 
and emission spectra (Figure III.3-2(b), solid trace) of {Ru[Ln2bpy-DTTA2(H2O)4]3}4- (Ln = 
Y3+, Eu3+) were recorded in bi-distilled water (1.5×10-5 mM) (Table III.3-1). The spectra of 
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the two-lanthanide complexes look identical in terms of band shapes and positions, and only 
those of the Eu3+ complex are shown here. 
 
Figure III.3-2. Normalized absorption and luminescence spectra of 1.5·10-5 
M aqueous solutions of Na4{Ru[Eu2bpy-DDTA2(H2O)4]3}: (a) 295 K 
absorption spectrum, (b) 295 K steady-state excitation spectrum (dotted 
trace) monitored at 625 nm (upwards arrow) and emission spectrum (solid 
trace) upon excitation at 450 nm (downwards arrow); (c) same as (b) but at 
77 K; (d) 295 K gated excitation spectrum (dotted trace) monitored at 614 
nm, (upwards arrow) and emission spectrum (solid trace) upon excitation at 
293 nm (downwards arrow) recorded with a 0.05 ms delay, (e) 77 K gated 
excitation spectrum (dotted trace) recorded at 614 nm (upwards arrow) and 
emission spectrum (solid trace) upon excitation at 450 nm (downwards 
arrow) recorded with a 0.15 ms delay. 
The absorption bands arising on the high-energy side of the spectrum displayed on Figure 
III.3-2(a), as well as the one peaking at 293 nm, are assigned to ligand-centred (LC) ππ* 
transitions.30 The remaining intense bands around 250 and 450 nm (the latter of which being 
responsible for the deep orange color of the complexes), are attributed to spin-allowed metal-
to-ligand-charge-transfer (1MLCT) d→π* transitions; the shoulders at 330 and 360 nm are 
probably the metal-centred (MC) d→d transitions. The presence of a second absorption band 
on the low-energy side of the 1MLCT transition, i.e. at 530-550 nm, would indicate the 
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presence of the bis-aqua complexes {Ru[Ln2bpy-DTTA2(H2O)4]2}2-,30 which is not the case 
here. 
Table III.3-1. Transition wavelengths and energies determined from the spectra 
presented in Figure III.3-2 and lifetimes (τobs) of Eu(5D0). 
λ 
[nm] 
λ-1 
[cm-1] 
Assignment τobs 
[ms] 
        < 200 > 50000 bpy LC ττ*   
    215 46512 bpy LC ττ*  
    247 40486 [Ru(bpy)3]2+ MLCT dτ*  
    256 39063 [Ru(bpy)3]2+ MLCT dτ*  
    293 34130 bpy LC ττ*  
    330 30303 Ru2+ MC d d  
    360 27778 Ru2+ MC d d  
    400 25000 [Ru(bpy)3]2+ 1MLCT dτ*  
    430 23256 [Ru(bpy)3]2+ 1MLCT dτ*  
    462 21645 [Ru(bpy)3]2+ 1MLCT dτ*  
    584 17123 [Ru(bpy)3]2+ 3MLCT dτ*  
    625 16000 [Ru(bpy)3]2+ 3MLCT dτ*  
    660 15151 [Ru(bpy)3]2+ 3MLCT dτ*  
    680 14706 [Ru(bpy)3]2+ 3MLCT dτ*  
       578 17301 Eu(5D0  7F0)  
   588 17007 Eu(5D0  7F1)  
   594 16835 Eu(5D0  7F1)  
   614 16287 Eu(5D0  7F2)  
   621 16103 Eu(5D0  7F2)  
   687 14556 Eu(5D0  7F4)  
   695 14388 Eu(5D0  7F4)  
0.04 ± 0.001 (295 K) 
 
0.64 ± 0.001 (77 K) 
 
Steady-state excitation of solutions of the three Ln complexes at 295 K and 450 nm (see 
downwards arrow in Figure III.3-2(b)) into the [Ru(bpy)3]2+ 1MLCT absorption band leads to 
the emission spectrum presented in Figure III.3-2(b) (solid trace). The broad and intense 
emission band extending from 550 to nearly 850 nm with a peak and a shoulder at 625 and 
660 nm, respectively, is due to transitions from [Ru(bpy)3]2+ 3MLCT excited states to the 
Ru(1A1) ground state.31 When monitoring the [Ru(bpy)3]2+ 3MLCT emission at 625 nm (see 
upwards arrow in Figure III.3-2(b)) the excitation spectrum closely follows the absorption 
spectrum (Figure III.3-2(a)(b)). 
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Upon cooling an aqueous solution of {Ru[Eu2bpy-DTTA2(H2O)4]3}4- 1.5×10-5 M to 77 K, a 
dramatic change is observed in the emission spectrum in terms of band shapes and positions 
(see solid trace, Figure III.3-2(c)) with respect to the corresponding room-temperature data: 
the 77 K spectrum is blue-shifted, with maxima at 584 nm and 625 nm with an shoulder 
around 680 nm. In addition, a sharp band is observed at 614 nm being assigned to the 
Eu(5D0→7F2) transition. 
When monitoring the [Ru(bpy)3]2+ 3MLCT emission of an aqueous solution of 
Na4{Ru[Eu2bpy-DTTA2(H2O)4]3} 1.5×10-5 M at 625 nm, the excitation spectrum at 77 K 
again closely matches the absorption spectrum (Figure III.3-2(a)(c)), indicating no drastic 
change of the [Ru(bpy)3]2+ absorption properties between 77 K and 295 K. 
The ruthenium(II) tris(bipyridine) complex is usually considered as being essentially 
photochemically inert towards ligand substitution at room temperature:15 the quantum yield of 
[Ru(bpy)3] disappearance in aqueous solution lies in the range 10-5 – 10-3, depending on pH 
and temperature. A detailed mechanism for the ligand photo-substitution reaction has been 
proposed by Durham and al.:16 thermally activated formation of a MC excited state leads to 
the cleavage of a Ru-N bond with subsequent formation of a five-coordinate square pyramidal 
species. When coordinating anions are present, as in the chloride salt, an hexacoordinate 
monodentate bipyridyl species can lose one bpy ligand upon formation of [Ru(bpy)2X2], or by 
a self-annealing process (chelate ring closure), with reformation of [Ru(bpy)3]. The self-
annealing protective step has been shown to be favored in aqueous solution.16 In our case, due 
to the presence of polyamino-carboxylate complexed by lanthanides, steric hindrance should 
disfavour the formation of the 5-coordinate species and no change of the spectra has been 
observed after illumination. 
III.3.3 Sensitized Eu luminescence 
The weak and sharp Eu(5D0→7F2) emission band observed at 614 nm in the steady-state 
emission spectrum at 77 K (Figure III.3-2(c)) is masked by the broad and much stronger 
[Ru(bpy)3]2+ 3MLCT emission extending from 550 to nearly 800 nm. Fortunately, the 
luminescence lifetime of the Eu(5D0) excited state is several orders of magnitude longer 
compared to that of the 3MLCT excited state of [Ru(bpy)3]2+, which lies in the µs range.32, 33 
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Thus, the Eu(5D0→7FJ) emission spectrum can be unraveled by means of time-gated emission 
spectroscopy, i.e. upon enforcing an appropriate delay time (here 0.05 ms) between the 
excitation pulse and detection of the emission. This method has been applied to the solution of 
Na4{Ru[Eu2bpy-DTTA2(H2O)4]3} 1.5⋄10-5 mM in H2O and the resulting room-temperature 
spectrum  obtained under excitation at 293 nm (maximum of the bpy ππ* absorption band) is 
displayed on Figure III.3-2(d). It exhibits several sharp bands, which can unambiguously be 
attributed to Eu(5D0→7FJ, J = 0-4) transitions. 
The excitation spectrum (dotted trace, Figure III.3-2(d)) obtained under monitoring the 
Eu(5D0→7F2) emission band at 614 nm, resembles the absorption spectrum of Figure 
III.3-2(a), except for the relative band intensities. In the excitation spectrum, the ligand-
centred (LC) transition around 293 nm is much more intense with respect to the 1MLCT band 
around 450 nm. This observation is in line with the fact that at 295 K no Eu(5D0→7FJ) 
luminescence could be measured upon excitation of the [Ru(bpy)3]2+ 1MLCT excited state(s) 
at 450 nm. This indicates that at room temperature, there is either no [Ru(bpy)3]2+→ Eu3+ 
energy transfer and/or very efficient non-radiative quenching of the Eu(5D0→7FJ) 
luminescence (Figure III.3-3).  
However, the situation is different at 77 K, where excitation at 450 nm into the [Ru(bpy)3]2+ 
1MLCT absorption band leads to the Eu(5D0→7FJ) emission spectrum (Figure III.3-2(e)) when 
a time delay 0.15 ms is enforced. In addition, the excitation spectrum obtained upon 
monitoring the hypersensitive 5D0→7F2 transition (dotted trace, Figure III.3-2(e)) closely 
matches the absorption spectrum, even in terms of relative band intensities. The similarities in 
the two excitation spectra recorded at 295 and 77 K prove that the sharp-line emission occurs 
through excitation of the [Ru(bpy)3]2+ unit and is not due to other species present in the 
sample at trace levels. 
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Figure III.3-3. Energy diagram accounting for the most important pathways 
of energy transfer in aqueous solutions of Na4{Ru[Eu2bpy-DDTA2(H2O)4]3}. 
The most straightforward explanation for the observation of Eu(5D0) luminescence at 77 K 
and not at 295 K is a decrease in the efficiency of non-radiative quenching processes upon 
lowering the temperature. Additionally, the blueshift of the emission spectrum of the 
[Ru(bpy)3]2+ donor upon cooling leads to an increased spectral overlap1 with the Eu(7FJ→5D0) 
absorption spectrum of the acceptor. Unfortunately, the latter could not be measured due to 
the too small molar absorption coefficients of these transitions. 
To gain more information about the quenching of the Eu(5D0) luminescence by its chemical 
environment at 295 K and at 77 K, the luminescence lifetime of Na4{Ru[Eu2bpy-
DTTA2(H2O)4]3} in H2O was determined upon monitoring the maximum of the Eu(5D0→7F2) 
emission band at 614 nm. At room temperature, excitation was into the ligand ππ* absorption 
at at 293 nm while at 77 K the complex was excited into the [Ru(bpy)3]2+ 1MLCT absorption 
at 450 nm. Mono-exponential decays of the europium emission were observed at both 
temperatures, yielding Eu(5D0) luminescence lifetimes of 0.40 ± 0.001 ms and 0.64 ± 0.001 
ms at 295 K and 77 K, respectively. These values are in agreement with the presence of two 
water molecules in the first coordination sphere of the Eu3+ ions (Figure III.1-1). 
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III.3.4  1H Relaxivity of {Ru[Gd2bpy-DTTA2(H2O)4]3}4- 
The longitudinal 1H relaxation rates for {Ru[Gd2bpy-DTTA2(H2O)4]3}4- were measured as a 
function of the magnetic field at two temperatures (298 and 310 K) and normalized to 
millimolar Gd3+ concentration to obtain the longitudinal proton relaxivity, r1, in mM-1s-1.34 At 
NMR frequencies below 100 MHz the relaxivities measured for the Ru-metallostar are 
slightly higher than those for the Fe-metallostar (Figure III.3-4).10 Both profiles show a 
relaxivity hump between 10 and 100 MHz characteristics for slowly rotating molecules. In 
that frequency range the relaxivities of both metallostars are considerably higher than those 
observed for the dinuclear complex [Gd2bpy-DTTA2(H2O)4]- used as building block for the 
metallostars. 
 
Figure III.3-4. 1H NMRD profiles and of (●) {Ru[Gd2bpy-
DTTA2(H2O)4]3}4- at 25°C, () {Fe[Gd2bpy-DTTA2(H2O)4]3}4- at 25°C, () 
{Ru[Gd2bpy-DTTA2(H2O)4]3}4- at 37°C, () {Fe[Gd2bpy-DTTA2(H2O)4]3}4- 
at 37°C, () [Gd2bpy-DTTA2(H2O)4]2- at 25°C and (◊) [GdDOTA(H2O)]- at 
25°C. 
The slight differences in the NMRD profiles of the metallostars cannot be explained by 
inaccurate gadolinium concentrations, because its amplitude varies with magnetic field and 
temperature. The slightly lower relaxivity for {Fe[Gd2bpy-DTTA2(H2O)4]3}4- suggests that 
the iron-containing metallostar solution might contain a small amount of the bis-complex 
{Fe[Gd2bpy-DTTA2(H2O)4]2}2- in solution, having faster rotation correlation times τR and 
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different electronic relaxation. In this case the observed r1 would be the weighted mean of a 
small contribution due to the bis-complex and a major contribution due to the tris-complex. 
Livramento et al. 10 tried to perform a combined analysis of multi frequency 17O and 1H 
relaxation data on {Fe[Gd2bpy-DTTA2(H2O)4]3}2- using Solomon-Bloembergen-Morgan 
(SBM) theory35-37 together with the Lipari-Szabo model-free approach38, 39 for internal 
rotation (SBM-LS). In this approach the electron spin relaxation rates, 1/Tie, are due to the 
time dependent transient zero-field-splitting (ZFS) and no static ZFS is considered. However, 
a simultaneous analysis of 17O and 1H relaxation data was not possible; in particular, an 
acceptable fit of the 17O transverse relaxation rates seemed to be incompatible with the low-
field NMRD data.10, 34, 40  
In a first attempt, we analyzed the NMRD profiles at 25° C of both {Ru[Gd2bpy-
DTTA2(H2O)4]3}4- and {Fe[Gd2bpy-DTTA2(H2O)4]3}4- using the same SBM-LS approach. 
We fixed the distances between the electron spin and the nuclear spin to the usual values of 
rGdH = 3.1 Å (first sphere water protons) and aGdH = 3.5 Å (outer sphere water protons). To 
reduce the number of fitted parameters further we fixed the constant for intermolecular 
translational diffusion to 298diffD = 2.5×10
-9 m2 s-1 and the exchange rate constant for first sphere 
water molecules to 298
ex
k = 8.3×106 s-1, a value that is common for DTTA complexes.10, 11, 41, 42 
Only five parameters are left for fitting the NMRD profiles: the global and local rotational 
correlation times 298
g
!  and 298
l
! , respectively, the transient ZFS parameter, 2
t
!  and its 
correlation time, 298
v
! , and the order parameter S2. It can clearly be seen from the fitted curves 
(Figure III.3-5 and Figure III.3-6, dashed lines) that SBM theory is not able to reproduce the 
flat dispersion at Larmor frequencies between 0.5 and 8 MHz. Relaxivities at high resonance 
frequencies (≥ 40 MHz) are however well reproduced by the SBM-LS approach. 
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Figure III.3-5. 1H NMRD profiles at 25°C of {Ru[Gd2bpy-
DTTA2(H2O)4]3}4-. The lines represent the least-squares fitting of all data 
points following S-B-M theory with Lipary-Szabo (- - -) and Florence 
approach (solid trace). 
 
Figure III.3-6. 1H NMRD profiles at 25°C of {Fe[Gd2bpy-
DTTA2(H2O)4]3}4-. The lines represent the least-squares fitting of all data 
points following S-B-M theory with Lipary-Szabo (- - -) and Florence 
approach (solid trace). 
In a second attempt we used the approach of Bertini et al.27 and Kruk et al.28 also called the 
"modified Florence method".43 This method includes a transient and a static ZFS, and 
assumes a slow reorientation of the paramagnetic complex and a lack of correlation between 
the rotation and translation of the complex and the electron spin dynamics.28 The electron spin 
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relaxation uses the pseudo-rotation model for the modulation of the transient ZFS and is 
described by a Redfield formulation. It has been shown that the modified Florence method is 
well-suited for fitting experimental NMRD profiles for slowly-rotating complexes of Gd3+.43  
Table III.3-2. Parameters at 298 K obtained for {Ru[Gd2bpy-DTTA2(H2O)4]3}4- and 
{Fe[Gd2bpy-DTTA2(H2O)4]3}4- complexes from fitting 1H NMRD data (kex298 has been fixed). 
 {FeII[Gd2bpy-DTTA2(H2O)4]3}4- {RuII[Gd2bpy-DTTA2(H2O)4]3}4- 
 SBM with Lipari-
Szabo 
modified 
Florence 
SBM with Lipari-
Szabo 
modified 
Florence 
298
ex
k  (106 s-1) 8.3 (fixed) 8.3 (fixed) 8.3 (fixed) 8.3 (fixed) 
298
g
!  (ps) 1200 832 1120 833 
298
l
!  (ps) 143 - 59 - 
298
v
!  (ps) 23 16 28 23 
∆t2 (1020s-2) 0.17 0.082 0.12 0.051 
∆s2 (1020s-2) - 0.982 - 0.580 
S2 0.50  - 0.61 - 
 
The influence of the static ZFS on NMRD profiles depends on its symmetry and its 
orientation with respect to the Zeeman interaction.44, 45 If we limit the description to second-
order, the static ZFS parameter 2s!  can be expressed in terms of the axial (D) and rhombic (E) 
coefficients as 2/3×D2+2×Ε 2. 46   For simplicity we assumed axial symmetry (E = 0) and 
coinciding tensors for the static ZFS and the dipole-dipole interaction. NMRD profiles for 
both {Ru[Gd2bpy-DTTA2(H2O)4]3}4- and {Fe[Gd2bpy-DTTA2(H2O)4]3}2- are well reproduced 
up to 100 MHz (Figure III.3-5 and Figure III.3-6). At higher frequencies the modified 
Florence approach underestimates the relaxivities because it assumes rigid molecules and 
neglects internal motion.  
The fitted parameters of both analyses are given in Table II.3-2. Because 2
t
!  and 298
v
!  from 
SBM-LS analysis should be considered to be fitting parameters only without specific physical 
meaning, we will not discuss them. The global rotational correlation times 298
g
!  are very 
similar, as expected from the similar size of the metallostars. The small differences in the 
local correlation times and the order parameters have to be regarded with caution. These 
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parameters are strongly correlated and essentially defined by the high-field data points. The 
fitted order parameters S2 are relatively high indicating fairly rigid complexes.  
The rotational correlation times obtained with the modified Florence approach are about 2/3 
of 298
g
!  because, as already mentioned, no internal rotation is considered in this approach. 
Correlation times due to electron spin relaxation, 
S
! , can be calculated in the low field limit 
from 2
t
!  and 298
v
! .27 Both calculated values, 710 ps (Ru-metallostar) and 635 ps (Fe-
metallostar), are smaller than the rotational correlation times 298
R
!  justifying the use of the 
modified Florence approach.27 Benmelouka et al.44 measured static ZFS parameters on frozen 
solutions of several DTTA-type Gd3+-complexes. Our 2
s
!  values (Table III.3-1) are close to 
those, which can be calculated from D and E values in Table 1 in reference 44 (with 2
s
!  
values in the range 0.87×1020 s-2 to 0.92×10 20 s-2). However, a rhombic distortion from axial 
symmetry which is close to theoretical maximum ratio of E/D=1/3 has been found for frozen 
solutions. We tried without success to fit the NMRD profiles for both metallostars using this 
E/D = 0.3. One possible explanation for this failure is that at 300 K we observe a mixture of 
different coordination polyhedra for Gd3+ in solution, each having different static ZFS 
parameters. The distribution at room temperature among these structural isomers can well be 
different from what is observed at 4 K in frozen solutions. A further problem arises from the 
assumption that the tensors for static ZFS and for dipole-dipole interaction coincide. There are 
two water molecules in the first coordination sphere of Gd-DTTA- and the assumption used 
can only be strictly valid for one of them. Treating the two inner sphere water molecules 
differently in the data fitting would lead to an unreasonable number of parameters, even if we 
assume that the distances rGdH and exchange rate constants kex are equal. 
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III.4 CONCLUSION 
In this chapter III, we describe the self-assembly of the d/f heptametallic edifices 
{Ru[Ln2bpy-DTTA2(H2O)4]3}4- with Ln = Y3+, Gd3+, Eu3+. Besides the higher stability of the 
[Ru(bpy)3]2+ unit compared to its iron(II) analogue, the ruthenium-based metallostar shows 
interesting photophysical properties in addition to its capacity to act as MRI contrast agent. 
Structural characterization in solution was achieved by 1H NMR on the diamagnetic yttrium 
complex by analyzing the aromatic protons of the bipyridyl unit. The gadolinium complex 
gives rise to NMRD profiles in accordance with those of the iron-based metallostar.2 NMRD 
profiles of both Ru2+ and Fe2+ based metallostars have been analysed using SBM theory 
including a Lipary-Szabo treatment of internal motion and using the modified Florence 
approach developed for slowly rotating, rigid complexes. Data-analysis showed the 
incapability of SBM theory to reproduce correctly NMRD profiles between 0.5 and 8 MHz 
for slowly rotating compounds. Parameters of static ZFS as obtained from the modified 
Florence method are in reasonable agreement with low temperature EPR results.44 
Comparison of both methods shows that inclusion of internal motion is necessary to have a 
correct description of high-frequency relaxivity. 
The photophysical data determined for Na4{Ru[Eu2bpy-DTTA2(H2O)4]3} demonstrate the 
feasibility of d→f visible-sensitized europium 5D0→7FJ luminescence in aqueous solution. 
This opens the way for the development of bimodal biological art bimodal bioprobes 
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IV.1 INTRODUCTION 
Colloidal and functionalized nanoparticles are presently under intensive study to produce 
useful tools for molecular diagnosis, therapies, and biotechnology. Several papers reported 
interesting behavior for nanoparticles as for example a longer vascular half-life than for small 
molecular agents, suggesting a real potential as contrast agents for medical imaging.1-5 
Among metallic elements, Pd, Pt, and Au nanoparticles have been widely synthesized because 
noble metals are easier to reduce than transition metals. In a cluster, noble metal atoms 
spontaneously form large particles (diameter > 10 nm) to reduce their surface energy. A 
practical means of preventing this cohesion is to isolate nanoparticles by coating them with 
protective agents. These chemically synthesized metal nanoparticles can be generally 
categorized into two subgroups, colloidal clusters and clusters covalently bonded to ligands. 
Gold clusters have been reported recently with protective agents in colloids such as 
polyacrylonitrile, polyallyl amine hydrochloride and polyvinyl pyrolidone,6-9 or covalently 
stabilized with a mercapto bond such as dodecane thiol.10, 11 
Gold nanoparticles are easily functionalized by thiol derivatives, opening multimodal 
perspectives. As MRI contrast agent, nanoparticles coated with Gd3+ chelates present the 
advantage of offering a rigid core to the contrast agents, minimizing internal degrees of 
freedom. Another interesting aspect is the high electron density of these objects, promising 
gold nanoparticles as agent for X-ray spectroscopy. In 2007, Tillement et al.12 reported 
multilayer Gd3+ chelates capped gold nanoparticles combining magnetic resonance imaging 
(MRI) and X-ray computed tomography (CT) imaging. They showed that their particles are 
suited for freely circulating in the blood vessels without undesirable accumulation in the 
lungs, spleen and liver.  
The creation of perfect nanometer-scale crystallites (nanocrystals), identically replicated in 
almost unlimited quantities, in a state that can be manipulated and understood as pure 
macromolecular substances, is an ultimate challenge of modern materials research with 
outstanding fundamental and potential technological consequences.13  
Bulk Au metal is chemically stable and has diamagnetic properties. However, recent studies 
revealed that Au nanoparticles can show magnetism at nanoscale (nm). In 1999, Hori et al.14 
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presented magnetization of Pd and Au nanoparticles with a diameter of around 3 nm at 4.2 K 
where poly-N-vinyl-2-pyrrolidone (PVP) was used as protective agents to the metal particles. 
The data of magnetization of nanoparticles of both elements showed an unexpectedly large 
magnetic moment suggesting the existence of some spin correlation mechanism in the 
nanoparticles.  
Electronic and magnetic properties induced by close-packed monolayers of thiols on gold 
were presented in 2003 by Carmeli et al.15. Particules formed with octadecanethiolated or 
ethanethiolated molecules self-assembled on gold show a surprisingly large ferromagnetism 
and the phenomenon can be considered as a new type of magnetism. Charge transfer between 
the substrate and the adsorbed layer is indicated as the origin of this magnetism.  
Direct observation of intrinsic magnetization behavior of Au in thiol-capped gold 
nanoparticles with permanent magnetism at room temperature was reported in 2004 by Hori 
et al.7 The magnetic moment per Au atom in the particle attains its maximum value in the 
magnetization-diameter curve at a diameter of about 3 nm. Because Au metal is a typical 
diamagnetic material, they supposed that the ferromagnetic polarization mechanism is quite 
different from the ferromagnetism observed in transition metals and the size effect suggests 
the existence of some spin-correlation effect at the nanoscale. 
The origin of orbital magnetism of thiol capped gold films and nanoparticles as a consequence 
of spin-orbit coupling was discussed in 2005 by Hernando et al.16 A great difference exists 
between the magnetic behavior observed for nanoparticles and for thin films for the case of 
gold capped with thiol groups. For both cases, a large anisotropy can be detected. However, 
whereas the magnetic moment reaches giant values (10 or even 100 µB per atom) for films, it 
is extremely low (0.01 µB per atom) for NPs. There is experimental evidence associating the 
appearance of magnetic properties with the charge transfer that takes place by thiol bonding. 
Uncapped gold thin films as well as uncapped gold NPs have been shown to be diamagnetic 
as bulk gold metal. 
An exhaustive characterization of thiol-capped gold nanoparticles (NPs) with two different 
average particle sizes was presented in 2006 by Guerrero et al.17 The set of analyzed samples 
shows microstructures at the nanoscale with different proportions of Au atoms bonded either 
to S or to Au atoms. It was experimentally shown that the presence of a ferromagnetic-like 
behavior is associated to the formation of NPs with simultaneous presence of Au–Au and Au–
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S bonds. In order to explain such magnetic behavior, they proposed a model based on the 
spin–orbit coupling so that localized charges and/or spins of the Au–S bonds can trap 
conduction electrons from Au–Au bonds in orbits.  
The preparation, the characterization and the magnetic properties of gold and gold-iron oxide 
particles prepared in the presence of aqueous solution of thiol functionalized 
neoglycoconjugates (GNPs) was described in 2006 by De la Fuente et al.18 Iron-free gold or 
gold-iron oxide particles with controlled gold-iron ratios were obtained. The average core-size 
diameters are in the range of 1.5-2.5 nm. They observed a permanent magnetism up to room 
temperature in the iron-free gold GNPs. This magnetism was not present in the corresponding 
gold-iron oxide.  
An experiment showing that magnetic impurities reduce the ferromagnetic order temperature 
in thiol-capped Au glyconanoparticles was reported in 2006 by Crespo et al.19 The 
spontaneous magnetization of AuFe glyconanoparticles exhibits a fast decrease with 
temperature that contrasts with the almost constant value of the magnetization observed in Au 
NPs. Moreover, hysteresis disappears below 300 K. Both features indicate that Fe impurities 
reduce the high local anisotropy field responsible for the ferromagnetic behavior in Au 
glyconanoparticles. As a consequence, the amazing ferromagnetism in Au NPs should not be 
associated with the presence of magnetic impurities.  
A direct observation of the intrinsic magnetization behavior of Au in thiol-capped gold 
nanoparticles with permanent magnetism at room temperature were reported in 2008 by 
Garitaonandia et al.20 They show that silver and copper nanoparticles synthesized by the same 
chemical procedure also present room-temperature permanent magnetism. The observed 
permanent magnetism at room temperature in Ag and Cu dodecanethiol-capped nanoparticles 
proves that the physical mechanisms associated to this magnetization process can be extended 
to more elements, opening the way to new and still not-discovered applications and to new 
possibilities to research basic questions of magnetism.  
We present here well-defined thiol-capped gold nanoparticles coated with DTTA 
derivatives,21 complexed with gadolinium(III) and yttrium(III) lanthanides (Gd-DtNP and Y-
DtNP). We provide characterization of solutions of gold nanoparticles using TEM, dynamic 
light scattering (DLS), ICP-MS, STEM coupled EPX analysis and protons relaxation 
enhancement in water. Relaxivity and bulk magnetic susceptibility measurements have been 
Chapter IV. DTTA thiol capped gold nanoparticles DtNP 
110  Thesis Loïck Moriggi 
used to observe whether there is a significant paramagnetic behavior of the gold core in these 
DtNP systems. 
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IV.2 EXPERIMENTAL SECTION 
IV.2.1 Synthesis of lanthanide functionalized gold nanoparticles (Ln-DtNP) 
All commercial reagents were used as received unless otherwise noted. Compound 3 (Figure 
IV.2-1) has been synthesized as described in literature.22 
 
Figure IV.2-1. Synthetic route of the compound Dt. 
Synthesis of compound 2 
To a solution of compound 1 (S-(4-Methylphenyl)thioacetate) (2.75 g, 16.5 mmol) and  of N-
bromosuccinimide (2.90 g, 16.5 mmol) in CC14 (41.3 ml), was added AIBN 
(azobisisobutyronitrile) (23 mg). The reaction mixture was refluxed with stirring over night. 
The solution was cooled to room temperature and the succinimide removed by filtration. After 
evaporation of the volatiles, the residue was purified by column chromatography (SiO2) 
eluted with petroleum ether / DCM (95:5). Concentration of the eluate gave the bromide 2 as 
colorless oil, which solidifies in the fridge (2.2 g, 55%). 1H NMR (δ, CDCl3): 2.32 (s, 3H), 
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4.46 (s, 2H), 7.10 (d, 2H, J = 8.1 Hz), 7.38 (d, 2H, J = 8.1 Hz); 13C NMR (δ, CDCl3): 30.2, 
32.5, 129.5, 129.7, 134.6, 139.0, 193.5. 
Synthesis of compound 4 
Compound 3 (N,N’-[(imino)bis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine] tetrakis(1,1-
dimethylethyl) ester) (3.15 g, 5.62 mmol), was dissolved in dry CH3CN (393 ml) under argon. 
Compound 2 (2.13 g, 8.5 mmol) and K2CO3 (2.3 g, 17 mmol) were added. The solution was 
heated to 83°C with stirring for 36 h under argon atmosphere and then cooled to room 
temperature. The resulting mixture was filtrated, evaporated under reduced pressure and 
purified by column chromatography on a neutral alumina stationary phase eluted with 
CH2Cl2/MeOH (100: 4). Compound 4 (brown oil) was obtained (594 mg, 0.87 mmol). (yield: 
15.4%) 1H NMR, 400 MHz, CDCl3, δ in ppm : 1.42 (s, 36 H); 2.59 (m, 4 H); 2.81 (m, 4 H); 
3.39 (s, 8 H); 3.59 (s, 2 H); 7.26 (d, 2 H, J = 7.34 Hz); 7.39 (d, 2 H, J = 7.34 Hz). MS (ESI): 
m/z: 681.34 [MH]+.  
Synthesis of compound Dt  
The compound 4 (594 mg, 0.87 mmol) was deprotected by saponification with KOH (750 mg, 
13.4 mmol) under stirring for 32 h in boiling H2O/MeOH (50/50) (80 ml). After evaporation, 
the crude product was acidified at pH≈2 and purified by ion-exchange chromatography on 
Bio-Rad AG 50W-4X resin eluted with a gradient of HCl (1-5 M) and then aqueous NH3 0.5 
M. The pure fractions were evaporated; the resulting yellow oil was dried under vacuum (194 
mg, 0.428 mmol) (yield: 49.2%). 1H NMR, 400 MHz, D2O, δ in ppm: 2.85 (m, 8 H); 3.39 (m, 
8 H); 3.60 (s, 16 H); 3.64 (s, 4 H), 7.31 (d, 4 H, J = 7.83 Hz); 7.51 (d, 4 H, J = 7.82 Hz). MS 
(ESI): m/z: 458.23 [MH]+.  
DTTA thiol capped gold nanoparticles (DtNP)  
Three batches (DtNP(1); DtNP(2); DtNP(3)) have been synthesized with different HAuCl4/Dt 
ratios (Figure IV.2-2). 
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 HAuCl4 + Dt NaBH4
0°C
! "!!  DtNP 
 in CH3OH  in H2O/ acetic acid   
(1) 15.5 µmol  121.0 µmol  DtNP(1) 
(2) 15.5 µmol  17.7 µmol  DtNP(2) 
(3) 46.5 µmol  171.0 µmol  DtNP(3) 
Figure IV.2-2. Quantities of gold and Dt used to synthesise the three DtNP 
samples. 
 At 0°C, in methanolic solution of HAuCl4 (DtNP(1): 6 mg, 15.5 µmol, 2 ml MeOH ; 
DtNP(2): 6 mg, 15.5 µmol, 2 ml MeOH ; DtNP(3): 6 mg, 15.5 µmol, 2 ml MeOH), an 
aqueous solution of compound Dt (DtNP(1): 55 mg, 121.0 µmol, 18 ml ; DtNP(2):  8 mg, 
17.7 µmol, 3 ml ; DtNP(3): 77.5 mg, 171.0 µmol, 29 ml) was added with glacial acetic acid 
(DtNP(1): 195 µl ; DtNP(2): 32 µl ; DtNP(3): 389 µl). Then, an aqueous solution of NaBH4 
(DtNP(1): 1.95 ml, 0.35 M ; DtNP(2): 320 µl, 0.35 M ; DtNP(3): 3.89 ml, 0.35 M) was added 
at once. Black-brown flocculates appeared after about 10 mn. Flocculates were recovered by 
centrifugation and dissolved in pure water.  
Ln-DtNP 
The DtNP batches have been complexed with gadolinium(III) (Gd-DtNP(1), Gd-DtNP(2) and 
Gd-DtNP(3)) and yttrium(III) (Y-DtNP(2), and Y-DtNP(3)).  
Stock solutions of GdCl3 and YCl3 were prepared in double distilled water. Concentrations 
were determined by complexometric titration with standardized Na2H2edta solution using 
xylenol orange as indicator (H4edta = ethylene- diaminetetraacetic acid). Solutions of Ln-
DtNP were prepared by mixing solutions of LnCl3 and solutions of the functionalized gold 
nanoparticles DtNP under stirring at room temperature. An excess of LnCl3 was used and the 
pH was adjusted to about 7-7.5 by adding solution of NaOH. Solutions were filtered with a 
0.4 µm micropore filters and purified with a size-exclusion column (Sephadex LH20). The 
absence of free metal was checked in each sample by the xylenol orange test. A part of Y-
DtNP(3) and Gd-DtNP(3) solutions have been diluted to obtain solutions Y-DtNP(3)-2 and 
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Gd-DtNP(3)-2, Gd-DtNP(3)-3 and Gd-DtNP(3)-4 respectively. Solution concentrations were 
determined with ICP-MS technique (see below). 
IV.2.2 Transmission Electron Microscopy (TEM, STEM/EDX) 
Visualization of gold nanoparticles was performed with a transmission electron microscope 
(TEM) JEOL 2010 UHR in the Interdisciplinary Centre for Electron Microscopy (CIME) at 
EPFL (Lausanne, Switzerland). Samples were prepared by dropping a gold nanoparticle 
solution onto a carbon-coated copper grid, and allowing the solvent to evaporate at room 
temperature and standard pressure. TEM images have been treated with Adobe Photoshop 
software and Feret’s diameter distributions of each TEM image have been calculated with 
ImageJ 1.41k software.23 
Imaging on a scanning transmission electron microscope (STEM) with mapping by energy 
dispersive X-ray (EDX analysis) was performed on the same samples prepared for TEM 
spectroscopy. STEM and EDX signals can be obtained simultaneously, allowing direct 
correlation of image and quantitative EDX data. 
IV.2.3 Dynamic light scattering (DLS)  
The dynamic light scattering was performed in cubic cells of 0.5 ml with a Zetasizer Nano 
from Malvern Instruments Ltd. The hydrodynamic diameter distributions were analyzed for 
the aqueous samples (real part of the refractive index n = 1.6, imaginary part of the refractive 
index k = 0.1),24 characterized with a single angle 173° backscatter system incorporating a 
633nm laser. 
IV.2.4 Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)  
Yttrium, gadolinium, and gold concentrations in solution were determined by ICP-MS 
analysis using an ELAN 6100 DRC mass spectrometer (Perkin Elmer, Norfolk, Canada) 
interfaced to an Apex sample introduction system (Epond SA, Vevey, Switzerland) at the 
Institut de Minéralogie et Géochimie, University of Lausanne. The argon flow rates of the 
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spectrometer amounted to 0.76-0.80, 1.20 and 15 L/min for the nebulizer, auxiliary and main 
flows, respectively. The ICP RF power was set at 1275 W. The solution uptake rate was close 
to 100 µL/min. Typical sensitivities obtained during optimization of the spectrometer were in 
the range of 20-25 ! 103 cps for Mg24, 60-80 ! 103 cps for In115 and 70-90 ! 103 cps for U238 (1 
ppb Perkin Elmer optimization solution). The CeO and Ba2+ production rates were below 1.5 
and 2.9 %, respectively. The instrumental background measured on masses 8.5 and 220 was 
below 1-2 cps. The isotopes analyzed in sample solutions were Y89, Rh103, Gd157 and Au197. 
The measurement protocol included a 40 ms dwell time per isotope; peak hopping mode was 
employed. 8 runs per measurement were performed, with each containing 50 scans of the 
isotope intensities. Wash times amounted to 60 s for sample solutions and to 120 s after each 
(re-)standardization. In order to obtain a stable signal, a 60 s sample flush preceded each 
measurement. 
The blank solution contained distilled water used to dilute the sample solutions. Two 
standards with known concentrations of Y3+, Gd3+ and Au3+ were prepared from titrated 
solutions. Standard solution I had 0.997 ppm Y3+, 1.002 ppm Gd3+ and 2.220 ppm Au3+, while 
standard solution II contained 0.111 ppm Y3+, 0.165 ppm Gd3+ and 0.240 ppm Au3+ 
(henceforth, all values in ppm or percents correspond to weight concentrations). All blank, 
standard and sample solutions were acidified by adding 0.2 % HNO3 and doped with 0.38 
ppm Rhodium for internal standardization. In order to minimize the calibration drift of the 
instrument, the standard solutions were re-measured after each two-sample solution.  
To evaluate the analytical uncertainties of our measurements, a repetitive analysis of a sample 
solution was performed (see Table IV.2-1). Very low concentration (ppb-level) of Y and Gd 
detected in some solutions, which should have been free of Y and Gd (respectively Gd-DtNP 
and Y-DtNP), are concerned with contamination issues during standardization as well as 
analysis of Y- and Au-rich solutions. 
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Table IV.2-1. Standardization table carried out for the three elements Y(III), Gd(III) and Au(III) 
on a mixed solution of Gd-DtNP and Y-DtNP, divided in two container (1st place, 2nd place) with 
the ICP-MS technique. 
  1st place 2nd place 
  after standardisation 
  Y Gd Au Y Gd Au 
  [ppm] [ppm] [ppm] [ppm] [ppm] [ppm] 
1st standardisation 0.564 0.603 1.161 0.566 0.603 1.159 
2nd standardisation 0.569 0.598 1.129 0.569 0.597 1.129 
3rd standardisation 0.563 0.595 1.126 0.565 0.595 1.141 
average 0.565 0.599 1.139 0.567 0.599 1.143 
st. Dev. (1 sigma) 0.002 0.003 0.016 0.002 0.003 0.012 
RSD (%) 0.435 0.558 1.395 0.266 0.577 1.071 
IV.2.5 Bulk magnetic susceptibility 
Gd-DtNP  and Y-DtNP solutions containing 5% (v/v) of tert-butyl alcohol were placed in a 5 
mm NMR tube. The bulk magnetic susceptibility was determined with measurement using an 
inner co-axial tube containing 10% (v/v) tert-butyl alcohol in D2O from the frequency shift of 
the tert-butyl alcohol signal on a Bruker Avance-II 800 NMR spectrometer coupled to an 
Ultra-Compact UltraShield Plus magnet (18.8 T). The frequency shift of the two resonance 
signals from the methyl protons of the tert-butyl alcohol, originating from the inner and outer 
tubes, corrected by 0.091 ppm due the presence of D2O in the reference, represents the bulk 
magnetic susceptibility shift. 
IV.2.6 1H Relaxivity 
The 1/T1 NMRD profiles of Gd-DtNP(1) and Gd-DtNP(3) were obtained at 25.0°C on a 
Stelar Spinmaster fast field cycling NMR relaxometer (2.35·10-4 - 0.47 T; proton Larmor 
frequencies 0.01–20 MHz) equipped with a VTC90 temperature control unit, on Bruker 
Minispecs (0.71 T (30 MHz), 0.94 T (40 MHz), and 1.41 T (60 MHz)), on a Bruker Avance-
200 console connected to 2.35 T (100 MHz), and 4.7 T (200 MHz) cryomagnets and on a 
Bruker DRX-400 (9.4 T, 400 MHz). The diamagnetic corrections to the 1H longitudinal 
relaxation rates were 0.37 s-1 (25.0°C), and 0.33 s-1 (37.0°C). Least-squares fitting of NMRD 
data was performed with the approach of Bertini et al.25 and Kruk et al.26 also called the 
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"modified Florence method".27 This method includes a transient and a static ZFS, and 
assumes a slow reorientation of the paramagnetic complex and a lack of correlation between 
the rotation and translation of the complex and the electron spin dynamics.26 The electron spin 
relaxation uses the pseudorotation model for the modulation of the transient ZFS and is 
described by a Redfield formulation. It has been shown that the "modified Florence method" 
is well suited for fitting experimental NMRD profiles for slowly-rotating complexes of 
Gd3+.27  
IV.2.7 Molecular modeling 
A molecular model of Y-DtNP containing 201 gold atoms and 56 Y-Dt chelates was built 
using the CAChe program.28 The structure was partially optimized using molecular mechanics 
(MM3 force field).  
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IV.3 RESULTS AND DISCUSSION 
IV.3.1 Particles size distributions. 
The size diameters distributions are determined from transmission electron microscope 
(TEM) images and dynamic light scattering (DLS) analysis. Figure IV.3-1 shows a 
distribution of Feret's diameter, which is the greatest distance possible between any two 
points along the boundary of a region of interest, obtained with a single TEM image.  
 
(1) 
 
(2) 
 
(3) 
 
 
(4) 
 
Figure IV.3-1. (1) TEM image. (2) After photoshop treatment erasing the noisy background. (3) After 
ImageJ 1.41k software treatment. (4) Feret’s diameter (greatest distance possible between any two 
points along the boundary of a region of interest) distribution. 
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Feret’s diameter distributions provided by TEM images are obtained over about 300 particles 
for Gd-DtNP(1), Gd-DtNP(2) and Y-DtNP(2) and over 674 particles for Gd-DtNP(3) and are 
compared with DLS mean hydrodynamic diameters  distribution in Figure IV.3-2. The two 
size distribution techniques present good accordance for both Gd-DtNP(1) and Gd-DtNP(3) 
samples.  
 
 
  
 
 
Figure IV.3-2. Diameter size distributions obtained with transmission electron microscope (TEM) 
images treatment and dynamic light scattering (DLS). 
Samples Gd-DtNP(2) and Y-DtNP(2) show DLS diameter distributions shifted to higher 
values compared to TEM images size distributions. These two samples are both derived from 
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the solution DtNP(2), which was synthesized with a ratio Au/Dt = 1.1 (see Figure IV.3-2). 
Because the Au/Dt ratios for DtNP(1) and DtNP(3) are respectively 7.8 and 3.7, one can 
expect that distributions indicate larger nanoparticles in the two DtNP(2) derived samples. 
The difference between Gd-DtNP(2) and Y-DtNP(2) size distributions come probably from 
aggregation which occurred during the synthesis. In fact, three aggregation processes might 
be identified before analysis of the particle size distribution by TEM. The first process can 
occur during the nanoparticle synthesis. DtNP nanoparticles are synthesized following 
reduction of gold salt with sodium borohydride (NaBH4) in the presence of thiolated 
derivatives of DTTA in methanol inducing aggregation and precipitation. The formed DtNP 
are then dispersed in water. As second, the complexation of DTTA with the lanthanide(III) 
can induce partial aggregation of nanoparticles. This aggregation can however be considered 
as reversible by increasing pH of the solution to 7. The third aggregation process can occur 
when TEM samples are prepared by dropping solutions of gold nanoparticles onto carbon-
coated-copper grids and evaporating the solvent to dry.  
Even if aggregation can perhaps occur, analyzed TEM images do not show the presence of 
considerable amounts of aggregates and thus certainly only single nanoparticle size 
distributions are obtained. Size distribution including formation of nanoparticle clusters in 
solution is probably better determined with dynamic light scattering (DLS). DLS utilizes time 
variation of the scattering signal from suspended particles under Brownian motion to extract 
information on particle size distribution. Multiple scattering is avoided or filtered out by the 
apparatus used. However, if particle-particle interaction exists, particle motion is not purely 
Brownian. The apparent particle size computed from the measured diffusion coefficient with 
the Stokes-Einstein equation can increase or decrease with particle concentration resulting 
that the size and its distribution are not necessarily the real hydrodynamic size.29 To confirm 
that such particle-particle interaction do not influence hydrodynamic radius, we performed 
experiments with concentrated (DtNP-(1)) and diluted (DtNP-(3)) samples, resulting in the 
same size distributions. 
In conclusion, Gd-DtNP(1) and Gd-DtNP(3) present similar diameter size distributions 
measured with both experimental techniques. Gd-DtNP(2) and Y-DtNP(2) show noticeable 
aggregation of nanoparticles. The supposed origins of aggregation are from nanoparticle 
synthesis and lanthanide complexation processes. 
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IV.3.2 DtNP structural description 
State of the art. In 1996, Whetten et al.13 reported on series of gold nanocrystals, passivated 
by self-assembled monolayers of straight-chain alkythiolate molecules. Initial examination of 
crude mixtures by high-resolution electron microscopy showed particles having all faceted, 
crystalline gold cores with diameters in the 1.5-3.5 nm range. Fractionation of the crude 
mixture through cycles of fractional crystallization showed a discrete sequence of 
energetically optimal fcc structures of a truncated octahedral morphological motif.  
In 1997, Cleveland et al.30 determined theoretically via energy-minimization methods and 
experimentally by synchrotron x-ray diffraction analysis the properties of small gold 
nanocrystals passivated by a alkylthiolate self assembled monolayer with ratios of S to 
surface Au atoms in the range of 1:2 to 1:3 and in the 1.5 – 2.5 nm range diameter. 
Quantitative comparison of the experimental diffraction patterns with patterns calculated from 
the structures provides evidence for a definite transition from the Marks-type decahedral 
structures to a particular truncated-octahedral morphology in the 1.7 to 2.0 nm range (≈200 
atoms). 
The structural size-evolution in gold nanoparticles may be described as a sequence of 
transitions, rather than a continuum of sizes and structures as showed in 1999 by Barnett et 
al.31 First, there are specific “molecular” structures, at the extremely small size range, with 
equivalent cluster diameter smaller than 1 nm (< 30 atoms). Then there is noncrystallographic 
order, in particular Marks decahedra structures32 and finally culminating for sizes larger than 
2 nm (250 atoms) with the so called crystallites of bulk lattice structure with specific faceted 
morphologies as truncated octahedra, variants thereof and their twins. 
In 2006, Barnard et al.33 presented a systematic study focused on the variety of face-centered 
cubic (fcc) gold nanoparticles less than 3 nm in size (13 to 171 atoms) using density 
functional theory including relativistic effects. They showed that among the equilibrium shape 
of fcc gold nanoparticles, the cuboctahedral shape is energetically preferred for small sizes, 
less than 1.5 nm, and the truncated octahedron dominates at larger sizes, over 1.5 nm. They 
have shown also that small icosahedral and decahedral clusters are actually more likely to 
exhibit deviations from ideal atomic positions than fcc nanocrystals of comparable size. 
Following those information and considering the magic numbers describing the total number 
of points Gn and the total number of surface point Sn for cuboctahedron (CO) (eq IV.3-1)34 
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and truncated octahedron (TO) (eq IV.3-2)34 morphology, Table IV.3-1 can be built 
describing the discrete series of gold nanoparticles that we should face on our study. 
G
n
=
1
3
2n +1( ) 5n2 + 5n + 3( )  and  Sn = 10n
2
+ 2  IV.3-1 
G
n
= 16n
3
+15n
2
+ 6n +1  and  S
n
= 30n
2
+ 2  IV.3-2 
With n describing the shell number, the particle edge length can be approximated as n+1 
times gold atomic diameter (270 pm) and the diameter equal to 2 2  times the edge length 
for cuboctahedron and 4 2  times the edge length for truncated octahedron shapes. 
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Table IV.3-1. Magic numbers describing the total number of points Gn and the total number of surface 
point Sn for cuboctahedron (CO) and truncated octahedron (TO) morphology.  
Shell 
number 
n 
morphology atoms/edge Gn Sn Sn / Gn 
edge 
length 
NP 
diameter 
          % [nm] [nm] 
1 CO 2 13 12 92 0.54 0.76 
2 CO 3 55 42 76 0.81 1.15 
1 TO 2 38 32 84 0.54 1.53 
2 TO 3 201 122 61 0.81 2.29 
3 TO 4 586 272 46 1.08 3.05 
4 TO 5 1289 482 37 1.35 3.82 
5 TO 6 2406 752 31 1.62 4.58 
6 TO 7 4033 1082 27 1.89 5.35 
7 TO 8 6266 1472 23 2.16 6.11 
8 TO 9 9201 1922 21 2.43 6.87 
9 TO 10 12934 2432 19 2.70 7.64 
10 TO 11 17561 3002 17 2.97 8.40 
11 TO 12 23178 3632 16 3.24 9.16 
12 TO 13 29881 4322 14 3.51 9.93 
13 TO 14 37766 5072 13 3.78 10.69 
14 TO 15 46929 5882 13 4.05 11.46 
15 TO 16 57466 6752 12 4.32 12.22 
16 TO 17 69473 7682 11 4.59 12.98 
17 TO 18 83046 8672 10 4.86 13.75 
18 TO 19 98281 9722 10 5.13 14.51 
19 TO 20 115274 10832 9 5.40 15.27 
20 TO 21 134121 12002 9 5.67 16.04 
21 TO 22 154918 13232 9 5.94 16.80 
22 TO 23 177761 14522 8 6.21 17.56 
23 TO 24 202746 15872 8 6.48 18.33 
24 TO 25 229969 17282 8 6.75 19.09 
25 TO 26 259526 18752 7 7.02 19.86 
26 TO 27 291513 20282 7 7.29 20.62 
 
IV.3.3 Molecular modeling 
A partially optimized spatial arrangement of Y-DtNP containing 56 Y-Dt chelates and 201 
gold atoms is assessed by molecular mechanics (MM3 field) (Figure IV.3-3).  
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Figure IV.3-3. Partially optimized structure (MM3 force field) of Y-DtNP 
containing 201 gold atoms, 56 Y-Dt chelates and 112 water molecules. 
The gold core, composed of 201 Au atoms, has been built as a truncated octahedron before 
optimization. The number of Y-Dt complexes around the gold core has been chosen following 
the free space observed on the gold core surface. We estimate, because of steric hindrance 
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evidence, that a maximum of about 60 Y-Dt can be expected for a gold core composed of 201 
gold atoms (Au/Y-Dt = 3.35).  
 
Figure IV.3-4. Rough estimations of the distance between a sulfur and an 
yttrium (d(S-YIII)) and the diameter of the gold core of a system composed of 
56 Y-Dt and 201 gold atoms. 
As Figure IV.3-4 shows, a rough estimation of the distance between sulfur linked to gold 
surface and yttrium(III) can be given: d(S-YIII) = 1.3 ± 0.3 nm. This distance is mainly 
determined by the conformation of the methylene bridges linking the DTTA unit on the 
central nitrogen to the benzene ring. The diameter of the 201 gold atoms core can be as well 
estimated to 1.9 ± 0.3 nm. The total diameter of the constructed nanoparticles is about 4.5 nm. 
IV.3.4 STEM/EDX 
The STEM/EDX results are presented in Figure IV.3-5. This experiment confirms the 
presence of lanthanide chelates Ln-Dt on the surfaces of gold nanoparticles.  
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(1) 
 
(2) 
Figure IV.3-5. STEM with EDX analysis. (1) STEM images, with the pathway 
(line 11) describing the EDX analysis result in (2). The lower point of the 
pathway (line 11) is the starting point 0 in the graph (2).  
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X rays emitted along line 11 (Figure IV.3-5) after excitation of the encountered atoms by 
electrons give relative percentages of sulfur, gold and gadolinium elements. 
IV.3.5 ICP/MS 
Gold, gadolinium and yttrium compositions of the samples derivatived from DtNP(1), 
DtNP(2) and DtNP(3) have been analyzed with ICP/MS and the resulting concentrations are 
summarized in Table IV.3-2. The Au/Ln ratio for Gd-DtNP(1) hasn’t been established for 
technical reason. As introduced in the experimental part, Gd-DtNP(3)-2, Gd-DtNP(3)-3 and 
Gd-DtNP(3)-4 are diluted solutions of Gd-DtNP(3), and Y-DtNP(3)-2 is a diluted solution of 
Y-DtNP(3). 
Table IV.3-2. Au, Gd and Y concentrations from ICP-MS analysis. 
Sample Au Gd3+ Y3+ Au/Ln3+ 
  [µM] [µM] [µM]  
Gd-DtNP(1) - 378.1 (0.8) - - 
Gd-DtNP(2) 87 (2) 15.3 (0.2) - 5.7 
  Y-DtNP(2) 53 (1) - 3.4 (0.1) 16.3 
Gd-DtNP(3) 709 (10) 200.6 (0.5) - 3.5 
Gd-DtNP(3)-2 428 (7) 120.4 (0.3) - 3.5 
Gd-DtNP(3)-3 214 (4) 55.5 (0.2) - 3.8 
Gd-DtNP(3)-4 126 (2) 34.2 (0.2) - 3.7 
  Y-DtNP(3) 1570 (25) - 824 (1.6) 1.9 
  Y-DtNP(3)-2 894 (13) - 479 (1.0) 1.9 
 
Regarding the results presented in Table IV.3-2, one has to keep in mind that the Au/Ln3+ 
ratios are mean values over the solutions. From TEM and DLS experiments, it is known that 
the size of DtNP particles varies between 1.5 and 15.5 nm, inducing a strong variation of 
Au/Ln3+ ratios for the different particles present in the solutions. 
IV.3.6 Magnetic properties 
Paramagnetic species induce chemical shifts in nuclear magnetic resonance frequencies via 
three possible mechanisms, which are the diamagnetic, the hyperfine and the bulk magnetic 
susceptibility. The shifts provoked by the diamagnetic mechanism are generally small and 
may be neglected in comparison to the other mechanisms. The hyperfine mechanism, which 
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has two components, the scalar (contact) contribution and the dipolar (pseudo-contact) 
contribution, require interaction with the paramagnetic center either trough bond (contact) or 
through space (pseudo-contact). Finally, the shifts induced by the bulk magnetic susceptibility 
mechanism (Δx) originate from the partial alignment of the magnetic moments of the 
paramagnetic species by the external magnetic field. The Evans method35, 36 is a simple 
technique for the accurate determination of the susceptibility of paramagnetic molecules in 
solution. It utilizes the bulk magnetic susceptibility shift of an inert compound caused by the 
presence of a paramagnetic solute. Thus the 1H NMR chemical shift for an inert reference 
compound such as t-butyl alcohol can be exploited in order to determine the effective 
magnetic moment, µeff, of the paramagnetic species in solution.37. The bulk magnetic 
susceptibility shift (Δx) may be expressed in a good approximation by equ IV.3-3:38 
! x ppm[ ] =
4" # s
T
#
µeff
2.84
$
%&
'
()
2
c mM[ ] #103  IV.3-3 
The concentration of paramagnetic solute, c, is given in mmol l-1, the factor s is dependent on 
the shape of the sample and its position in the magnetic field (s = 1/3, -1/6 and 0 for a 
cylindrical sample parallel to the main field, a cylindrical perpendicular to the main field and 
a spherical sample, respectively), T is the absolute temperature and µeff is the effective 
magnetic moment for a particular paramagnetic centre. 
For a Gd3+ paramagnetic (µeff = 7.94)39 contribution in a solution at 298.15°C using a NMR 
sample having a cylinder shape is expressed in equ IV.3-4: 
!
x
Gd
3+( ) =
4"
298.15
#
1
3
#
7.94
2.84
$
%&
'
()
2
c #103 = 109.8 # c mM[ ]  IV.3-4 
In considering the gadolinium(III) concentrations determined by ICP-MS and the 1H NMR 
chemical shifts induced by the bulk magnetic susceptibility mechanism for the inert reference 
compound t-butyl alcohol, effective magnetic moments for each solution can be obtained and 
compared to the effective moment of gadolinium(III) ion. (Table IV.3-3). 
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Table IV.3-3: 1H-NMR shift Δx observed between the protons of t-
butyl alcohol in the reference and in the Gd-DtNP samples at 800 
MHz. The gadolinium(III) concentration [Gd3+] has been measured 
by ICP-MS. 
 T Δx [Gd
3+] µeff 
 [K] [ppm] [mM]  
Gd-dtNP(1) 297.0 0.0397 0.344 8.12 
Gd-dtNP(2) 297.9 0.0016 0.015 7.86 
Gd-dtNP(3) 297.9 0.0238 0.192 8.43 
Gd-dtNP(3)-2 297.9 0.0123 0.116 7.81 
Gd-dtNP(3)-3 297.9 0.0072 0.053 8.80 
Gd-dtNP(3)-4 297.9 0.0034 0.033 7.64 
 
The measured chemical shifts agree very well with calculated shifts using the effective 
magnetic moment of Gd3+ (Figure IV.3-6). A linear regression of the experimental data 
results in an effective magnetic moment of the Gd-DtNP of µeff = 8.19. 
 
 
Figure IV.3-6. t-butyl alcohol 1H NMR chemical shift Δx due to the 
presence of paramagnetic Gd-DtNP (measured at 18.8 T) versus 
gadolinium(III) concentration obtained from ICP-MS analysis. The red line 
corresponds to shifts calculated with equ IV.3-4 (µeff = 7.94).  
The t-butyl alcohol 1H NMR signal in presence of Y-DtNP samples (Y-DtNP(2), Y-DtNP(3), 
and Y-DtNP(3)-2) present no significant shift, in respect to t-butyl alcohol 1H NMR signal in 
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the internal diamagnetic reference. The effective magnetic moment of Y-DtNP is thus small 
(µeff = < 0.2). 
From the results obtained with gadolinium(III) and yttrium(III) DtNP solutions, we can 
conclude that the gold core of our nanoparticles does not induce a significant effective 
magnetic moment as it has been expected following the literature.7, 14-18, 20 Yamamoto et al.40 
in a recent review describe results from X-ray magnetic circular dichroism (XMCD) 
spectroscopy and element-specific magnetization (ESM) experiments allowing revealing 
intrinsic magnetic polarization in Au nanoparticles with a mean diameter of 1.9 nm. 
Following the external magnetic field and temperature dependence of the ESM signal, they 
suggest that magnetization of Au nanoparticles consists of ferromagnetism from surface 
atoms (obeying the Curie law) and a temperature-independent Pauli-paramagnetic part from 
the core atoms. The explanation for the observed overall ferromagnetic polarization of the 
particles is the large ratio of the number of atoms on the surface in respect to the number in 
the core. But even more important, it has been found that protective agent interacting with the 
surface play a crucial role for the magnetization of gold nanoparticles: the electronic 
properties of Au particles strongly depend on the type of binding atoms used. Dodecanthiol-
protected gold nanoparticles showed much smaller magnetization than gold nanoparticules 
protected by polymers such as polyacrylonitril (PAN) and polyallyl amine hydrochloride 
(PAAHC). The PAAHC polymer has amino (-NH2) functional group and the interaction 
between the surface of Au nanoparticles and NH2 is considered to be weak if compared to 
strong ligands such as mercapto (-SH) and carbonyl group (-CO). Experimental results 
suggest that PAAHC-Au can be regarded as a nearly freestanding cluster, and thus the surface 
magnetic moment survives. The most characteristic property of gold nanoparticles coated 
with dodecanthiol is the strong covalent bond between the thionic group and Au and thus 
ligand molecules with strong affinity to the metal tend to quench the magnetic moment at the 
surface of nanoparticles. However, as we mentioned in the introduction of this chapter IV, 
distinct magnetization behavior was recently reported for Au nanoparticles protected by 
molecules with thiol functional group. Yamamoto et al.40 attributed these observations to a 
charge transfer process from the surface to the molecule.  
The absence of a marked magnetic moment of gold nanoparticles coated with thiol groups 
excludes its use as MRI contrast agent per se and coating of AuNP with weakly interacting 
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ligands would lead to freestanding cluster, which would probably cluster in solution. This 
behavior will exclude its use as MRI contrast agent. 
IV.3.7 1H relaxivity 
Dilution effect 
Longitudinal 1H nuclear spin relaxation rates at 30 MHz and 25°C have been measured for 
four different samples to determine whether a dilution effect can be observed from the 
relaxivity, r1, of the Gd-DtNP system. An aggregation of nanoparticles at higher 
concentrations would at the chosen observation frequency lead to an increase in T1 due to 
longer rotational correlation times. Measured relaxivities (Table IV.3-4, Figure IV.3-7) are 
within experimental error independent on the gadolinium concentration. Therefore, no 
aggregation of the nanoparticles is observed in the concentration range we worked in the Gd-
DtNP systems. 
Table IV.3-4. Longitudinal relaxation rate T1 observed at 30 MHz and 25°C 
and calculated relaxivities r1 for various gadolinium concentrations. 
 Gd3+ T1 r1 
  [µM] [ms] [mM-1s-1] 
Gd-DtNP(1) 378 42.6 61 
Gd-DtNP(2) 15.3 844.6 53 
Gd-DtNP(3) 201 82.6 59 
Gd-DtNP(3)-2 120 136.1 58 
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Figure IV.3-7. Measured relaxivities (30 MHz, 25° C) as a function of 
gadolinium concentration. 
Furthermore, different batches from synthesis result in the same relaxivitiy, which allows us 
to conclude that Gd-DtNP can be synthesized with good reproducibility at least in respect to 
r1. 
1H nuclear magnetic relaxation dispersion (NMRD) 
The NMRD profiles of Gd-DtNP(1) and Gd-DtNP(3) are presented in Figure IV.3-8. Both 
DtNP batches lead to very similar relaxivities, which are below 200 MHz much higher than 
that of the Ru metallostar {Ru[Gd2bpyDTTA2(H2O)4]3}4- (see chapter III) and the bimetallic 
compound [Gd2bpy-DTTA2(H2O)4]2-.41 
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Figure IV.3-8: 1H nuclear magnetic relaxation dispersion profiles, recorded at 
25°C of Gd-DtNP(1), Gd-DtNP(2), Gd-DtNP(3), Ru-based metallostar 
{Ru[Gd2bpy-DTTA2(H2O)4]3}4- and the [Gd2bpy-DTTA2(H2O)4]2- bimetallic 
complex. 
Several aspects can be considered to understand the high r1 values. In a first attempt a 
contribution from the Au-core of the nanoparticle has to be looked at. A high magnetic 
moment of the gold center would lead to a contribution to relaxivity due to Curie relaxation. 
This contribution increases with the square of the magnetic field and is of importance only at 
very high resonance frequencies. From our results of bulk susceptibility measurements 
(chapter IV.3.6) and from the NMRD profiles in Figure IV.3-8 it can be seen that T1-Curie 
relaxation can be neglected. The only contribution to relaxation enhancement observed for the 
water protons comes thus from dipolar interaction between the electron spin of Gd3+ and first 
sphere and outer sphere water molecules. 
Because the gadolinium chelates are tightly bound to the nanoparticles, we expect a relatively 
long rotational correlation time and therefore we used the approach developed by of Bertini et 
al.25 and Kruk et al.26 also called the "modified Florence method".27 This method includes a 
transient and a static ZFS, and assumes a slow reorientation of the paramagnetic complex and 
a lack of correlation between the rotation and translation of the complex and the electron spin 
dynamics.26 The electron spin relaxation uses the pseudorotation model for the modulation of 
the transient ZFS and is described by a Redfield formulation. It has been shown that the 
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"modified Florence method" is well-suited for fitting experimental NMRD profiles for 
slowly-rotating complexes of Gd3+.27 NMRD profiles of several compounds with Gd-DTTA 
chelating units have been previously analyzed which allowed to fix in the fitting process 
several parameters to reasonable values (see chapter III): the number of inner sphere water 
molecules, q = 2, the exchange rate constant, kex298 = 8.3⋅106 s-1, the Gd-water proton distance 
for inner sphere water molecules, rGdH = 3.1 Å, the closes distance of approach of outer sphere 
water molecules, aGdH = 3.5 Å, the diffusion constant for outer sphere water molecules Ddiff298 
= 2.5⋅109 m2 s-1. As can be seen from Figure IV.3-10, the experimental NMRD profile is fitted 
perfectly even at high frequencies. Because the modified Florence approach uses only a 
global rotational movement of the particles and does not include internal rotation, significant 
deviations between experimental and calculated relaxivities are observed with flexible 
molecules (see chapter III). The relatively good agreement between measured and calculated 
r1 values at ν > 200 MHz suggests that Gd-DtNP are very rigid. This high rigidity can either 
be due to very dense packing of Gd-Dt units at the surface of the Au-core as nicely shown on 
the molecular model (Figure IV.3-9) or it can be due to interactions between the benzene 
wings of Dt (π stacking). 
 
Figure IV.3-10. Gd-DtNP(1) NMRD curve (dotes) and the fit using the modified 
Florence approach (black line). 
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Table IV.3-5. Fit parameters of the modified Florence approach for the two 
systems {Ru[bpy-DTTA2(H2O)4]3}4- and Gd-DtNP(1). 
 {RuII[Gd2bpy-DTTA2(H2O)4]3}4- Gd-DtNP(1) 
298
ex
k  (106 s-1) 8.3 (fixed) 8.3 (fixed) 
298
g
!  (ps) 833 1181 
298
v
!  (ps) 23.0 22.2 
∆t2 (1020s-2) 0.051 0.045 
∆s2 (1020s-2) 0.580 0.387 
 
Due to the (-1) charge of the Gd-Dt units, our Gd-DtNP nanoparticles are strongly negatively 
charged at the surface, attracting many positively charged counter ions. It could therefore be 
questioned if analyzing the NMRD profiles without a contribution of second sphere water 
molecules is appropriate. The excellent fit of the experimental data as well as the reasonable 
parameters obtained (Table IV.3-6) shows that if there is such a contribution, its contribution 
to r1 is small. A classical molecular dynamics simulation of the Y-DtNP in aqueous solution 
would probably give more insight on the behavior of water molecules and cations on the 
surface of the particle.  
The fitted parameters given in Table IV.3-7 show that 
 
!
t
2  and τv298, which determine electron 
spin relaxation, are close to values found for the Ru-metallostar which is build using the same 
DTTA chelating unit. The amplitude of the static zero-field splitting, 
 
!
s
2 , is however about 
30% lower that for {Ru[Gd2bpyDTTA2(H2O)4]3}4-. The rotational correlation time 
 
!
R
298  of the 
Ru-based metallostar is about 30% smaller than 
 
!
R
298  of the Gd-DtNP(1) complex, which is 
oddly the same ratio between their relaxivity values at low field. The rotational correlation 
time 
 
!
R
298  can be used to estimate the radius of the rotating particle in a medium with viscosity 
η by means of the Debye-Stokes-Einstein theory (equ IV.4-8). With this approach, an average 
diameter of 2.2 nm for Gd-DtNP(1) (eq IV.4-8) is obtained which is the lower end of the 
particle size distribution measured (chapter IV.3.1). 
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Finally, the relaxivites r1 for Gd-DtNP show no substantial decrease by increasing the 
temperature from 25°C to 37°C (for Gd-DtNP(1) @ 60 MHz: r1@25°C = 50.3 mM-1s-1, r1 
@37°C = 48.2 mM-1s-1). A decrease of the rotational correlation time of the complex by 
increasing the temperature is to a large part compensated by the increase of the water 
exchange rate for water exchange from the first sphere of the Gd-Dt complexes. This behavior 
shows that water exchange is too slow for optimum relaxivity. Replacing the DTTA chelating 
units by another one with q=2 and faster water exchange would lead to even higher r1 values. 
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IV.4 CONCLUSION 
In conclusion, we developed small, water-dispersible, stable gold nanoparticles covalently 
linked to Gd-DTTA derivative complexs on the surface. Characterizations of these DTTA 
thiol capped gold nanoparticles (DtNP) using TEM images, dynamic light scattering 
technique and STEM with EDX analysis indicate a particle size distribution from 2-15 nm, 
coated by Ln-Dt complexes on the surface.  
Molecular modeling shows a rough distance in the range of 1.3 nm between lanthanide(III) 
ion and gold core surface and the structure that possess Ln-DtNP offers to gadolinium(III) 
centers a tightly bounding on the surface of particles. Accurate Au, Gd and Y concentrations 
have been determined with ICP-MS technique. 
Bulk magnetic susceptibility of different concentrations of gadolinium Gd-DtNP and yttrium 
Y-DtNP samples has been established and no significant magnetic contribution can be 
attributed to the gold core. NMRD profiles of Gd-DtNP systems at 25°C show very high 
relaxivities and present a broad relaxivity humps indicating a large particle size with slow 
rotational motion.  
The modified Florence approach fits well the experimental points of the NMRD profile of 
Gd-DtNP, indicating that if there is interaction between gadolinium(III) ions on the surface of 
the gold core, that would certainly induce a minor change in the relaxation paramagnetic 
enhancement of water protons. A good fit of experimental relaxivities with the applied 
theoretical model shows that the particles are very rigid. The fitted parameters of the 
electronic relaxation are finally in good coherence with what was expected from the Ru-based 
metallostar values.  
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V.1 CONCLUSIONS 
During the last two decades, great efforts have been spent to develop new paramagnetic 
gadolinium chelates as contrast agents for medical magnetic resonance imaging (MRI) giving 
better contrast and decreasing acquisition time.1-3 The parameters that can be tuned in order to 
obtain more efficient agents, meaning to increase water proton relaxivity, are the rotational 
tumbling time of the complex, the exchange rate of water molecules in the first coordination 
sphere of Gd3+ and the number of water molecules in the first coordination sphere.  
The relaxivity values are strongly magnetic-field-dependent and at fields of 3T and above, 
relaxivity usually drops rapidly. In contrast to that field-dependence, raising the number of 
inner-sphere water molecules leads to an increase in relaxivity, which is proportional to the 
number of water molecules independent on the magnetic field. Therefore, several research 
groups devoted their efforts to the synthesis of chelates allowing the presence of more than 
one water molecule in the first coordination sphere of the metal.4-7 
Our group developed small to medium sized molecules binding two to six Gd3+ ions with 
heptadentate acyclic chelate devoted to a potential MRI contrast agent: the heptadentate 
acyclic DTTA chelating groups (H4DTTA = diethylenetriaminetetraacetic acid = N,N’-
[iminobis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine].8-12 In these complexes, each Gd3+ 
binds two water molecules that exchange relatively rapidly with the bulk, leading to 
moderately high relaxivities.  
A stringent condition for all chelating ligands is that the complex formed with the gadolinium 
ion is thermodynamically and kinetically very stable and therefore all commercial MRI 
contrast agents have only one water molecule in the first coordination sphere. The safety of 
gadolinium based contrast agents became an important issue since it has become the leading 
suspect for Nephrogenic Systemic Fibrosis (NSF), a disease with high morbidity and 
mortality.13-16 Besides the application in medical diagnostics, MRI contrast agents are also 
used in medical research and pharmacological studies. These studies in general performed in 
vitro or in animals, depend on the development of new agents delivering good contrast at high 
magnetic fields. Restrictions concerning high complex stability are however often less severe 
than in case of clinical use. 
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The research focuses on the elaboration of platforms that can be used to create a diverse set of 
multifunctional devices capable of detecting starting diseases and delivering a therapy. 
In this thesis, three compounds have been studied, all of them containing the DTTA chelate 
unit (H4DTTA = diethylenetriaminetetraacetic acid = N,N’-[iminobis(ethane-2,1-diyl)]bis[N-
(carboxymethyl)glycine]), a derived from the parent TTAHA6-.  
The first compound studied, the methylated derivative H4DTTA-Me (N,N’-
[(methylimino)bis(ethane-2,1-diyl)]bis[N-(carboxymethyl)glycine]), mimics the DTTA 
chelating unit linked by a methylene group to organic backbones and allowed to study its 
physicochemical properties. We report the synthesis and physicochemical characterization of 
the ligand DTTA-Me4- and its gadolinium complex. The complex shows thermodynamic 
protonation and stability constants similar to DTTA bound to bpy or a xylene via a CH2 
group. From 1H NMR it was concluded that the first protonation of the ligand DTTA-Me4- 
occurs on the central nitrogen, followed by protonation of the two terminal nitrogen atoms 
and deprotonation of the central one. The next protonation steps are a repeated protonation of 
the central nitrogen followed by the protonation of carboxylic acids. The pGd value, which is 
indicative for the stability at physiological conditions, is very close to that of [Gd(DTPA-
BMA)(H2O)]. 
To measure the conditional relative stability constant for two gadolinium complexes, we 
propose a method based on relaxivity measurements. This versatile method allows the 
determination of the relative stability for any couple of ligands, provided its 1H NMR 
relaxivities are sufficiently different at an appropriate magnetic field. Using this method, we 
found that in a slightly basic environment (pH 8.3) the [Gd(DTTA-Me)(H2O)2]- complex has 
a higher stability in respect to [Gd(DTPA-BMA)(H2O)] as has been shown by the direct 
competition experiment using relaxivities as the indicator. Transmetellation with Zn2+ is 
however, less favorable for the heptadentate DTTA-Me4- compared to the octadentate DTPA-
BMA3-. Whereas the long time behavior of both complexes is similar, showing relatively 
strong transmetalation, the metal exchange from Gd3+ to Zn2+ is about twice as fast for 
DTTA-Me4- due to the higher stability of the zinc complex. In contrast to DO3A-based 
ligands with two water molecules in the first coordination sphere, the formation of ternary 
complexes with the bidentate lactose anion is very week. Even at a 10-fold excess of the 
anion, the measured relaxivity decreases only very slightly.   
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From the results, it can be concluded that the Gd3+ complex of heptadentate DTTA-Me4- 
behaves similarly as that of the commercial octadentate DTPA-BMA3-. Considering recent 
suspicions against [Gd(DTPA-BMA)(H2O)] for being involved in Nephrogenic Systemic 
Fibrosis (NSF) disease, DTTA-type chelates will not be admitted as contrast agents in clinical 
MRI. However, their use in vitro and in animal studies is absolutely conceivable, mainly at 
high magnetic fields, where the increase of inner-sphere-coordination water actually seams to 
be the only promising way to increase the relaxivity.  
The second compound is a close derivative to the iron-based metallostar {Fe[Gd2bpy-
DTTA2(H2O)4]3}4-, where the iron(II) central ion is replaced by a ruthenium(II) ion. We 
describe first the synthesis of self-assembly of the d/f heptametallic edifices {Ru[Ln2bpy-
DTTA2(H2O)4]3}4- with Ln = Y3+, Gd3+, Eu3+. Besides the higher stability of the [Ru(bpy)3]2+ 
unit compared to its iron(II) analogue, the ruthenium-based metallostar shows interesting 
photophysical properties in addition to its capacity to act as MRI contrast agent. Structural 
characterization in solution was achieved by 1H NMR on the diamagnetic yttrium complex by 
analyzing the aromatic protons of the bipyridyl unit. The gadolinium complex gives rise to 
NMRD profiles in accordance with those of the iron-based metallostar.2 NMRD profiles of 
both Ru2+ and Fe2+ based metallostars have been analysed using SBM theory including a 
Lipary-Szabo treatment of internal motion and using the modified Florence approach 
developed for slowly rotating, rigid complexes. Data-analysis showed the incapability of 
SBM theory to reproduce correctly NMRD profiles with long τR. Parameters of static ZFS as 
obtained from the modified Florence method are in reasonable agreement with low 
temperature EPR results.17 Comparison of both methods shows that inclusion of internal 
motion is necessary to have a correct description of high-frequency relaxivity. 
The photophysical data determined for Na4{Ru[Eu2bpy-DTTA2(H2O)4]3} demonstrate the 
feasibility of d→f visible-sensitized europium 5D0→7FJ luminescence in aqueous solution. 
This opens the way for the development of smart bimodal biological probes. 
The third compound represents a common approach achieving high relaxivity with loading a 
rigid macromolecule with many chelate units binding Gd3+.18-21 This compound is represented 
by Gd-DTTA thiol derivative capped gold nanoparticles (Gd-DtNP). We developed small, 
water-dispersible, stable nanoparticles covalently linked by mercapto bond to Gd-DTTA 
derivative complex on the surface. Characterization of Ln-DtNP was performed using TEM 
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images, dynamic light scattering technique and STEM with EDX analysis, indicating 2-15 nm 
particle diameters, having close compact gadolinium complexes on the surface.  
Molecular modeling shows a rough distance of 1.3 nm between gadolinium(III) ion and gold 
core surface and the Gd-DtNP structure offers to gadolinium(III) centers a tightly bounding 
on the surface of particles. Accurate Au, Gd and Y concentrations have been determined with 
ICP-MS technique. 
Bulk magnetic susceptibility of different gadolinium concentration samples has been 
established following the Evans method and no significant magnetic contribution can be 
attributed to the gold core. NMRD profiles of Gd-DtNP at 25°C show very high relaxivities 
and present broad relaxivity humps indicating very large systems with slow rotational motion.  
The modified Florence approach fits correctly the NMRD profil of Gd-DtNP, and the 
electronic relaxation fit parameters are in good coherence with what was expected from the 
Ru-based metallostar values and confirms that our Gd-DtNP systems are very rigid nano-
object.  
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V.2 PERSPECTIVES 
The synthesis of the d/f heptametallic self-assembly edifices {Ru[Ln2bpy-DTTA2(H2O)4]3}4- 
with Ln = Y3+, Gd3+, Eu3+ opens a door to similar but more complex self-assenbly structures. 
We present here two very interesting multimetallic edifices that have promising potentiel for 
fundamental studies in relaxivity and luminescence studies (Figure V.2-1 and Figure V.2-2).  
 
Figure V.2-1: Self-assembled multimetallic edifice {TPTz{Ru[Ln2bpy-
DTTA2(H2O)4]2}3}6-. 
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Figure V.2-2: Self-assembled multimetallic edifice {HAT{Ru[Ln2bpy-
DTTA2(H2O)4]2}3}6-. 
DTTA thiol capped gold nanoparticles Ln-DtNP introduced in chapter IV have strong 
potentiel to bring fondamental insights on very rigid structures used as MRI contrast agent. 
Several varation of these nano-objects can be imagined. For instance, increase the length of 
the carbon chaines linking the central nitrogen of the DTTA chelate to the benzene will bring 
more flexibitily. One has thus to think about Gd-DtNP structures containing short and long 
DTTA thiol derivatives for bringing relaxivity efficiency at middle and high fields.  
However, conventional gadolinium-based MRI contrast agents have sensitivity in the 
micromolar range, which with certain exceptions is usually inadequate for molecular MRI. 
This first generation of extracellular gadolinium chelates also have extremely short 
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intravascular half-lifes and rapid renal excretion, which further limits their utility for most 
molecular imaging applications.  
The next step towards powerful imaging involves specific recognition between the GdIII 
complex and a target of interest. The sensitivity of targeted magnetic nanoparticles is 
currently in the nanomolar range and will likely be improved through the use of agents with 
higher relaxivities than the present constructs. The ability to image nanoparticles with T1, T2 
and off-resonance techniques provides multiple possibility to ensure probe specificity. Future 
nanoparticles will further enhance specificity by allowing multi-modality imaging (MRI, 
fluorescence, PET) of the contrast agent to be performed.22 First generation polymer-coated 
nanoparticles are currently approved for clinical use and subsequent generations of 
nanoparticles (Combinex, Advanced Magnetics, Cambridge MA)23 have already completed 
phase 3 clinical trials. MRI of nanoparticles in the cardiovascular system thus has the 
potential to become a powerful technology in both the basic science as well as the clinical 
settings.  
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VI.1 APPENDIX TO CHAPTER II:  
VI.1.1 Protonation and Stability Constants by Potentiometric Measurements 
 
Figure VI.1-1. Distribution diagram for DTTA-Me ligand. 
 
Figure VI.1-2. Distribution diagram of Zn-DTTA-Me. 
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Figure VI.1-3. Distribution diagram of Gd-DTTA-Me. 
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VI.1.2 1H-NMR in D2O 
Table VI.1-1.1H NMR (400 MHz) DTTA-Me4- 
chemical shifts vs pD in D2O at room temperature and 
I=0.1 M KCl. 
 δ [ppm] δ [ppm] δ [ppm] δ [ppm] 
pD s2 d1 d2 s1 
2.096 2.990 3.837 3.456 3.504 
2.439 2.987 3.829 3.479 3.513 
2.466 2.986 3.828 3.483 3.514 
2.934 2.971 3.830 3.526 3.526 
2.947 2.968 3.830 3.527 3.527 
3.050 2.959 3.831 3.531 3.531 
3.442 2.902 3.832 3.559 3.474 
3.446 2.884 3.833 3.561 3.457 
3.940 2.733 3.828 3.532 3.295 
3.949 2.741 3.828 3.533 3.304 
4.426 2.582 3.819 3.484 3.125 
4.440 2.560 3.817 3.475 3.100 
4.935 2.472 3.811 3.442 2.999 
5.449 2.429 3.807 3.425 2.949 
5.454 2.429 3.807 3.425 2.950 
5.943 2.421 3.802 3.417 2.938 
5.969 2.421 3.799 3.414 2.937 
6.456 2.424 3.794 3.410 2.938 
6.460 2.427 3.791 3.406 2.940 
6.967 2.445 3.768 3.388 2.950 
7.038 2.452 3.761 3.383 2.956 
7.430 2.494 3.716 3.347 2.984 
7.457 2.517 3.703 3.336 2.999 
7.952 2.613 3.601 3.248 3.056 
8.460 2.732 3.451 3.137 3.137 
8.938 2.826 3.351 3.052 3.194 
8.945 2.814 3.358 3.060 3.184 
9.440 2.848 3.320 3.025 3.207 
9.463 2.846 3.316 3.023 3.206 
9.906 2.844 3.301 3.003 3.197 
9.953 2.847 3.299 3.004 3.201 
10.436 2.816 3.288 2.983 3.168 
10.450 2.815 3.290 2.984 3.167 
10.923 2.732 3.274 2.942 3.083 
11.442 2.474 3.235 2.821 2.821 
11.986 2.309 3.210 2.750 2.667 
12.481 2.234 3.197 2.715 2.573 
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Figure VI.1-4.1H NMR (400 MHz) spectra describing DTTA-Me4- 
chemical shifts vs pD in D2O at room temperature and I=0.1 M KCl.  
VI.1.3 Conditional Relative Stability Constant 
 
K
L1 / L2
*  of [Gd(DTTA-Me)(H2O)2]− 
Relative to [Gd(DTPA-BMA)(H2O)] 
All relaxivities 1mr  measured on samples of different mixtures of sol L1 and sol L2 can be fitted 
together or treated alone to obtain the conditional relative stability constant *KL1/L2. 
Fit to obtain the conditional relative stability constant 
All relaxivities 
1
m
r  measured on samples of different mixtures of sol L1 and sol L2 can be fitted 
together to obtain the conditional relative stability constant *KL1/L2. If GdmC , 1
L
m
C  and 2L
m
C  are 
the total concentrations of Gd3+, L1 and L2, in the mixture m, the concentration of complex 
GdL2 is given by 
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The mixtures are prepared from stock solutions sol L1 and sol L2 with total ligand 
concentrations 1
0
L
C , 2
0
L
C  and total gadolinium concentrations 1
0
Gd
C , 2
0
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Furthermore, a constant dilution by a factor f = 0.71 was used. The concentrations of the 
samples can be expressed as a function of mole fraction of ligand L2 , 2L! , as  
( )( )
( )
1 2
0 2 0 2
1 1
0 2
2 2
0 2
(6) 1
(7) 1
(8)
Gd Gd Gd
m L L
L L
m L
L L
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The relaxivity 
1
m
r  as a function of 
2L
!  is given by 
[ ] [ ]
1 2
2 2
1 1 1
1
GdL GdLm
Gd Gd
m m
GdL GdL
r r r
C C
! " ! "
= # +$ % $ %
& ' & '
 
where [GdL2] is obtained from (5) – (8).  
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The only fitted parameters are K*L1/L2, 11GdLr  and 21GdLr . 
Table VI.1-2. Concentrations and measured 
relaxation times as a function of sample composition 
for [Gd(DTTA-Me)(H2O)2]-/[Gd(DTPA-BMA)(H2O)] 
mixtures. 
 1
0
L
C  2
0
L
C  1
0
Gd
C  2
0
Gd
C  
 [mM] [mM] [mM] [mM] 
sol L1 12.76 / 4.27 / 
sol L2 / 12.81 / 4.29 
     
2L
!  1L
m
C  2L
m
C  Gd
m
C  T1 fL1a fL2b 
 [mM] [mM] [mM] [ms] [mM] [mM] 
0 9.38 - 3.14 50.7 0.74 - 
0.16 7.61 1.45 3.03 53.2 0.71 0.71 
0.33 6.08 2.99 3.04 54.4 0.71 0.71 
0.50 4.58 4.58 3.06 56.3 0.72 0.72 
0.67 3.00 6.10 3.05 60.4 0.71 0.71 
0.84 1.46 7.69 3.06 67.1 0.72 0.71 
1 - 9.32 3.12 79.7 - 0.73 
 a dilution factor fL1 = CmL1/(C0L2 ·(1- χL2)) 
 b dilution factor fL2 = CmL2/(C0L2 · χL2) 
 
Single relaxivity to obtain the conditional relative stability constant 
If we consider a single relaxivity 1mr , where GdmC , 1
L
m
C  and 2L
m
C  are the total concentrations of 
Gd3+, L1 and L2, in the mixture m: 
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Figure VI.1-5:Demonstration of the equation for calculating the conditional 
relative stability constant 
 
K
L1/ L2
*  
We resume parameters for single relaxivity approach and for the fit in the next table: 
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Table VI.1-3. Conditional, K*L1/L2, and thermodynamic, KL1/L2, relative 
stability constants between Gd3+ complexes with DTTA-Me4- (L1) and DTPA-
BMA3- (L2) from relaxivity experiments (25°C, 60 MHz, I=0.1 M NaCl). 
%L2 pH a r1m K*L1/L2 (pH 8.3) αL1 αL2 KL1/L2
b 
  [s-1 mM-1]     
0 8.30 6.18 / 334.1 / / 
16 8.29 6.10 7.01 343.1 13.0 185 
33 8.33 5.94 6.27 308.7 12.0 162 
50 8.33 5.70 6.16 308.7 12.0 159 
67 8.29 5.32 6.37 343.1 13.0 168 
84 8.27 4.76 7.35 361.9 13.6 196 
100 8.30 4.02 / / 12.8 / 
Fit 8.30c d 6.4 332.4 12.7 168 
a pH values at the end of the competition. b From eq II.3-10. c average over pHs of 
solutions 16, 33, 50, 67 and 84 % L2. d 11
GdL
r (fitted) = 6.18 (0.01) , 2
1
GdL
r (fitted) = 
4.03 (0.01). 
 
function [y]=DTTAm_DTPABMA(x,p) %\FWD=0; \DEFPAR(R_DTTAm,R_DTPABMA,Co_GdDTTAm,Co_GdDTPABMA,Co_DTTAm,
Co_DTPABMA,K)\NARGOUT=1;
% **********************************************************
% Six paramètres:
%   R_DTTAm:relxivité du complexe Gd_DTTAm (mM-1s-1)
%   R_DTPABMA:relxivité du complexe Gd_DTPABMA (mM-1s-1)-
%   Cm_Gd: concentration en Gd3+ de la solution mélange
%   Co_DTTAm: concentration en DTTAm de la solution mère 1, solution contenant 1:3 de Gd3+:DTTAm
%   Co_DTPABMA: concentration en DTPABMA de la solution mère 2, solution contenant 1:3 de Gd3+:DTPABMA
%   K: KGd_DTTAm/KGd_DTPABMA, rapport des constantes de stabilités des deux complexes
% INITIAL DATA CONTENTS:
% x(:,1) = pourcentage représentant le volume de solution mère 2 par volume total de la solution mélange
% y(:,1) = Relaxivité totale de la solution mélange (mM-1s-1)
% CONDITIONS ON VISUALISEUR:
% - Nombre de variables indépendantes = 7
%            L.MORIGGI  - LCIB - EPFL - 2007
% **********************************************************
% ------------       PARAMETERS       ----------------------
R_DTTAm     = p(1);
R_DTPABMA   = p(2);
Co_GdDTTAm  = p(3);
Co_GdDTPABMA= p(4);
Co_DTTAm    = p(5);
Co_DTPABMA  = p(6);
K           = p(7);
% ------------       VARIABLES DEPENDANTES ----------------
pc_vol2    = x(:,1);          % pourcentage représentant le volume de solution mère 2 par volume total 
de la solution mélange
% ------------       DEBUT DU CALCUL        ---------------
% *** INIT RESULTS (1 columns)
y  = NaN * ones(size(x,1),1);
Cm_Gd = (1-pc_vol2/100).*Co_GdDTTAm + (pc_vol2/100).* Co_GdDTPABMA ;
Cm_GdDTPABMA =  ((K.*Co_DTTAm.*(1-pc_vol2./100)-K.*Cm_Gd+Cm_Gd+Co_DTPABMA.*pc_vol2./100)-
((K.*Co_DTTAm.*(1-pc_vol2./100)-K.*Cm_Gd+Cm_Gd+Co_DTPABMA.*pc_vol2/100).^2 - 4.*(1-
K).*(Cm_Gd.*Co_DTPABMA.*pc_vol2./100)).^(1/2))./(2.*(1-K))
R_total      =  R_DTTAm.*(Cm_Gd-Cm_GdDTPABMA)./Cm_Gd + R_DTPABMA.*(Cm_GdDTPABMA./Cm_Gd)
% ***                         OUTPUT                                ***
y(:,1) = R_total ;            % relxivité de la solution mélange (mM-1s-1)
return;
function [y]=Ki_parRMN(x,p) %\FWD=0; \DEFPAR(K1,K2,K3,K4,K5,deltaA0,deltaA1,deltaA2,deltaA3,deltaA4,
deltaA5,deltaB0,deltaB1,deltaB2,deltaB3,deltaB4,deltaB5,deltaC0,deltaC1,deltaC2,deltaC3,deltaC4,deltaC5,
deltaD0,deltaD1,deltaD2,deltaD3,deltaD4,deltaD5)\NARGOUT=4;
% **********************************************************
% Pour ligand du type H4L
% vingt quatre paramètres:
%   K1,K2,K3,K4, K5:constantes cumulatives betaHL/L, betaH2L/L,
%   betaH3L/L et betaH4L/L
%   deltaA0,deltaA1,deltaA2,deltaA3,deltaA4,deltaA5: déplacement chimique du CH3 pour les cinq espèces L4-
,HL3-,H2L2-,H3L-,H4L 
%   deltaB0,deltaB1,deltaB2,deltaB3,deltaB4,deltaB5: déplacement chimique des ethylènes liés aux acétates 
pour les cinq espèces L4-,HL3-,H2L2-,H3L-,H4
%   deltaC0,deltaC1,deltaC2,deltaC3,deltaC4,deltaC5: déplacement chimique des ethylènes-amines 
extérieures pour les cinq espèces L4-,HL3-,H2L2-,H3L-,H4
%   deltaD0,deltaD1,deltaD2,deltaD3,deltaD4,DeltaD5: déplacement chimique des ethylènes-amine centrale 
pour les cinq espèces L4-,HL3-,H2L2-,H3L-,H4
% INITIAL DATA CONTENTS:
% x(:,1) = pH de la solution
% y(:,4) = (DELTA) : déplacement chimique d'un proton d'une espèce (exemple,déplacement des protons CH3 
de l'espèce H4L
% CONDITIONS ON VISUALISEUR:
% - Nombre de variables indépendantes = 29
%            L.MORIGGI  - LOCIB - EPFL - 2007
% **********************************************************
% ------------       PARAMETERS       ----------------------
K1       = p(1);
K2       = p(2);
K3       = p(3);
K4       = p(4);
K5       = p(5);
deltaA0     = p(6);
deltaA1     = p(7);   
deltaA2     = p(8);
deltaA3     = p(9);     
deltaA4     = p(10);
deltaA5     = p(11);
deltaB0     = p(12);
deltaB1     = p(13);
deltaB2     = p(14);
deltaB3     = p(15);   
deltaB4     = p(16);
deltaB5     = p(17);
deltaC0     = p(18);
deltaC1     = p(19);     
deltaC2     = p(20);
deltaC3     = p(21);
deltaC4     = p(22);
deltaC5     = p(23);
deltaD0     = p(24);
deltaD1     = p(25);
deltaD2     = p(26);
deltaD3     = p(27);     
deltaD4     = p(28);
deltaD5     = p(29);
% ------------       VARIABLES DEPENDANTES ----------------
IT    = x(:,1);          % pH
% ------------       DEBUT DU CALCUL        ---------------
% *** INIT RESULTS (2 columns)
y  = NaN * ones(size(x,1),4);
aH = 10.^(-(IT)) ;
beta1 = K1 ;
beta2 = K1*K2 ;
beta3 = K1*K2*K3 ;
beta4 = K1*K2*K3*K4 ;
beta5 = K1*K2*K3*K4*K5 ;
p0 = 1./(1 + beta1*aH + beta2*aH.^2 + beta3*aH.^3 + beta4*aH.^4+ beta5*aH.^5);
deltaA = p0.*deltaA0 + beta1*p0.*aH.*deltaA1 + beta2*p0.*aH.^2*deltaA2 + beta3*p0.*aH.^3*deltaA3 + 
beta4*p0.*aH.^4*deltaA4 + beta5*p0.*aH.^5*deltaA5;
deltaB = p0.*deltaB0 + beta1*p0.*aH.*deltaB1 + beta2*p0.*aH.^2*deltaB2 + beta3*p0.*aH.^3*deltaB3 + 
beta4*p0.*aH.^4*deltaB4 + beta5*p0.*aH.^5*deltaB5;
deltaC = p0.*deltaC0 + beta1*p0.*aH.*deltaC1 + beta2*p0.*aH.^2*deltaC2 + beta3*p0.*aH.^3*deltaC3 + 
beta4*p0.*aH.^4*deltaC4 + beta5*p0.*aH.^5*deltaC5;
deltaD = p0.*deltaD0 + beta1*p0.*aH.*deltaD1 + beta2*p0.*aH.^2*deltaD2 + beta3*p0.*aH.^3*deltaD3 + 
beta4*p0.*aH.^4*deltaD4 + beta4*p0.*aH.^5*deltaD5;
% ***                         OUTPUT                                ***
y(:,1) = deltaA ;             % déplacement chimique observé pour le methyl 
y(:,2) = deltaB ;             % déplacement chimique observé pour les ethylènes liés aux acétates
y(:,3) = deltaC ;             % déplacement chimique observé pour les ethylènes-amines extérieures
y(:,4) = deltaD ;             % déplacement chimique observé pour les ethylènes-amine centrale
return;
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VI.1.4 Transmetallation of [Gd(DTTA-Me)(H2O)2]- with Zn2+ 
Table VI.1-4: Evolution of R
1
m
R
1,0
(T= 310 K; B = 1.41 T, 60 MHz; pH 7.0) versus time for 
[Gd(DTTA-Me)(H2O)2]- and [Gd(DTPA-BMA)(H2O)] complexes in presence of equimolar amounts 
of Zn2+ ions in phosphate buffer solution. Evolution of [Gd(DTTA-Me)(H2O)2]- in phosphate buffer 
solution without Zn2+ ions. 
[Gd(DTTA-Me)(H2O)2]- [Gd(DTPA-BMA)(H2O)] 
[Gd(DTTA-Me)(H2O)2]- without 
Zn2+ ions 
Time T1 1/T1m  R1m/R1,0 Time T1 1/T1m  R1m/R1,0 Time T1 1/T1m  R1m/R1,0 
min ms s-1 mM-1   min ms s-1 mM-1   min ms s-1 mM-1   
0 73.1 13.435 1.19 0 105 9.279 0.96 0 86.5 11.316 1 
13 80.6 12.162 1.07 20 95.2 10.259 1.06 12 85.6 11.437 1.01 
23 90 10.866 0.96 40 98.2 9.938 1.03 20 85.9 11.396 1.01 
27 94 10.393 0.92 61 108 9.014 0.93 27 86.1 11.369 1 
36 102 9.559 0.84 80 117 8.302 0.86 79 85.7 11.424 1.01 
44 107 9.101 0.8 100 121 8.019 0.83 131 85.5 11.451 1.01 
58 114 8.527 0.75 132 130 7.447 0.77 184 85.4 11.465 1.01 
71 119 8.158 0.72 166 135 7.162 0.74 236 85.2 11.492 1.02 
74 125 7.755 0.69 222 142 6.797 0.7 289 85.1 11.506 1.02 
87 130 7.447 0.66 277 148 6.512 0.67 341 85.1 11.506 1.02 
103 134 7.218 0.64 332 154 6.249 0.65 393 85.4 11.465 1.01 
118 138 7.001 0.62 387 159 6.044 0.63 446 85.4 11.465 1.01 
141 147 6.558 0.58 443 162 5.928 0.61 498 84.9 11.534 1.02 
153 151 6.378 0.56 498 167 5.743 0.59 550 85.1 11.506 1.02 
190 160 6.005 0.53 553 172 5.569 0.58 603 85 11.52 1.02 
227 169 5.672 0.5 609 178 5.373 0.56 655 84.9 11.534 1.02 
263 178 5.373 0.47 664 184 5.19 0.54 708 85 11.52 1.02 
299 185 5.16 0.46 719 189 5.046 0.52 760 85 11.52 1.02 
336 193 4.936 0.44 774 195 4.883 0.51 812 85.1 11.506 1.02 
372 199 4.78 0.42 830 201 4.73 0.49 865 84.9 11.534 1.02 
408 205 4.633 0.41 885 207 4.586 0.47 917 84.9 11.534 1.02 
444 212 4.472 0.4 940 214 4.428 0.46 969 84.7 11.561 1.02 
480 221 4.28 0.38 995 220 4.3 0.45 1022 84.8 11.547 1.02 
516 230 4.103 0.36 1051 226 4.18 0.43 1074 84.6 11.575 1.02 
553 239 3.939 0.35 1106 233 4.047 0.42 1127 84.7 11.561 1.02 
589 248 3.787 0.33 1161 240 3.922 0.41 1179 84.4 11.603 1.03 
981 362 2.517 0.22 1222 256 3.661 0.38 1231 84.4 11.603 1.03 
1013 372 2.443 0.22 1270 263 3.557 0.37 1284 84.5 11.589 1.02 
1078 390 2.319 0.2 1367 275 3.391 0.35 1336 84.6 11.575 1.02 
1142 408 2.206 0.19 1464 288 3.227 0.33 1388 84.5 11.589 1.02 
1206 426 2.102 0.19 1560 301 3.077 0.32 1441 84.2 11.631 1.03 
1271 443 2.012 0.18 1657 315 2.93 0.3 1493 84.3 11.617 1.03 
1335 459 1.934 0.17 1754 329 2.795 0.29 1545 84.2 11.631 1.03 
1357 475 1.86 0.16 1850 343 2.67 0.28 1598 84.2 11.631 1.03 
1425 493 1.783 0.16 1947 357 2.556 0.26 1650 84.1 11.646 1.03 
1494 511 1.712 0.15 2044 371 2.45 0.25 1703 84.3 11.617 1.03 
1563 529 1.645 0.15 2140 386 2.346 0.24 1755 84 11.66 1.03 
1632 547 1.583 0.14 2237 401 2.249 0.23 1807 84.1 11.646 1.03 
1700 564 1.528 0.14 2334 416 2.159 0.22 1860 84.3 11.617 1.03 
1769 581 1.476 0.13 2431 430 2.081 0.22 1912 84.3 11.617 1.03 
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1838 597 1.43 0.13 2527 450 1.977 0.2 1964 84 11.66 1.03 
1907 613 1.386 0.12 2624 460 1.929 0.2 2017 84 11.66 1.03 
1975 630 1.342 0.12 2721 480 1.838 0.19 2069 84.1 11.646 1.03 
2044 646 1.303 0.12 2817 490 1.796 0.19 2121 83.8 11.688 1.03 
2113 661 1.268 0.11 2914 510 1.716 0.18 2174 84.1 11.646 1.03 
2182 676 1.234 0.11 3011 530 1.642 0.17 2226 84.1 11.646 1.03 
2250 691 1.202 0.11 3107 540 1.607 0.17 2279 84 11.66 1.03 
2319 706 1.171 0.1 3204 560 1.541 0.16 2331 84.2 11.631 1.03 
2388 719 1.146 0.1 3301 580 1.479 0.15 2383 84.2 11.631 1.03 
2456 732 1.121 0.1 3398 590 1.45 0.15 2436 84.1 11.646 1.03 
2525 745 1.097 0.1 3494 610 1.394 0.14 2488 83.7 11.702 1.03 
2594 757 1.076 0.1 3591 630 1.342 0.14 2540 83.6 11.717 1.04 
2663 770 1.054 0.09 3688 650 1.293 0.13 2593 84 11.66 1.03 
2731 780 1.037 0.09 3784 660 1.27 0.13 2645 83.2 11.774 1.04 
2800 790 1.021 0.09 3833 670 1.248 0.13 2698 83.7 11.702 1.03 
2869 800 1.005 0.09 3929 690 1.204 0.12 2750 83.7 11.702 1.03 
2938 810 0.99 0.09 4026 710 1.163 0.12 2802 83.7 11.702 1.03 
3006 820 0.975 0.09 4123 730 1.125 0.12 2855 83.5 11.731 1.04 
3075 830 0.96 0.08 4220 740 1.106 0.11 2907 83.8 11.688 1.03 
3144 840 0.945 0.08 4316 760 1.071 0.11 2959 83.7 11.702 1.03 
3213 840 0.945 0.08 4413 780 1.037 0.11 3012 83.6 11.717 1.04 
3281 850 0.931 0.08 4510 800 1.005 0.1 3064 83.7 11.702 1.03 
3350 860 0.918 0.08 4606 820 0.975 0.1 3068 83.5 11.731 1.04 
3419 860 0.918 0.08 4703 840 0.945 0.1 3121 83.3 11.76 1.04 
3487 870 0.904 0.08 4800 860 0.918 0.1 3173 83.8 11.688 1.03 
3556 880 0.891 0.08 4896 870 0.904 0.09 3225 83.5 11.731 1.04 
3625 880 0.891 0.08 4993 900 0.866 0.09 3278 83.5 11.731 1.04 
VI.1.5 Search for Adduct Formation between [Gd(DTTA-Me)(H2O)2]− and L-lactate 
Table VI.1-5. Relaxivity 
1
m
r  (T = 298 K; B = 0.235 T, 10 MHz; pH 7.0) versus L-lactate equivalents 
for 1 mM solutions of [Gd(DTTA-Me)(H2O)2]-, and [Gd(DO3A)(H2O)2], [Gd(MBzDO3AM)(H2O)2]3-. 
L-lactate equivalent [Gd(DO3A)(H2O)2] [Gd(DTTA-Me)(H2O)2]- [Gd(MBzDO3AM)(H2O)2]3-  
  r1m r1m r1m 
   s-1 mM-1  s-1 mM-1  s-1 mM-1 
0.00 7 7.11 9.38 
0.24 - 7.02 - 
0.97 - 7.01 5.8 
1.49 - 7.04 - 
1.95 - 6.97 4.6 
5.00 5.7 - 4.28 
7.57 - 6.71 - 
10.00 5 - 4.25 
12.20 - 6.56 - 
20.00 4.4 - 4.2 
20.07 - 6.13 - 
30.33 - 5.60 - 
40.00 3.9 - 4.12 
40.08 - 5.47 - 
50.01 - 5.15 - 
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VI.2 APPENDIX TO CHAPTER III: EXPERIMENTAL DATA 
This chapter will be in french . 
La mise en place de la synthèse du composé {Ru[Ln2bpy-DTTA2(H2O)4]3}4- a demandé 
différentes expériences preliminaires. Elles sont résumées ci-dessous en deux tableaux.  
Le premier tableau (Table VI.1-1) indique les expériences effectuées sur le ligand dimethyl 
bipy. 
Le deuxième tableau (Table VI.2-2) indique les expériences effectuées sur le ligand 
bipyDTTA2H8. 
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Table VI.2-1: Bilan des manipes effectuées sur le dimethylbipy. 
TEST AVEC ET SANS SEL SUR DIMETHYLBIPY 
Métal Ligand L Conditions Observations Conclusions 
Ru(DMSO)4(Cl)2 dimethylbipy 2/3 H2O-1/3DMF 
Une nuit à 75°C et 
5h à 100°C 
 
- Après 3 min, légère coloration. 
- Après une nuit, coloration orangée. 
- Après 4h à 100°C, coloration orangée. 
- Présence de RuL3 et de RuL2 majoritairement, un sous 
produit non identifié. (spectre de masse) 
 
Ru(DMSO)4(Cl)2 dimethylbipy 2/3 H2O 
1/3DMF  
Une nuit à 75°C 
4 h à 100°C 
10 éq. NaCl  
- Après 3 min, légère coloration. 
- Après une nuit, coloration orangée. 
- Après 4h à 100°C, coloration orangée. 
- Présence de RuL3 et de RuL2 majoritairement, un sous 
produit non identifier (spectre de masse). 
- Présence de 10 équ. NaCl 
ne semble pas importuner la 
complexation du 
Ru(DMSO)4(Cl)2 
- RuII(TOS)2(H2O)6 dimethylbipy 2/3 H2O - Quasi instantanément, devient rouge sang. - Le métal RuII(TOS)2(H2O)6 
a une cinétique d’échange 
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1/3DMF 
Une nuit à 75°C 
4 h à 100°C 
- Après 20 min, solution rouge-noir. 
- Présence de RuL3 et de RuL2Cl majoritairement (spectre de 
masse). 
plus rapide que celle du 
Ru(DMSO)4(Cl)2. 
- RuII(TOS)2(H2O)6 dimethylbipy 2/3 H2O 
1/3DMF 
Une nuit à 75°C 
4 h à 100°C 
10 éq. NaCl 
- Quasi instantanément, devient rouge sang. 
- Après 20 min, solution rouge très foncé. 
- Présence de RuL3 et de RuL2, et d’une demi-douzaine 
d’autre sous produits.(spectre de masse). 
Les réactions avec 
RuII(TOS)2(H2O)6 sont 
sensibles à la présence des 
10 équ. de NaCl. Se limiter à 
utiliser NaOH ou KOH pour 
remonter le pH lors de la 
complexation des DTTA. 
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Table VI.2-2: Bilan des manipes effectuées pour établir la voie de synthèse du composé ruthenium(II) {Ru[Ln2bpy-DTTA2(H2O)4]3}4-. 
Métal Ligand L Conditions Observations Remarques Conclusions 
Fe(NH4)2(SO4)  
X 6 H2O 
Gd@BipyDTTA 
acide 
H2O OK Publication Bruno Livramento [Chemistry-A 
European Journal (2006) vol. 12 (4) pp. 989-
1003] 
 
Travail 2006      
Métal Ligand L Conditions Observations Remarques Conclusions 
- GdCl3 
- Ru(DMSO)4(Cl)2 
Gd@BipyDTTA 
acide 
MeOH/H2O  Pas de produit final. Manip pas poussée a fond ?  
Effectué par Angélique Sour et Bruno 
Livramento. 
 
- Ru(DMSO)4(Cl)2 BipyDTTA ester DMSO 100 °C 
NaOH/HCL 
NaBF4 et 
NaCF3SO3 
- Présence de RuL3, 
RuL2 et autre sous 
produits (spectre de 
masse) 
- Suivi par RMN 
- Ru catalyse la coupure CH2-N entre la 
pyridine et l’azote central du BipyDTTA 
ester. 
- A cette température, RuII se fait facilement 
réduire par résidu protique pour former du 
Ru0 ou peut former des oligomers Ru-O-Ru. 
Complexé avec le 
DTTA acide avec un 
Ln avant l’ajout de 
RuII.  
- RuII(TOS)2(H2O)6 Dimethylbipy H2O - 50°C  Rouge foncé. -Milieu de solvatation adéquat. -Refaire avec 
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2:30 h sous 
argon 
Présence de RuL3 
majoritairement. 
-RuIITOS2(H2O)6 réagit très rapidement avec 
les dimethylbipy. 
Gd@BipyDTTA 
acide. 
- GdCl3 
- RuII(TOS)2(H2O)6 
Gd@BipyDTTA
acide 
H2O (50°C) -
6h sous argon 
- Après 15 minutes à 
50°C, le Rouge foncé 
apparaît.  
 
- Problème à obtenir le spectre de masse 
(Na+, charges du composé,…). 
- Petit accident: excès de ruthénium. 
- Le metal RuII(TOS)2(H2O)6 est nettement 
plus réactif que Ru(DMSO)4(Cl)2. 
-Le RuII aqua est très 
prometteur. 
-Eviter le sodium pour 
faciliter la masse 
(résine d’échangeuse 
d’ion (Dowex50W), 
tampon (Et)3H2CO3). 
- GdCl3 
- RuII(TOS)2(H2O)6 
Gd@BipyDTTA 
acide 
H2O - sous 
argon une nuit 
à T ambiant + 
2 h à 60°C  
N(Et)3 
HCl 
 
- Après 5 min à T 
ambiant. Solution 
rose. 
- Après une nuit, 
légèrement plus rosé. 
-Après chauffage, 
rose plus intense. 
- pH ajusté avec N(Et)3  pour la complexation 
du bipy(DTTA)2 par Gd. 
-Triethylamine a coordonné le RuII ? 
- Problème de coordination dû aux Cl- ? 
-Aucun signal en electrospray, ni en malditoff 
différentes matrices (DHB, SA, CHCA, HPA, 
THAP). 
- Ne pas utiliser de 
N(Et)3.  
- Gd(TOs)3 Gd@BipyDTTA 
acide 
2/3 H2O -
1/3DMF 
- Après 10 min, sol. 
rouge claire. 
- Après adjonction du métal à la solution de 
ligand, une opacité apparaît (référence trouvée 
- Ne pas utiliser le 
Gd(TOS)3 - 
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- RuII(TOs)2(H2O)6 
(70°C) 
NaOH+KOH 
3h sous Argon 
- Après 20 min, rouge 
foncé. 
sur l’efficacité des Ln(TOS) à catalyser les 
réactions d’acetylations… 
- Les différents spectres de masse n’indiquent 
toujours rien… 
- Gd(TOS)3 obtenu en faisant réagir un excès 
d’oxyde de gadolinium GdO3 à de l’acide 
tosylique à 100°C pendant 1h30. Filtration de 
l’excès de GdO3. 
catalysateur de 
réaction d’acetylation. 
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Après avoir trouvé les conditions adéquates de synthèse du composé {Ru[Ln2bpy-
DTTA2(H2O)4]3}4-, une procédure a été établie et optimisée à l’aide du composé yttrium(III) 
pour la synthèse des composés lanthanides {Ru[Gd2bpy-DTTA2(H2O)4]3}4- et {Ru[Eu2bpy-
DTTA2(H2O)4]3}4-. Les deux sous-chapitres suivant (VI.2.1 et VI.2.2) sont la procédure 
théorique en prévision de la synthèse et pratique, lors de la synthèse. 
VI.2.1 Suivi théorique par RMN de la formation de RuII[Y2bipy(DTTA)2]3·Na4 
Solution YCl3: Solubiliser 780 mg YCl3*7H2O (MMYCl3*7H2O=195.27 +126.1 = 321.4g/mol, 
nYCl3 = 2.42 mmol) dans 2 g D2O. Obtention d’une solution YCl3 de concentration 870 
µmolY3+/gsolYCl3. 
Peser 100 mg de solution YCl3 (870 µmolY3+/gsolYCl3, nYCL3= 87.05 µmol) et titrer avec ~ 17.4 
ml EDTA 5 mM (nEDTA = 87.05 µmol) 
Solution bipyDTTA2: solubiliser 200 mg bipyDTTA2 acide (MMbipyDTTA22acide = 850.83 
g/mol, nbpyDTTA2acide = 235.1 µmol) dans 373.1 mg D2O. Obtention d’une solution de 
bipyDTTA2 de concentration 410 µmolbipyDTTA2acid/gsolbipy. 
Peser 20 mg de solution bipyDTTA2 acide (410 µmolbipyDTTA2acid/gsolbipy, nbpyDTTA2acide = 8.2 
µmol) et 25 mg de solution YCl3 (870.5 µmolY3+/gsolYCl3, nYCL3= 21.76 µmol) et titrer avec 
1.073 ml EDTA 5 mM (nEDTA = 5.36 µmol).  
Solution bipyDTTA2Y2: Additionner 452.2 – 461.2 mg de la solution YCl3 (870.5 
µmolY3+/gsolYCl3, nYCl3 = 393.6–401.5 µmol, 0-2% excès) à 480 mg de solution bipyDTTA2 
acide (410 µmolbipyDTTA2acid/gsolbipy, nbipyDTTA2 acide = 196.8 µmol). Peser le ballon. Remonter le 
pH (nH+= 2.165 mmol, ~11 équivalents bipyDTTA2) avec NaOD 13.6M (~158 µl, nNaOD = 
2.14 mmol) et NaOD 0.5M (~50 µl, 25 µmol) jusqu’à pH 5.5. Peser le ballon. Obtention 
d’une solution de bipyDTTA2Y2 de masse = ~1140.2 mg et de concentrations 172.6 
µmolbipyDTTA2acid/gsol et 345.2 µmolY3+/gsol. 
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Suivi RMN de la réaction : RuII(TOs)-22(H2O)6 + 3 [bipyDTTA2Y2]-→ 
[RuII(bipyDTTA2Y2)3]-4 
Solution RuII(TOS)-22(H2O)6: Peser 27.6 mg RuII(TOS)2(H2O)6 (MM= 551.56 g/mol, nRuII= 
50.0 µmol), fermé par un septum. Remplacer air par Argon. Injecter 300 mg D2O dégazés– 
obtention d’une solution de 327.6 mg de concentration 152.6 µmolRuII/gsolRuII. 
Solution [Ru(bipyDTTA2Y2)3]-4: Mélanger 300 mg de solution de bipyDTTA2Y2, (172.6 
µmolbipyDTTA2acid/gsol , nbipyDTTA2Y2 = 51.78 µmol) sous argon avec 111.99 – 113.1 mg de la 
solution de Ru(tos)2(H2O)6 (152.6 µmolRuII/gsolRuII, nRuII= 17.09 – 17.26 µmol, 1 – 0% déficit 
molaire de RuII par rapport à bipyDTTA2Y2).  
Tube RMN: Faire le vide à -20°C et sceller le tube RMN 3 contenant ~420 mg de milieu 
réactionnel (40.7 µmolRuII/gsol, 123.3 µmolbipyDTTA2acid/gsol). Suivi RMN 1H  - 400 MHz à 
298.15 K. 
VI.2.2 Suivi pratique par RMN de la formation de RuII[Y2bipy(DTTA)2]3·Na4 
ETAPE 1 : Solution de YCl3: 
Snapcup (10 ML, monocol) : ……………. g YCl3 (MMYCl3=195.27 g/mol, nYCl3 = 
……………. mmol) sont solubiliser dans ……………. g D2O. Obtention d’une solution YCl3 
de concentration ~ ……………. µmolY3+/gsolYCl3. 
Titrage :- 1 - Titré ……………. mg de solution YCl3 avec  …………….  ml EDTA 5 mM 
(nEDTA = ……………. µmol). Concentration obtenue : ……………. µmolY3+/gsolYCl3). - 2 - 
Titré ……………. mg de solution YCl3 avec ……………. ml EDTA 5 mM (nEDTA = 
……………. µmol). Concentration obtenue : ……………. µmolY3+/gsolYCl3). Concentration 
solution YCl3 : ……………. µmolY3+/gsolYCl3 
ETAPE 2 : Solution de bipyDTTA2 
Ballon 1 (10 ML, monocol, masse à sec sans bouchon = ……………. G)) : On mélange 
…………….  mg de bipyDTTA2 (poudre rose) (MMbipyDTTA2acid = 850.83 g/mol ; nbipyDTTA2acid 
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= ~……………. µmole, nDTTA = ~……………. µmole) à ………… g de D2O  → conc. 
DTTA ≈ ……………. µmolDTTA/gsolbipy 
Titrage : - 1 - On prélève ……………. mg de solution bipyDTTA2 acide (conc. DTTA : 
……………. µmolDTTA/gsolbipy, nDTTA = ~……………. µmole) et on ajoute 1.2 fois de 
solution d’YCl3 (……………. µmolY3+/gsolYCl3, nYCL3= ……………. µmol), donc 
……………. mg de solution d’YCl3. On titre avec ……………. ml EDTA 5 mM (nEDTA = 
……………. µmol). Obtention d’une sol. bipyDTTA acide de ……………. 
µmolbipyDTTA2acid/gsolbipy.. - 2 - On prélève ……………. mg de solution bipyDTTA2 acide 
(conc. DTTA : ……………. µmolDTTA/gsolbipy, nDTTA = ~……………. µmole) et on ajoute 1.2 
fois de solution d’YCl3 (……………. µmolY3+/gsolYCl3, nYCL3= ……………. µmol), donc 
……………. mg de solution d’YCl3. On titre avec ……………. ml EDTA 5 mM (nEDTA = 
……………. µmol). Obtention d’une sol. bipyDTTA acide de ……………. 
µmolbipyDTTA2acid/gsolbipy..- 3 - On prélève ……………. mg de solution bipyDTTA2 acide (conc. 
DTTA : ……………. µmolDTTA/gsolbipy, nDTTA = ~……………. µmole) et on ajoute 1.2 fois de 
solution d’YCl3 (……………. µmolY3+/gsolYCl3, nYCL3= ……………. µmol), donc 
……………. mg de solution d’YCl3. On titre avec ……………. ml EDTA 5 mM (nEDTA = 
……………. µmol). Concentration solution DTTA :……………. µmolDTTA/gsolbipy. Masse 
actuel du ballon 1 moins masse du ballon sec : …………….  g de solution. Nombre de mole 
de DTTA contenu dans le ballon : ……………. µmol DTTA 
ETAPE 3 : Solution de bipyDTTA2Y2 
Ballon 1 (10 ML, monocol) : Ajouter au ……………. g de solution de bipy contenu dans le 
ballon 1(nDTTA= ……………. µmol) 1-2% d’excès d’Yttrium ( nYCL3= ……………. µmol, 
……………. µmolY3+/gsolYCl3) ≈ ……………. g de solution deutéréeYCl3. Remonter le pH 
(nH+= …………….  mmol, ~6 équivalents DTTA) avec NaOD 13.6M (nNaOD = ……………. 
mmol, ~……………. µl,) et NaOD 0.5M (……………. µmol, ~……………. µl,) jusqu’à pH 
5.5. Masse actuel du ballon moins masse du ballon sec : …………….  g de solution. Nombre 
de mole de DTTA contenu dans le ballon : ……………. µmol DTTA. Nombre de mole de 
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bipyDTTA2 contenu dans le ballon : ……………. µmole bipyDTTA2. Concentration solution 
bipyDTTA2 :……………. µmolbipyDTTA2acid/gsolbipy 
Tube RMN (PP, 5MM) : Injecter 400 µl de la solution de bipyDTTA2Y2. Fermeture du tube 
avec capuchon plastique. Spectre RMN 1H - 400 MHz à 298.15 K – nom du fichier : 
……………. Masse actuel du ballon 1 moins masse du ballon sec : …………….  g de 
solution. Nombre de mole de bipyDTTA2 contenu dans le ballon : ……………. µmole 
bipyDTTA2. 
ETAPE 4 : Spectre 1H du Ru(TOS)2(H2O)6: 
BALLON 2 (5 ML, monocol) : Dégazer 1 ml D2O 
TUBE RMN 2 (PP, 5MM) : Solubiliser dans un tube RMN 5mm ~10 mg RuII(TOS)2(H2O)6 
(MM= 551.56 g/mol, nRuII= 9.1 µmol) dans 400 µl D2O dégazé. Concentration en RuII= ~22.7 
mM. Faire le vide et sceller le tube RMN 2. Spectre RMN 1H - 400 MHz à 298.15 K – nom 
du fichier : ……………. 
ETAPE 5 : Synthèse du RuII[(bipyDTTA2Y2)]34- : 
Dégazé 10 ml D2O 
BALLON 1: Dégazé la solution de bipyDTTA2Y2 (nombre de mole de bipyDTTA2Y2 : 
……….…. µmole). 
BALLON 3 (20 ML, monocol, masse à sec + septum = ……………. G) : On pèse du RuII pour 
avoir 1% déficit molaire de 1/3 bipyDTTA2  (nRuII= ……………. µmol, MM= 551.56 g/mol) 
=……………. mg RuII(TOS)2(H2O)6, dans un ballon fermé par un septum. Remplacé air par 
Argon. On injecte ~ 2 g D2O dégazés sur le RuII. On transfère par canule toute la solution de 
bipyDTTA2Y2. Masse actuel du ballon moins masse du ballon sec : …………….  g de 
solution. Nombre de mole de DTTA contenu dans le ballon : ……………. µmol DTTA. 
Nombre de mole de bipyDTTA2 contenu dans le ballon : ……………. µmole bipyDTTA2. 
Concentration solution bipyDTTA2 :……………. µmolbipyDTTA2acid/gsolbipy 
TUBE RMN (PP, 5MM) : On transfère par canule sous Argon ~ 500 mg de la solution de 
bipyDTTA2Y2RuII dans le tube RMN contenu dans un schlenk mis sous argon et on scelle le 
  Chapter VI. Appendix 
Thesis Loïck Moriggi  179 
tube RMN. Spectre RMN 1H  - 400 MHz à 298.15 K en chauffant périodiquement par bain 
marie à 100°C. 
BALLON 3 (5 ML, monocol, …………….  G) : On met le reste de la solution aussi sous 100°C 
toujours sous pression d’argon. Masse actuel du ballon 3 moins masse du ballon sec 
+septum : ……………. g de solution. Nombre de mole de bipyDTTA2 contenu dans le 
ballon : ……………. µmole bipyDTTA2. 
ETAPE 6 : Synthèse du RuII[(bipyDTTA2Y2)]34- : 
BALLON 4 (10 ML, monocol) : Faire une solution contenant 2 équivalents bipyDTTA2Y2  
(……………. µmole bipyDTTA2) de triethylamine (……………. µmole triethylamine, 
MM=101.19 g/mol, ……………. mg triethylamine) et 2 ml de D2O. Dégazé la la solution. 
BALLON 3 (20 ML, monocol, masse à sec + septum = ……………. G) : Après ~2 heures de 
réaction, ajouter par canule la solution du ballon 4 (2 équivalents bipyDTTA2Y2  de 
triethylamine  dégazée ) à la solution du ballon 3. 
TUBE RMN (PP, 5MM) : On transfère par canule sous Argon ~ 500 mg de la solution de 
bipyDTTA2Y2RuII dans le tube RMN contenu dans un schlenk mis sous argon et on scelle le 
tube RMN. Spectre RMN 1H  - 400 MHz à 298.15 K en chauffant périodiquement par bain 
marie à 100°C. 
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VI.2.3 {Ru[Gd2bpy-DTTA2(H2O)4]3}4- and {Fe[Gd2bpy-DTTA2(H2O)4]3}4- relaxivities 
(NMRDs)  
Table VI.2-3: Variable temperature proton relaxivity (r1/mM-1s-1) of {Ru[Gd2bpy-DTTA2(H2O)4]3}4- 
(cGd(III): 8.31 mM). Results for {Fe[Gd2bpy-DTTA2(H2O)4]3}4- come from Joao Bruno Figueiredo 
Livramento thesis. 
 
 
 
 
 Proton relaxivities r1 / mM-1s-1  
 {Ru[Gd2bpy-DTTA2(H2O)4]3}4- {Fe[Gd2bpy-DTTA2(H2O)4]3}4- 
ν (1H) / MHz 25°C 37°C 25°C 37° 
0.01 31.15 26.70 29.53 23.43 
0.01 31.10 26.50 29.57 23.48 
0.02 31.03 26.39 29.59 23.50 
0.03 31.16 26.52 29.62 23.49 
0.04 31.14 26.59 29.60 23.41 
0.06 31.11 26.50 29.61 23.39 
0.09 31.11 26.69 29.70 23.45 
0.13 31.19 26.70 29.60 23.35 
0.18 31.13 26.61 29.62 23.32 
0.26 31.08 26.48 29.45 23.31 
0.38 30.95 26.26 29.28 23.10 
0.55 30.70 26.17 28.80 22.93 
0.78 29.99 25.77 28.16 22.39 
1.13 29.26 25.09 27.19 21.77 
1.62 28.31 24.05 26.02 20.87 
2.34 26.76 22.49 24.56 19.77 
3.36 25.10 20.78 23.07 18.56 
4.83 23.83 19.42 22.16 17.35 
6.95 23.50 19.08 21.96 16.64 
8.0 23.91  22.38 16.86 
10.0 25.84 20.01 23.35 17.34 
12 27.66 21.02 24.51 17.89 
14 29.50 21.95 25.04 18.29 
16 31.12 22.68 26.04 19.13 
18 32.20 23.41 
 
27.03 20.17 
20 33.11 24.22 33.01 26.01 
30 34.90 28.77 33.62 26.49 
40 37.44 30.34 32.02 26.00 
60 34.64 28.88 33.16 26.83 
100 29.76 26.32 27.09 23.80 
200 16.17 16.40 16.37 15.85 
400 7.59 7.88 9.32 8.53 
800 4.25 4.05 5.96 5.82 
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VI.3 APPENDIX TO CHAPTER IV  
VI.3.1 Gd-DtNP(1), Gd-DtNP(2) anb Gd-DtNP(3) relaxivities (NMRD) 
Table VI.3-1: Variable temperature proton relaxivity (r1/mM-1s-1) of system Gd-DtNP(1) (cGd(III): 
0.378 mM), Gd-DTNP(2) (cGd(III): 0.015 mM) and Gd-DtNP(3) (cGd(III): 0.201 mM). 
  Proton relaxivities r1 / mM-1s-1  
 Gd-DTNP(1) Gd-DTNP(2) Gd-DTNP(3) 
ν (1H) / MHz 25°C 37°C 25°C 25°C 
0.01 45.81 44.28 - 43.73 
0.01 45.76 44.31 - 43.55 
0.02 45.56 44.16 - 43.70 
0.03 45.77 44.11 - 43.69 
0.04 45.74 44.19 - 43.62 
0.06 45.80 44.25 - 43.68 
0.09 45.49 44.16 - 43.57 
0.13 45.56 43.85 - 43.59 
0.18 45.36 43.87 - 43.29 
0.26 45.06 43.56 - 43.16 
0.38 44.68 43.00 - 42.11 
0.55 43.58 41.98 -- 41.32 
0.78 42.20 40.42 - 40.19 
1.13 39.77 38.85 - 38.56 
1.62 38.35 36.64 - 36.81 
2.34 36.01 34.67 - 34.90 
3.36 34.16 32.76 - 33.30 
4.83 32.99 31.00 - 32.81 
6.95 35.27 31.99 - 34.93 
10.0 41.13 36.38  - 40.54 
12 44.22 - - 44.79 
14 48.90 - - 47.78 
18 - - - 53.17 
20 54.61 - 48.94 55.94 
30 61.13 54.38 54.53 58.51 
40 59.16 53.35 52.15 54.76 
60 50.30 48.20 40.51 41.04 
100 32.75 - - - 
200 14.11 - - - 
400 
6.65 - - - 
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